Original Article
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
N Engl J Med 1996; 334:1150-1155May 2, 1996
- Abstract
Background
Lung cancer and cardiovascular disease are major causes of death in the United States. It has been proposed that carotenoids and retinoids are agents that may prevent these disorders.
Methods
We conducted a multicenter, randomized, double-blind, placebo-controlled primary prevention trial — the Beta-Carotene and Retinol Efficacy Trial — involving a total of 18,314 smokers, former smokers, and workers exposed to asbestos. The effects of a combination of 30 mg of beta carotene per day and 25,000 IU of retinol (vitamin A) in the form of retinyl palmitate per day on the primary end point, the incidence of lung cancer, were compared with those of placebo.
Results
A total of 388 new cases of lung cancer were diagnosed during the 73,135 person-years of follow-up (mean length of follow-up, 4.0 years). The active-treatment group had a relative risk of lung cancer of 1.28 (95 percent confidence interval, 1.04 to 1.57; P = 0.02), as compared with the placebo group. There were no statistically significant differences in the risks of other types of cancer. In the active-treatment group, the relative risk of death from any cause was 1.17 (95 percent confidence interval, 1.03 to 1.33); of death from lung cancer, 1.46 (95 percent confidence interval, 1.07 to 2.00); and of death from cardiovascular disease, 1.26 (95 percent confidence interval, 0.99 to 1.61). On the basis of these findings, the randomized trial was stopped 21 months earlier than planned; follow-up will continue for another 5 years.
Conclusions
After an average of four years of supplementation, the combination of beta carotene and vitamin A had no benefit and may have had an adverse effect on the incidence of lung cancer and on the risk of death from lung cancer, cardiovascular disease, and any cause in smokers and workers exposed to asbestos.
Media in This Article
Figure 1
Kaplan–Meier Curves of the Cumulative Incidence of Lung Cancer among Participants Receiving Active Treatment and Those Receiving Placebo.Figure 2
Kaplan–Meier Curves of the Cumulative Incidence of Death from All Causes and Confirmed Cardiovascular Causes among Participants Receiving Active Treatment and Those Receiving Placebo.Article Activity
- Article
Lung cancer is the leading cause of death from cancer in the United States, accounting for approximately 29 percent of deaths from cancer and 6 percent of all deaths.1 New approaches are essential to prevent lung cancer in persons who have smoked cigarettes or who have had occupational exposure to asbestos. Twenty-nine percent of men and 25 percent of women who are 45 to 64 years of age currently smoke,2 and at least 40 percent of men and 20 percent of women in this age group are former smokers.3 An estimated 4000 to 6000 deaths from lung cancer per year are attributed to exposure to asbestos.4,5
On the basis of epidemiologic observations and laboratory studies, beta carotene and vitamin A have attracted wide interest as agents that may prevent lung cancer.6-9 The Beta-Carotene and Retinol Efficacy Trial (CARET) is one of several recent trials to assess the chemopreventive efficacy and safety of beta carotene and related agents.10-13
This report presents interim efficacy results of the CARET study, which coincided with the announcement of the steering committee's decision on January 11, 1996, to stop the trial's active intervention. Follow-up for additional end points is expected to continue for another five years.
Methods
Study Design
The study's strategy, design, detailed methods, eligibility, pilot-study findings, and recruitment information have been published elsewhere.9,14-16 Briefly, CARET was organized in 1983 and began randomization in Seattle in 1985 in two pilot studies: one enrolled 816 men with substantial occupational exposure to asbestos, who were randomly assigned in a 1:1 ratio to receive either a combination of 15 mg of beta carotene per day and 25,000 IU of retinol per day (active treatment) or placebo; the second enrolled 1029 men and women with extensive histories of cigarette smoking, to receive 30 mg of beta carotene per day, 25,000 IU of retinol per day, both vitamins, or neither vitamin (two-by-two design). The trial was expanded to include additional study centers in 1988 and 1991, and all subjects were randomly assigned in a 1:1 ratio to either active treatment or placebo. The pilot groups receiving active agents were consolidated in 1988 into a single group receiving a standard daily regimen of 30 mg of beta carotene plus 25,000 IU of retinol in the form of retinyl palmitate. Thus, in the pilot study with the cohort of smokers, three subjects were assigned to active treatment for every subject assigned to placebo; therefore, the rates rather than numbers of end points must be compared between active and placebo groups. The design14 called for active intervention until late 1997 (110,000 person-years), with reporting of results in 1998.
Eligibility, Recruitment, and Randomization
Workers exposed to asbestos were men 45 to 74 years of age in the pilot study and 45 to 69 years of age in the later period of recruitment. To be eligible for the study the subjects had to have first been exposed to asbestos on the job 15 years before randomization, and either have had a chest x-ray film positive for asbestos-related lung disease or have worked in specified high-risk trades — as plumbers and pipe fitters, steamfitters, shipyard boilermakers, nonshipyard boilermakers, shipyard electricians, ship scalers, insulators, plasterboard workers, or sheet-metal workers — for 5 years. The asbestos pilot study had no requirements regarding smoking15; subsequently, subjects were required to be current smokers or to have smoked within the previous 15 years. For the population of smokers, women and men were recruited from health insurance rolls and managed-care organizations if they were 50 to 69 years of age, had at least 20 pack-years of cigarette smoking, and either were currently smoking or had quit smoking within the previous six years. The participants agreed to limit their supplemental intake of vitamin A to less than 5500 IU per day and to take no supplemental beta carotene. A total of 4060 workers exposed to asbestos and 14,254 heavy smokers (44 percent of whom were women) were randomized. We provided detailed information for informed consent at recruitment and regularly thereafter, including a letter to each participant describing the results of the 1994 Alpha-Tocopherol, Beta Carotene Cancer Prevention Study (ATBC).10
Active agents and placebos were purchased from Hoffmann–LaRoche and formulated by Tishcon Corporation. Both formulations were given as capsules. Beta carotene beadlets were combined with retinyl palmitate in a single capsule and dispensed in bottles, which were weighed and their contents checked. We assessed the subjects' compliance by weighing the returned bottles to estimate the number of capsules remaining (in 85 percent of the assessments) or by relying on the subjects' own estimates (15 percent). Blood was collected annually from the original pilot participants and every two years from the other participants.
Subjects who stopped receiving study vitamins for any reason other than death were defined as inactive participants and were still followed for end points and counted in the analyses.
Data Collection and Monitoring of Safety and End Points
Each year active participants visited a study center once and were telephoned twice, at four-month intervals. Inactive participants were telephoned semiannually. Over 97 percent of scheduled contacts were completed. As of December 15, 1995, ascertainment of vital status was more than 98 percent complete.
Symptoms and signs and newly diagnosed medical conditions were monitored closely by questionnaire at all contacts and in limited physical examinations during study-center visits; laboratory values for liver function and serum analytes were monitored annually in participants randomized in the pilot studies (for use in adjusting estimates of relative risk with the case–cohort approach).17 The 13 monitored symptoms were graded according to the CARET symptom-assessment scale.16 An independent safety and end-points monitoring committee met semiannually to review in blinded fashion data coded according to intervention group. When the results of the ATBC Cancer Prevention trial10 became available, the committee reviewed the results of the first interim analysis and requested that the blinding be ended. Subsequently, the committee reviewed data unblinded.
Ascertainment and Evaluation of End Points
All initial reports of cancers and deaths from each study center were submitted to the coordinating center and entered into a tracking system. Participants and all study staff members involved in the ascertainment and evaluation of end points and assignment of final diagnoses remained unaware of the participants' treatment assignment throughout the trial. Clinical records and, for tumors involving the lung, pathology specimens were obtained for independent review by the end-points review committee, composed of two oncologists, two internists, and a pathologist. An end point was considered confirmed when the end-point review process was completed. Through December 15, 1995, a total of 2420 end points had been reported: 1446 cancers (in 1353 participants) and 974 deaths. Of the initial reports of lung cancer for which the end-point–review process was completed, 90 percent were confirmed; most of the remainder were found to be metastases and recurrences.
Statistical Analysis
The primary analysis, based on the intention to treat, was designed to test for differences between treatment groups in the incidence of lung cancer with a weighted log-rank statistic stratified according to the risk group (workers exposed to asbestos or heavy smokers), time of recruitment (pilot study or subsequent period), and study center (six centers).14 Parameter estimates and the results of statistical tests were similar with and without the weighting; we present here the unweighted results. Estimates of relative risk and confidence intervals were obtained from stratified Cox regression models with the same strata as the log-rank statistics. The cumulative incidence of end points was plotted through 5 1/2 years of follow-up because of the small number of participants beyond that time and involved 354 participants with new cases of lung cancer, 829 deaths, and 67,449 person-years of follow-up. Follow-up for all participants began at randomization.
The prespecified monitoring policy for stopping the trial early because of a benefit or adverse effect of the study vitamins was based on O'Brien–Fleming boundaries18 applied to the weighted number of confirmed lung-cancer end points, the primary end point. The critical P values were those of 0.0006 or lower for the first interim analysis in 1994 and those of 0.007 or lower for the second interim analysis in 1995. Results are based on active intervention through December 15, 1995, at which time the 18,314 participants had accumulated 73,135 person-years of follow-up (mean, 4.0 years; median, 3.7).
Results
Characteristics of the Participants
The two randomized groups were well matched, with a high-risk profile for lung cancer and cardiovascular disease in both the smokers and the workers exposed to asbestos (Table 1Table 1
Risk Factors among the Participants at Base Line.). All smokers were encouraged and assisted, if willing, to stop smoking, and all former smokers were encouraged to maintain that status. Among current smokers, there was a net smoking-cessation rate of 5 percent per year.Through December 15, 1995, 15 percent of the workers exposed to asbestos who were assigned to active treatment became inactive participants, as compared with 14 percent of those assigned to placebo. The respective values in the group of heavy smokers were 20 percent and 19 percent. Among the active participants, the mean rates of capsule consumption were 93 percent through five years of follow-up, with no significant differences between treatment groups. The percentage of participants who took non–study-related supplemental beta carotene or vitamin A in doses of more than 5500 IU per day was low (2 percent and 1 percent, respectively). After five years of study supplementation, the median serum beta carotene concentration in the active-treatment group was 2100 ng per milliliter, as compared with 170 ng per milliliter in the placebo group; serum retinol levels were about 10 percent higher than those in the placebo group (P<0.01). Except for slight skin yellowing in some of those receiving beta carotene (0.3 percent had yellowing of grade 3 or higher on the CARET symptom-assessment scale),16 there were no differences of clinical importance between groups in any of the 13 monitored symptoms and signs, in tests of liver function, or in newly diagnosed conditions.
Incidence of Lung Cancer
The incidence of lung cancer was the primary end point. Through December 15, 1995, 388 participants — 2 percent of the total — were reported to have new cases of lung cancer (5.4 per 1000 person-years). In the case of 286, the end points were confirmed, whereas in the case of 102, further review by the end-points committee was pending. Among the 388, 254 had died. Five participants had two primary lung cancers each. The 388 participants represent 79 percent of the 490 participants projected in our statistical design to have lung cancer by the end of the intervention. The 73,135 person-years of follow-up accrued correspond to 66 percent of the total of 110,000 person-years projected.14
The active-treatment group had a relative risk of lung cancer of 1.28 (95 percent confidence interval, 1.04 to 1.57; P = 0.02), as compared with the placebo group (Table 2Table 2
Incidence and Estimated Relative Risk of Lung Cancer and Death from All Causes.). This result includes relative risks of 1.40 (95 percent confidence interval, 0.95 to 2.07) for workers exposed to asbestos, 1.42 (95 percent confidence interval, 1.07 to 1.87) for heavy smokers who were smoking at the time of randomization, and 0.80 (95 percent confidence interval, 0.48 to 1.31) for heavy smokers who were no longer smoking at the time of randomization. There was no statistical evidence of heterogeneity of the relative risk among these subgroups. Figure 1Figure 1Kaplan–Meier Curves of the Cumulative Incidence of Lung Cancer among Participants Receiving Active Treatment and Those Receiving Placebo. shows the cumulative incidence of lung cancer after randomization; the incidence in the active-treatment and placebo groups was virtually identical for the first 18 months. There was no statistically significant effect of the intervention on survival after the diagnosis of lung cancer (relative risk of survival after diagnosis of lung cancer in the active-treatment group as compared with the placebo group, 1.05; 95 percent confidence interval, 0.80 to 1.37).Incidence of Other Cancers
Active treatment had no statistically significant effect on the risk of mesothelioma. There were 23 cases: 14 in the active-treatment group and 9 in the placebo group. The remaining 1030 new cases of cancer (including the 300 prostate cancers, the second most common cancer in this population) were distributed nearly evenly between the two treatment groups.
Mortality Rates
As shown in Table 2 and Figure 2Figure 2
Kaplan–Meier Curves of the Cumulative Incidence of Death from All Causes and Confirmed Cardiovascular Causes among Participants Receiving Active Treatment and Those Receiving Placebo., the mortality rate was 17 percent higher in the active-treatment group than in the placebo group (P = 0.02). Among the population of heavy smokers, the relative risk was not significantly different between those who were smoking at the time of randomization and those who were no longer smoking at that time (relative risk, 1.15 vs. 1.06).Analysis according to the cause of death (confirmed causes only; n = 764) showed that in the active-treatment group, as compared with the placebo group, the relative risk of death from any cause was 1.18 (95 percent confidence interval, 1.02 to 1.37); of death from lung cancer, 1.46 (95 percent confidence interval, 1.07 to 2.00); and of death from cardiovascular causes (codes 390 to 459 and 798 of the International Classification of Diseases, 9th Revision, Clinical Modification), 1.26 (95 percent confidence interval, 0.99 to 1.61). As shown in Figure 2, there was no significant difference between treatment groups in the incidence of death from all causes during the first 24 months. A review of all causes of death revealed no additional statistically significant differences between the treatment groups.
Discussion
CARET was initiated in 1983 to test the hypothesis that beta carotene and vitamin A, through complementary antioxidant and differentiation-promoting actions and possibly through immunologic protective effects, could reduce the incidence of lung cancer in high-risk populations. The trial met high standards for accrual, efficiency, quality assurance, and ascertainment of end points. There have been no side effects attributable to the intervention regimen. The participants have shown a high level of commitment to the trial.
The results of the trial are troubling. There was no support for a beneficial effect of beta carotene or vitamin A, in spite of the large advantages inferred from observational epidemiologic comparisons of extreme quintiles or quartiles of dietary intake of fruits and vegetables or of dietary intake or serum levels of beta carotene or vitamin A.19,20 With 73,135 person-years of follow-up, the active-treatment group had a 28 percent higher incidence of lung cancer than the placebo group, and the overall mortality rate and the rate of death from cardiovascular causes were higher by 17 percent and 26 percent, respectively.
These results confirm and extend the unexpected results reported for beta carotene in the ATBC Cancer Prevention Study in Finland.10 We cannot distinguish the effects of beta carotene from those of vitamin A, since the two agents were administered in combination, under the hypothesis that they might have a favorable effect through complementary molecular actions.9
The second interim analysis led our safety and end-points monitoring committee and steering committee to recognize the extremely limited prospect of a favorable overall effect, as well as the possibility of true adverse effects. The decision to stop the intervention was made by the steering committee on January 11, 1996. It is possible that the excess mortality in the active-treatment group may have vanished or become statistically insignificant with completion of the intended intervention period plus several years of follow-up; such reversals of findings have occurred both in the course of a single large, randomized trial21,22 and in subsequent randomized trials of the same agent or class of agents.23-25 However, it was impossible to ignore the results of the ATBC Cancer Prevention Study10 in deciding whether to stop the active-intervention phase.
We have no explanation for the possible adverse associations that we have observed to date. There was no evidence of systemic toxicity in any organ from the vitamin A or, except for the expected skin yellowing, the beta carotene. The regimen did not produce clinically important hypertriglyceridemia.26 We considered continuing the trial with the retinyl palmitate alone; however, the need to rerandomize, the extended follow-up required, and the uncertainty about the involvement of the vitamin A made this plan infeasible.
In this trial, beta carotene treatment raised the median serum beta carotene levels to 12 times the base-line levels and the placebo group's median values. Such levels may conceivably be toxic or at least cause serious disequilibrium with other compounds important to redox relations or other cellular mechanisms. Beta carotene has been postulated to have a pro-oxidant effect under certain nonphysiologic conditions.27,28 One study reported that the administration of beta carotene drastically lowered vitamin E levels,29 but we30 and three other groups10,31,32 have found no such effect. In preliminary analyses of serum beta carotene levels during active treatment, we could find no support for the hypothesis that subjects with the highest serum levels of beta carotene were at greater risk for lung cancer or death from cardiovascular causes, cancer, or any cause.
The results of our study and the ATBC Cancer Prevention Study10 in populations at high risk for lung cancer and cardiovascular disease and the finding of the Physicians' Health Study11 of no benefit or harm after 12 years of beta carotene treatment clearly do not support the widely accepted conclusion drawn from observational epidemiologic studies that beta carotene is a primary component responsible for the association of lower risks of cancer and death from cardiovascular causes with high intakes of fruits and vegetables.19,33 Such studies typically compare extreme subgroups for such dietary features, ignoring or only crudely adjusting for many other potentially relevant variables, such as the intake of red meat, physical activity, life situations, and other behavior.20 The dietary associations seemed well matched to serum beta carotene measurements; as in other observational analyses, in our study base-line serum beta carotene levels were inversely correlated with the subsequent incidence of lung cancer in both groups. However, randomized prevention trials are needed to test the hypothesis that increased beta carotene intake can be protective.
The results of four large-scale chemoprevention trials of beta carotene and related agents can be summarized. The ATBC Cancer Prevention Study10 tested daily supplementation with 20 mg of beta carotene and 50 mg of alpha-tocopherol (two-by-two factorial design) in 29,133 male smokers. The Physicians' Health Study11 tested supplementation with 50 mg of beta carotene on alternate days in 22,071 male physicians, 50 percent of whom had never smoked, 39 percent of whom were former smokers, and 11 percent of whom were currently smoking. We tested daily supplementation with a combination of 30 mg of beta carotene and 25,000 IU of retinyl palmitate. Finally, a study conducted in Linxian, China,34 assessed the value of daily supplementation with a combination of 15 mg of beta carotene, 50 μg of selenium, and 30 mg of alpha-tocopherol as compared with three other combinations of vitamins and minerals in a complex factorial design in 29,584 adults presumed to be vitamin- and mineral-deficient — a very different population from those examined in the other studies. In the ATBC Cancer Prevention Study, 876 new cases of lung cancer were diagnosed, yielding a relative risk of lung cancer of 1.18 among subjects who received beta carotene (with or without alpha-tocopherol), as compared with those who did not. In the Physicians' Health Study, 170 new cases of lung cancer were diagnosed, for a relative risk of lung cancer of 0.93 among men taking beta carotene, as compared with those who received placebo. In our study, there were 388 new cases of lung cancer, yielding a relative risk of such cancer of 1.28 among the subjects who received beta carotene and retinyl palmitate, as compared with those who received placebo. The Linxian study did not report the incidence of lung cancer. Among the subjects who received beta carotene, the relative risk of death from any cause was 1.08 in the ATBC Cancer Prevention Study (3570 deaths), 1.01 in the Physicians' Health Study (1947 deaths), 1.17 in our trial (974 deaths), and 0.91 in the Linxian study (2127 deaths).
Reversing or overcoming lifelong metabolic or exogenous risk factors may require 5 to 10 years or more to account for the latent periods of cancers. Favorable effects may be particularly difficult to achieve in the face of a continuing carcinogenic and atherogenic assault in smokers; alternatively, antioxidants and antiproliferative agents might act on the constituents of cigarette smoke. Long-term follow-up both during and after active treatment with potential chemopreventive agents is essential if we are to have any hope of observing long-term benefits and evaluating long-term risks. During the postintervention follow-up of our study subjects, as end points continue to accrue, we will conduct laboratory analyses and analyze various subgroups, particularly former smokers.
Our findings provide important new information with respect to public policy and public health. When these results are combined with those from the ATBC Cancer Prevention Study10 and the Physicians' Health Study,11 they make it clear that there can be little enthusiasm about the efficacy or safety of supplemental beta carotene or vitamin A in efforts to reduce the burdens of cancer or heart disease in certain populations. However, we still recommend the dietary intake of fruits and vegetables.
Other agents that prevent lung cancer and coronary heart disease must be identified and subjected to rigorous trials of safety and efficacy. Meanwhile, to reduce the risk of these diseases we must rely primarily on three approaches: smoking cessation, prevention of smoking, and avoidance of occupational and environmental exposure to carcinogenic substances.
Supported by grants (U01 CA63673, U01 CA63674, U01 CA47989, U01 CA48200, U01 CA48203, U01 CA48196, and U01 CA52596) from the National Cancer Institute.
Other contributing authors were Carl Andrew Brodkin, M.D. (University of Washington, Seattle), Martin G. Cherniack, M.D. (Yale University, New Haven, Conn.), James E. Grizzle, Ph.D. (Fred Hutchinson Cancer Research Center, Seattle), Marjorie Perloff, M.D. (National Cancer Institute, Bethesda, Md.), and Linda Rosenstock, M.D., M.P.H. (University of Washington, Seattle).
We are indebted to the study subjects, staff members, and investigators; to the members of the safety and end-points monitoring committee over the past several years (Anthony Miller, Robert Bruce, Julie Buring, Frank Iber, and O. Dale Williams); and to our colleagues who provided data from the Physicians' Health Study.
Source Information
From the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle (G.S.O., G.E.G., M.D.T., S.B.); the Departments of Environmental Health and Medicine, University of Washington, Seattle (G.S.O., G.E.G., S.B., S.H.); the Swedish Hospital Tumor Institute, Seattle (G.E.G.); the Department of Medicine, University of California at San Francisco, San Francisco (J.B.); the Department of Medicine, Yale University, New Haven, Conn. (M.R.C.); Kaiser Permanente Center for Health Research, Portland, Oreg. (A.G., B.V.); the Department of Medicine, University of Maryland, Baltimore (J.P.K.); and the Department of Medicine and Cancer Center, University of California at Irvine, Orange (F.L.M., J.H.W.).
Address reprint requests to Dr. Omenn at the Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, 1124 Columbia–MP859, Seattle, WA 98104.
- References
References
1
Wingo PA ,Tong T ,Bolden S . Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30[Erratum, CA Cancer J Clin 1995;45:127-8.]
CrossRef | Web of Science | Medline2
Cigarette smoking among adults -- United States, 1991
Medline3
National Center for Health Statistics, Schoenborn CA, Boyd GM. Smoking and other tobacco use: United States, 1987. Vital and Health Statistics. Series 10. No. 169. Washington, D.C.: Government Printing Office, 1989. (DHHS publication no. (PHS) 89-1597.)
4
Nicholson WJ ,Perkel G ,Selikoff IJ . Occupational exposure to asbestos: population at risk and projected mortality -- 1980-2030. Am J Ind Med 1982;3:259-311
CrossRef | Medline5
Omenn GS ,Merchant J ,Boatman E , et al. Contribution of environmental fibers to respiratory cancer. Environ Health Perspect 1986;70:51-56
CrossRef | Web of Science | Medline6
Peto R ,Doll R ,Buckley JD ,Sporn MB . Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-208
CrossRef | Web of Science | Medline7
Greenwald P . NCI cancer prevention and control research. Prev Med 1993;22:642-660
CrossRef | Web of Science | Medline8
Lippman SM ,Benner SE ,Hong WK . Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res 1994;54:Suppl:2025s-2028s
Web of Science | Medline9
Omenn GS ,Goodman G ,Thornquist M , et al. The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994;54:Suppl:2038s-2043s
Web of Science | Medline10
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
Full Text | Web of Science | Medline11
Hennekens CH ,Buring JE ,Manson JE , et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149
Full Text | Web of Science | Medline12
Buring JE ,Hennekens CH . The Women's Health Study: summary of the study design. J Myocard Ischemia 1992;4:27-2913
Manson JE ,Gaziano JM ,Spelsberg A , et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale, design, and methods. Ann Epidemiol 1995;5:261-269
CrossRef | Medline14
Thornquist MD ,Omenn GS ,Goodman GE , et al. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Control Clin Trials 1993;14:308-324
CrossRef | Medline15
Omenn GS ,Goodman GE ,Thornquist MD , et al. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers. Cancer Epidemiol Biomarkers Prev 1993;2:381-387
Web of Science | Medline16
Goodman GE ,Omenn GS ,Thornquist MD ,Lund B ,Metch B ,Gylys-Colwell I . The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 1993;2:389-396
Web of Science | Medline17
Prentice RL . A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11
CrossRef | Web of Science18
Fleming TR ,Harrington DP ,O'Brien PC . Designs for group sequential tests. Control Clin Trials 1984;5:348-361
CrossRef | Medline19
Steinmetz KA ,Potter JD . Vegetables, fruit, and cancer. Cancer Causes Control 1991;2:325-57, 427
CrossRef | Web of Science | Medline20
Omenn GS . What accounts for the association of vegetables and fruit with lower incidence of cancers and coronary heart disease? Ann Epidemiol 1995;5:333-335
CrossRef | Medline21
ISIS-1 (First International Study of Infarct Survival) Collaborative Group
CrossRef | Web of Science | Medline22
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group
CrossRef | Web of Science | Medline23
Aspirin Myocardial Infarction Study Research Group
CrossRef | Web of Science24
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
Web of Science | Medline25
Yusuf S ,Sleight P ,Rossi P , et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67:132-14126
Omenn GS ,Goodman GE ,Thornquist M ,Brunzell JD . Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the β-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 1994;3:711-713
Web of Science | Medline27
Burton GW ,Ingold KU . β-Carotene: an unusual type of lipid antioxidant. Science 1984;224:569-573
CrossRef | Web of Science | Medline28
Krinsky NI . Actions of carotenoids in biological systems. Annu Rev Nutr 1993;13:561-587
CrossRef | Web of Science | Medline29
Xu MJ ,Plezia PM ,Alberts DS , et al. Reduction in plasma or skin α-tocopherol concentration with long-term oral administration of β-carotene in humans and mice. J Natl Cancer Inst 1992;84:1559-1565
CrossRef | Web of Science | Medline30
Goodman GE ,Metch BJ ,Omenn GS . The effect of long-term β-carotene and vitamin A administration on serum concentrations of α-tocopherol. Cancer Epidemiol Biomarkers Prev 1994;3:429-432
Web of Science | Medline31
Nierenberg DW ,Stukel TA ,Mott LA ,Greenberg ER . Steady-state serum concentration of α tocopherol not altered by supplementation with oral β-carotene. J Natl Cancer Inst 1994;86:117-120
CrossRef | Web of Science | Medline32
McLarty JW. An intervention trial in high-risk asbestos-exposed persons. In: Newell GR, Hong WK, eds. The biology and prevention of aerodigestive tract cancers. Vol. 320 of Advances in experimental medicine and biology. New York: Plenum Press, 1992:141-9.
33
Block G ,Patterson B ,Subar A . Fruit, vegetables, and cancer prevention: a review of the epidemiology evidence. Nutr Cancer 1992;18:1-29
CrossRef | Web of Science | Medline34
Blot WJ ,Li J-Y ,Taylor PR , et al. Nutrition intervention trials in Linxian, China. J Natl Cancer Inst 1993;85:1483-1492
CrossRef | Web of Science | Medline
- Citing Articles (947)
Citing Articles
1
Yangchao Luo, Qin Wang. 2012. Bioactive Compounds in Corn. , 85-103.
CrossRef2
Heather Greenlee. (2012) Natural Products for Cancer Prevention. Seminars in Oncology Nursing 28:1, 29-44
CrossRef3
Annia Galano, Ana Martínez. (2012) Capsaicin, a Tasty Free Radical Scavenger: Mechanism of Action and Kinetics. The Journal of Physical Chemistry B120113105357009
CrossRef4
Adriana Pérez-González, Annia Galano. (2012) On the Outstanding Antioxidant Capacity of Edaravone Derivatives through Single Electron Transfer Reactions. The Journal of Physical Chemistry B120113105220007
CrossRef5
Lawrence H. Kushi, Colleen Doyle, Marji McCullough, Cheryl L. Rock, Wendy Demark-Wahnefried, Elisa V. Bandera, Susan Gapstur, Alpa V. Patel, Kimberly Andrews, Ted Gansler, . (2012) American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians 62:1, 30-67
CrossRef6
Jodi Tinkel, Hamdy Hassanain, Samer J. Khouri. (2012) Cardiovascular Antioxidant Therapy. Cardiology in Review1
CrossRef7
Helena P. Y. Sin, David T. L. Liu, Dennis S. C. Lam. (2012) Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration. Acta Ophthalmologicano-no
CrossRef8
Jorge Rafael León-Carmona, Annia Galano. (2011) Uric and 1-Methyluric Acids: Metabolic Wastes or Antiradical Protectors?. The Journal of Physical Chemistry B111205141530003
CrossRef9
Charles S. Dela Cruz, Lynn T. Tanoue, Richard A. Matthay. (2011) Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine 32:4, 605-644
CrossRef10
Justin T. Wilkinson, Frederick W. Fraunfelder. (2011) Use of Herbal Medicines and Nutritional Supplements in Ocular Disorders. Drugs 71:18, 2421-2434
CrossRef11
S. Briancon, S. Boini, S. Bertrais, F. Guillemin, P. Galan, S. Hercberg. (2011) Long-term antioxidant supplementation has no effect on health-related quality of life: The randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. International Journal of Epidemiology 40:6, 1605-1616
CrossRef12
Barbara Kitchenham, Dag I.K. Sjøberg, Tore Dybå, Dietmar Pfahl, Pearl Brereton, David Budgen, Martin Höst, Per Runeson. (2011) Three Empirical Studies on the agreement of reviewers about the Quality of Software Engineering Experiments. Information and Software Technology
CrossRef13
Michael E. Andrades, Rodrigo Lorenzi. 2011. Oxidative Stress in Cardiovascular Diseases. , 153-166.
CrossRef14
Ying Li, Paul Héroux, Igor Kyrychenko. (2011) Metabolic restriction of cancer cells in vitro causes karyotype contraction—an indicator of cancer promotion?. Tumor Biology
CrossRef15
Neha Agnihotri, P. C. Mishra. (2011) Scavenging Mechanism of Curcumin Toward the Hydroxyl Radical: A Theoretical Study of Reactions Producing Ferulic Acid and Vanillin. The Journal of Physical Chemistry A111116102620005
CrossRef16
Hye In Kim, Kyunga Kim, Jung Eun Lee. (2011) Evaluating adherence to recommended diets among cancer patients. Supportive Care in Cancer
CrossRef17
Annia Galano, Juan Raúl Alvarez-Idaboy, Misaela Francisco-Márquez. (2011) Physicochemical Insights on the Free Radical Scavenging Activity of Sesamol: Importance of the Acid/Base Equilibrium. The Journal of Physical Chemistry B 115:44, 13101-13109
CrossRef18
Danielle N. Margalit, Julie L. Kasperzyk, Neil E. Martin, Howard D. Sesso, John. Michael Gaziano, Jing Ma, Meir J. Stampfer, Lorelei A. Mucci. (2011) Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians’ Health Study. International Journal of Radiation Oncology*Biology*Physics
CrossRef19
Young-Jee Jeon, Seung-Kwon Myung, Eun-Hyun Lee, Yeol Kim, Yoon Jung Chang, Woong Ju, Hong-Jun Cho, Hong Gwan Seo, Bong Yul Huh. (2011) Effects of Beta-Carotene Supplements on Cancer Prevention: Meta-Analysis of Randomized Controlled Trials. Nutrition and Cancer111007072326003
CrossRef20
Staffan C. Andersson, Kimmo Rumpunen, Eva Johansson, Marie E. Olsson. (2011) Carotenoid content and composition in rose hips (Rosa spp.) during ripening, determination of suitable maturity marker and implications for health promoting food products. Food Chemistry 128:3, 689-696
CrossRef21
Daniel Pens Gelain, Matheus Augusto de Bittencourt Pasquali, Fernanda Freitas Caregnato, José Claudio Fonseca Moreira. (2011) Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation. Toxicology 289:1, 38-44
CrossRef22
Hans Konrad Biesalski, Peter J. Aggett, Robert Anton, Paul S. Bernstein, Jeffrey Blumberg, Robert P. Heaney, Jeya Henry, John M. Nolan, David P. Richardson, Ben van Ommen, Renger F. Witkamp, Ger T. Rijkers, Iris Zöllner. (2011) 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition. Nutrition 27:10, S1-S20
CrossRef23
Patrick Borel. (2011) Genetic variations involved in interindividual variability in carotenoid status. Molecular Nutrition & Food Researchn/a-n/a
CrossRef24
Masashi Miyazaki, Yasufumi Doi, Fumie Ikeda, Toshiharu Ninomiya, Jun Hata, Kazuhiro Uchida, Tomoko Shirota, Takayuki Matsumoto, Mitsuo Iida, Yutaka Kiyohara. (2011) Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study. Gastric Cancer
CrossRef25
W.-P. Koh, J.-M. Yuan, R. Wang, Y.-P. Lee, B.-L. Lee, M.C. Yu, C.-N. Ong. (2011) Plasma carotenoids and risk of acute myocardial infarction in the Singapore Chinese Health Study. Nutrition, Metabolism and Cardiovascular Diseases 21:9, 685-690
CrossRef26
Koichi Sugamura, John F. Keaney,. (2011) Reactive oxygen species in cardiovascular disease. Free Radical Biology and Medicine 51:5, 978-992
CrossRef27
Florian Strasser, An Broek, Aminah Jatoi. (2011) An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer. Supportive Care in Cancer
CrossRef28
Piya Paul, Punit Bansal, Pawan G. Nayak, Steve Thomas Pannakal, K.I. Priyadarsini, M.K. Unnikrishnan. (2011) Polyphenolic fraction of Pilea microphylla (L.) protects Chinese hamster lung fibroblasts against γ-radiation-induced cytotoxicity and genotoxicity. Environmental Toxicology and Pharmacology
CrossRef29
Vikram Sinai Talaulikar, Timothy Chambers, Isaac Manyonda. (2011) Exploiting the antioxidant potential of a common vitamin: Could vitamin C prevent postmenopausal osteoporosis?. Journal of Obstetrics and Gynaecology Researchno-no
CrossRef30
Fritz Böhm, Ruth Edge, George Truscott. (2011) Interactions of dietary carotenoids with activated (singlet) oxygen and free radicals: Potential effects for human health. Molecular Nutrition & Food Researchn/a-n/a
CrossRef31
J. C. Stevenson, H. N. Hodis, J. H. Pickar, R. A. Lobo. (2011) HRT and breast cancer risk: a realistic perspective. Climacteric1-4
CrossRef32
Prasanthi Karna, Sharmeen Chagani, Sushma R. Gundala, Padmashree C. G. Rida, Ghazia Asif, Vibhuti Sharma, Meenakshi V. Gupta, Ritu Aneja. (2011) Benefits of whole ginger extract in prostate cancer. British Journal of Nutrition1-12
CrossRef33
Toru Nyunoya, Thomas H. March, Yohannes Tesfaigzi, JeanClare Seagrave. (2011) Antioxidant Diet Protects Against Emphysema, but Increases Mortality in Cigarette Smoke-Exposed Mice. COPD: Journal of Chronic Obstructive Pulmonary Disease110811095900002
CrossRef34
Annia Galano, Dun Xian Tan, Russel J. Reiter. (2011) Melatonin as a natural ally against oxidative stress: a physicochemical examination. Journal of Pineal Research 51:1, 1-16
CrossRef35
Anette Karlsen, Mette Svendsen, Ingebjørg Seljeflot, Mary-Ann Sommernes, Joseph Sexton, Asgeir Brevik, Iris Erlund, Mauro Serafini, Nasser Bastani, Siv Fagertun Remberg, Grethe I. Borge, Monica Hauger Carlsen, Siv Kjølsrud Bøhn, Mari C. Myhrstad, Lars O. Dragsted, Asim K. Duttaroy, Karin Haffner, Petter Laake, Christan A. Drevon, Harald Arnesen, Andrew Collins, Serena Tonstad, Rune Blomhoff. (2011) Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers. British Journal of Nutrition 106:04, 557-571
CrossRef36
Xia Zhang, Wen-en Zhao, Liqiang Hu, Lei Zhao, Jinyong Huang. (2011) Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells. Archives of Biochemistry and Biophysics 512:1, 96-106
CrossRef37
Xiangwei Wu, Sherri Patterson, Ernest Hawk. (2011) Chemoprevention – History and general principles. Best Practice & Research Clinical Gastroenterology 25:4-5, 445-459
CrossRef38
Kuanrong Li, Rudolf Kaaks, Jakob Linseisen, Sabine Rohrmann. (2011) Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg). European Journal of Nutrition
CrossRef39
T. Bergstrom, J. Bergman, L. Moller. (2011) Vitamin A and C compounds permitted in supplements differ in their abilities to affect cell viability, DNA and the DNA nucleoside deoxyguanosine. Mutagenesis
CrossRef40
Joseph Levy, Yoav Sharoni. 2011. The Inside-Out Concept as Complement to the Use of Topical Sunscreen: The Case for Endogenous Skin Photoprotection from Sunlight by Natural Dietary Actives such as Tomato Carotenoids. , 313-327.
CrossRef41
Annia Galano, Misaela Francisco-Márquez, Juan R. Alvarez-Idaboy. (2011) Canolol: A Promising Chemical Agent against Oxidative Stress. The Journal of Physical Chemistry B 115:26, 8590-8596
CrossRef42
Michael Ristow, Sebastian Schmeisser. (2011) Extending life span by increasing oxidative stress. Free Radical Biology and Medicine 51:2, 327-336
CrossRef43
Marcos R. de Oliveira, Ricardo F. da Rocha, José C. F. Moreira. (2011) Increased susceptibility of mitochondria isolated from frontal cortex and hippocampus of vitamin A-treated rats to non-aggregated amyloid-β peptides 1-40 and 1-42. Acta Neuropsychiatricano-no
CrossRef44
Colleen G. Le Prell, David F. Dolan, David C. Bennett, Peter A. Boxer. (2011) Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss. Translational Research 158:1, 54-70
CrossRef45
Eun-Jung Rhee, Shriram Nallamshetty, Jorge Plutzky. (2011) Retinoid metabolism and its effects on the vasculature. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
CrossRef46
Rebeca Martínez-Tomás, Elvira Larqué, Daniel González-Silvera, María Sánchez-Campillo, María Isabel Burgos, Anna Wellner, Soledad Parra, Lucy Bialek, Marie Alminger, Francisca Pérez-Llamas. (2011) Effect of the consumption of a fruit and vegetable soup with high in vitro carotenoid bioaccessibility on serum carotenoid concentrations and markers of oxidative stress in young men. European Journal of Nutrition
CrossRef47
Tommaso Gori, Thomas Münzel. (2011) Oxidative stress and endothelial dysfunction: Therapeutic implications. Annals of Medicine 43:4, 259-272
CrossRef48
G. Martano, C. Vogl, E. Bojaxhi, N. Bresgen, P. Eckl, H. Stutz. (2011) Solid-phase extraction and GC-MS analysis of potentially genotoxic cleavage products of β-carotene in primary cell cultures. Analytical and Bioanalytical Chemistry 400:8, 2415-2426
CrossRef49
Pedro L. Prieto-Hontoria, Patricia Pérez-Matute, Marta Fernández-Galilea, Matilde Bustos, J. Alfredo Martínez, María J. Moreno-Aliaga. (2011) Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807:6, 664-678
CrossRef50
Yuri Kim, Nalinee Chongviriyaphan, Chun Liu, Robert M. Russell, Xiang-Dong Wang. (2011) Combined α-tocopherol and ascorbic acid protects against smoke-induced lung squamous metaplasia in ferrets. Lung Cancer
CrossRef51
B Freidlin, E L Korn. (2011) Assessing causal relationships between treatments and clinical outcomes: always read the fine print. Bone Marrow Transplantation
CrossRef52
Satoshi Hori, Elizabeth Butler, John McLoughlin. (2011) Prostate cancer and diet: food for thought?. BJU International 107:9, 1348-1359
CrossRef53
Elizabeth K. Lund, Nigel J. Belshaw, Giles O. Elliott, Ian T. Johnson. (2011) Recent advances in understanding the role of diet and obesity in the development of colorectal cancer. Proceedings of the Nutrition Society 70:02, 194-204
CrossRef54
Joshua H. Olson, Jay C. Erie, Sophie J. Bakri. (2011) Nutritional Supplementation and Age-Related Macular Degeneration. Seminars in Ophthalmology 26:3, 131-136
CrossRef55
S.-Y. Park, S. P. Murphy, L. R. Wilkens, B. E. Henderson, L. N. Kolonel. (2011) Multivitamin Use and the Risk of Mortality and Cancer Incidence: The Multiethnic Cohort Study. American Journal of Epidemiology 173:8, 906-914
CrossRef56
2011. References. , 481-517.
CrossRef57
John Cannell. (2011) Era or error?. Public Health Nutrition 14:04, 743
CrossRef58
Volker Böhm. 2011. Analysis of Carotenoids. , 199-210.
CrossRef59
Lori C. Sakoda, Melissa M. Loomis, Jennifer A. Doherty, Marian L. Neuhouser, Matt J. Barnett, Mark D. Thornquist, Noel S. Weiss, Gary E. Goodman, Chu Chen. (2011) Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes & Control 22:3, 449-461
CrossRef60
Claudia I. Henschke, Paolo Boffetta, Olga Gorlova, Rowena Yip, John O. DeLancey, Millennia Foy. (2011) Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 71:3, 328-332
CrossRef61
James P. Marcin, Nathan Kuppermann, Daniel J. Tancredi, Nicole S. Glaser. (2011) Insulin administration for treatment of pediatric diabetic ketoacidosis: Are lower rates of infusion beneficial?*. Pediatric Critical Care Medicine 12:2, 217-219
CrossRef62
Xiaohui Cui, Bernard Rosner, Walter C. Willett, Susan E. Hankinson. (2011) Antioxidant intake and risk of endometrial cancer: Results from the Nurses' Health Study. International Journal of Cancer 128:5, 1169-1178
CrossRef63
Michelle D. Shardell, Dawn E. Alley, Gregory E. Hicks, Samer S. El-Kamary, Ram R. Miller, Richard D. Semba, Luigi Ferrucci. (2011) Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. Nutrition Research 31:3, 178-189
CrossRef64
U. Van der Velden, D. Kuzmanova, I. L. C. Chapple. (2011) Micronutritional approaches to periodontal therapy. Journal of Clinical Periodontology 38, 142-158
CrossRef65
Shu-Ting Chan, Cheng-Hung Chuang, Chiao-Lin Yeh, Jiunn-Wang Liao, Kai-Li Liu, Miao-Ju Tseng, Shu-Lan Yeh. (2011) Quercetin supplementation suppresses the secretion of pro-inflammatory cytokines in the lungs of Mongolian gerbils and in A549 cells exposed to benzo[a]pyrene alone or in combination with β-carotene: in vivo and ex vivo studies. The Journal of Nutritional Biochemistry
CrossRef66
Adriana Pérez-González, Annia Galano. (2011) OH Radical Scavenging Activity of Edaravone: Mechanism and Kinetics. The Journal of Physical Chemistry B 115:5, 1306-1314
CrossRef67
Maria Marino, Roberta Masella, Pamela Bulzomi, Ilaria Campesi, Walter Malorni, Flavia Franconi. (2011) Nutrition and human health from a sex–gender perspective. Molecular Aspects of Medicine 32:1, 1-70
CrossRef68
Ian Yat Hin Wong, Simon Chi Yan Koo, Clement Wai Nang Chan. (2011) Prevention of age-related macular degeneration. International Ophthalmology 31:1, 73-82
CrossRef69
Shahin Gharakhanian, Donald P Kotler. (2011) Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think?. AIDS 25:4, 531-533
CrossRef70
X. Liu, M. Nugoli, J. Laferriere, S. M. Saleh, I. G. Rodrigue-Gervais, M. Saleh, M. Park, M. T. Hallett, W. J. Muller, V. Giguere. (2011) Stromal retinoic acid receptor promotes mammary gland tumorigenesis. Proceedings of the National Academy of Sciences 108:2, 774-779
CrossRef71
Jenn-Huei Lii, Fu-Xing Liao, Ching-Han Hu. (2011) Accurate prediction of the enthalpies of formation for xanthophylls. Journal of Computational Chemistryn/a-n/a
CrossRef72
Sayaka TAKEDA, Mamoru KIMURA, Ranko MARUSHIMA, Ayako TAKEUCHI, Kazue TAKIZAWA, Yuji OGINO, Yasunobu MASUDA, Masaaki KUNOU, Mineo HASEGAWA, Chizuko MARUYAMA. (2011) Mayonnaise Contributes to Increasing Postprandial Serum β-Carotene Concentration through the Emulsifying Property of Egg Yolk in Rats and Humans. Journal of Nutritional Science and Vitaminology 57:3, 209-215
CrossRef73
Hélder D. Silva, Miguel A. Cerqueira, Bartolomeu W.S. Souza, Clara Ribeiro, Maria C. Avides, Mafalda A.C. Quintas, Jane S.R. Coimbra, Maria G. Carneiro-da-Cunha, António A. Vicente. (2011) Nanoemulsions of β-carotene using a high-energy emulsification–evaporation technique. Journal of Food Engineering 102:2, 130-135
CrossRef74
Azusa Hara, Shizuka Sasazuki, Manami Inoue, Taichi Shimazu, Motoki Iwasaki, Norie Sawada, Taiki Yamaji, Junko Ishihara, Hiroyasu Iso, Shoichiro Tsugane, . (2011) Use of vitamin supplements and risk of total cancer and cardiovascular disease among the Japanese general population: A population-based survey. BMC Public Health 11:1, 540
CrossRef75
Annia Galano, Misaela Francisco-Márquez, J. Raúl Alvarez-Idaboy. (2011) Mechanism and kinetics studies on the antioxidant activity of sinapinic acid. Physical Chemistry Chemical Physics 13:23, 11199
CrossRef76
R. C. Patra, Amiya K. Rautray, D. Swarup. (2011) Oxidative Stress in Lead and Cadmium Toxicity and Its Amelioration. Veterinary Medicine International 2011, 1-9
CrossRef77
Anita Jerome-Morais, Alan M. Diamond, Margaret E. Wright. (2011) Dietary supplements and human health: For better or for worse?. Molecular Nutrition & Food Research 55:1, 122-135
CrossRef78
Ather Ali, Yuka Yazaki, Valentine Y Njike, Yingying Ma, David L Katz. (2011) Effect of fruit and vegetable concentrates on endothelial function in metabolic syndrome: A randomized controlled trial. Nutrition Journal 10:1, 72
CrossRef79
Charles H Hennekens, David DeMets. (2011) Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions. Clinical Investigation 1:1, 53-57
CrossRef80
Yoon Jung Chang, Seung-Kwon Myung, Sung Tae Chung, Yeol Kim, Eun-Hyun Lee, Young-Jee Jeon, Chang-Hae Park, Hong Gwan Seo, Bong Yul Huh. (2011) Effects of Vitamin Treatment or Supplements with Purported Antioxidant Properties on Skin Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials. Dermatology 223:1, 36-44
CrossRef81
I. T. Johnson. 2011. Anti-tumour properties of functional foods. , 202-233.
CrossRef82
Hussein A. N. Al-Wadei, Mohammad F. Ullah, Mohammed Al-Wadei. (2011) GABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: A review of experimental evidence. Molecular Nutrition & Food Researchn/a-n/a
CrossRef83
B. Poljsak. (2011) Strategies for Reducing or Preventing the Generation of Oxidative Stress. Oxidative Medicine and Cellular Longevity 2011, 1-15
CrossRef84
Bryan Corrin, Andrew G. Nicholson. 2011. Tumours. , 531-705.
CrossRef85
Bryan Corrin, Andrew G. Nicholson. 2011. Pulmonary manifestations of systemic disease. , 471-507.
CrossRef86
Ross L. Prentice. (2010) Chronic Disease Prevention Research Methods and Their Reliability, With Illustrations From the Women’s Health Initiative. Journal of the American Statistical Association 105:492, 1431-1443
CrossRef87
Miguel A. Rubio. (2010) Dieta y prevención de enfermedad coronaria. Clínica e Investigación en Arteriosclerosis 22, 58-69
CrossRef88
M. G. Soni, T. S. Thurmond, E. R. Miller, T. Spriggs, A. Bendich, S. T. Omaye. (2010) Safety of Vitamins and Minerals: Controversies and Perspective. Toxicological Sciences 118:2, 348-355
CrossRef89
S. Sahni, E. S. Zoltick, R. R. McLean, M. T. Hannan. (2010) Non-D Vitamins and Bone Health in Adults. IBMS BoneKEy 7:12, 431-446
CrossRef90
Alberto Ruano-Raviña, Mónica Pérez-Ríos, Juan Barros-Dios. 2010. Plants Antioxidants and Lung Cancer Risk. , 455-469.
CrossRef91
Ma_gorzata Nogala-Ka_ucka. 2010. Lipophilic Vitamins. , 135-161.
CrossRef92
Rohini Vishwanathan, Candice M. Gendron, Elizabeth F. Goodrow-Kotyla, Thomas A. Wilson, Robert J. Nicolosi. (2010) Increased consumption of dietary cholesterol, lutein, and zeaxanthin as egg yolks does not decrease serum concentrations and lipoprotein distribution of other carotenoids, retinol, and tocopherols. Nutrition Research 30:11, 747-755
CrossRef93
Ana Martínez, Rubicelia Vargas, Annia Galano. (2010) Theoretical study on the chemical fate of adducts formed through free radical addition reactions to carotenoids. Theoretical Chemistry Accounts 127:5-6, 595-603
CrossRef94
Serge Hercberg, Emmanuelle Kesse-Guyot, Nathalie Druesne-Pecollo, Mathilde Touvier, Alain Favier, Paule Latino-Martel, Serge Briançon, Pilar Galan. (2010) Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the SU.VI.MAX Study. International Journal of Cancer 127:8, 1875-1881
CrossRef95
2010. Micronutrients for Improvement of the Standard Therapy in Cancer. , 133-166.
CrossRef96
2010. Micronutrients in Cancer Prevention. , 103-131.
CrossRef97
2010. Scientific Rationale of Current Trends in Clinical Studies of Micronutrients for Prevention of Chronic Diseases. , 23-34.
CrossRef98
2010. Micronutrients in Healthy Aging. , 35-53.
CrossRef99
Nathan Bushue, Yu-Jui Yvonne Wan. (2010) Retinoid pathway and cancer therapeutics. Advanced Drug Delivery Reviews 62:13, 1285-1298
CrossRef100
Kyung-Jin Yeum, Robert M. Russell, Giancarlo Aldini. 2010. Antioxidant Activity and Oxidative Stress: An Overview. , 3-19.
CrossRef101
TOM G. HANSEN, STEEN W. HENNEBERG, NEIL S. MORTON, KAARE CHRISTENSEN, ANDREW J. DAVIDSON, KATHERINE J. LEE, POLLYANNA HARDY, ANDREW WOLF. (2010) Pro-Con Debate: Pro-con debate: cohort studies vs the randomized clinical trial methodology in pediatric anesthesia. Pediatric Anesthesia 20:9, 880-894
CrossRef102
Helman S. Alfonso, Alison Reid, Nicholas H. de Klerk, Nola Olsen, Robin Mina, Gina L. Ambrosini, John Beilby, Geoffrey Berry, Bill A.W. Musk. (2010) Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia. European Journal of Cancer Prevention 19:5, 355-359
CrossRef103
Alfredo Morabia, Michael C. Costanza. (2010) Vitamin D as in different. Preventive Medicine 51:3-4, 195-196
CrossRef104
Koji Suzuki, Takashi Inoue, Shuji Hashimoto, Junichi Ochiai, Yasuhiro Kusuhara, Yoshinori Ito, Nobuyuki Hamajima. (2010) Association of serum carotenoids with high molecular weight adiponectin and inflammation markers among Japanese subjects. Clinica Chimica Acta 411:17-18, 1330-1334
CrossRef105
Yingming Wang, D. Roger Illingworth, Sonja L. Connor, P. Barton Duell, William E. Connor. (2010) Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene. European Journal of Nutrition 49:6, 327-336
CrossRef106
Joel B Mason, Susan J Kim. (2010) Revisiting the Goldilocks Phenomenon: Folate and Colorectal Cancer Risk. The American Journal of Gastroenterology 105:9, 1914-1916
CrossRef107
W. Chanput, S. Nakai, C. Theerakulkait. (2010) Introduction of New Computer Softwares for Classification and Prediction Purposes of Bioactive Peptides: Case Study in Antioxidative Tripeptides. International Journal of Food Properties 13:5, 947-959
CrossRef108
Lina Badimon, Gemma Vilahur, Teresa Padro. (2010) Nutraceuticals and Atherosclerosis: Human Trials. Cardiovascular Therapeutics 28:4, 202-215
CrossRef109
Eva Szabo. (2010) Phase II Cancer Prevention Clinical Trials. Seminars in Oncology 37:4, 359-366
CrossRef110
Howard P. Glauert, Karen Calfee-Mason, Divinia N. Stemm, Job C. Tharappel, Brett T. Spear. (2010) Dietary antioxidants in the prevention of hepatocarcinogenesis: A review. Molecular Nutrition & Food Research 54:7, 875-896
CrossRef111
T. Byers. (2010) Anticancer Vitamins du Jour--The ABCED's So Far. American Journal of Epidemiology 172:1, 1-3
CrossRef112
Noriko Bando, Naomi Muraki, Kaeko Murota, Junji Terao, Rintaro Yamanishi. (2010) Ingested quercetin but not rutin increases accumulation of hepatic β-carotene in BALB/c mice. Molecular Nutrition & Food Research 54:S2, S261-S267
CrossRef113
Caitlin S. Boon, D. Julian McClements, Jochen Weiss, Eric A. Decker. (2010) Factors Influencing the Chemical Stability of Carotenoids in Foods. Critical Reviews in Food Science and Nutrition 50:6, 515-532
CrossRef114
J. S. Mandeville, C. N. N’soukpoé-Kossi, J. F. Neault, H. A. Tajmir-Riahi. (2010) Structural analysis of DNA interaction with retinol and retinoic acid. Biochemistry and Cell Biology 88:3, 469-477
CrossRef115
Giovambattista Pani, Tommaso Galeotti, Paola Chiarugi. (2010) Metastasis: cancer cell’s escape from oxidative stress. Cancer and Metastasis Reviews 29:2, 351-378
CrossRef116
Yvonne G. J. Helden, Sandra G. Heil, Frederik J. Schooten, Evelien Kramer, Susanne Hessel, Jaume Amengual, Joan Ribot, Katja Teerds, Adrian Wyss, Georg Lietz, M. Luisa Bonet, Johannes Lintig, Roger W. L. Godschalk, Jaap Keijer. (2010) Knockout of the Bcmo1 gene results in an inflammatory response in female lung, which is suppressed by dietary beta-carotene. Cellular and Molecular Life Sciences 67:12, 2039-2056
CrossRef117
Barbara K. Dunn, Peter Greenwald. (2010) Cancer Prevention I: Introduction. Seminars in Oncology 37:3, 190-201
CrossRef118
Todd M. Gibson, Leah M. Ferrucci, Joseph A. Tangrea, Arthur Schatzkin. (2010) Epidemiological and Clinical Studies of Nutrition. Seminars in Oncology 37:3, 282-296
CrossRef119
Carolyn Cook Gotay. (2010) Cancer prevention: major initiatives and looking into the future. Expert Review of Pharmacoeconomics & Outcomes Research 10:2, 143-154
CrossRef120
Katherine L. Tucker. (2010) Dietary patterns, approaches, and multicultural perspectiveThis is one of a selection of papers published in the CSCN–CSNS 2009 Conference, entitled Can we identify culture-specific healthful dietary patterns among diverse populations undergoing nutrition transition?. Applied Physiology, Nutrition, and Metabolism 35:2, 211-218
CrossRef121
Nina Roswall, Anja Olsen, Jane Christensen, Lars O. Dragsted, Kim Overvad, Anne Tjønneland. (2010) Source-specific effects of micronutrients in lung cancer prevention. Lung Cancer 67:3, 275-281
CrossRef122
Graham A. Colditz, Philip R. Taylor. (2010) Prevention Trials: Their Place in How We Understand the Value of Prevention Strategies. Annual Review of Public Health 31:1, 105-120
CrossRef123
Nina Roswall. (2010) Folate and lung cancer risk. Lung Cancer 67:3, 380-381
CrossRef124
Cheng-Hung Chuang, Chin-Shiu Huang, Miao-Lin Hu. (2010) Vitamin E and rutin synergistically inhibit expression of vascular endothelial growth factor through down-regulation of binding activity of activator protein-1 in human promyelocytic leukemia (HL-60) cells. Chemico-Biological Interactions 183:3, 434-441
CrossRef125
Daniel G. Federman, Sarah A. Stechschulte, Robert S. Kirsner. (2010) The Reply. The American Journal of Medicine 123:2, e19
CrossRef126
P E Watson, B W McDonald. (2010) The association of maternal diet and dietary supplement intake in pregnant New Zealand women with infant birthweight. European Journal of Clinical Nutrition 64:2, 184-193
CrossRef127
G. S. Omenn. (2010) Colloquium Paper: Evolution and public health. Proceedings of the National Academy of Sciences 107:suppl_1, 1702-1709
CrossRef128
Nusrat Shafiq, Meenu Singh, Sharonjeet Kaur, Pratibha Khosla, Samir Malhotra, Nusrat Shafiq. 2010. Dietary treatment for familial hypercholesterolaemia. .
CrossRef129
Annia Galano. (2010) Carbon nanotubes: promising agents against free radicals. Nanoscale 2:3, 373
CrossRef130
Hwa Jin Jung, Young R. Seo. (2010) Current issues of selenium in cancer chemoprevention. BioFactorsNA-NA
CrossRef131
S.-K. Myung, Y. Kim, W. Ju, H. J. Choi, W. K. Bae. (2010) Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials. Annals of Oncology 21:1, 166-179
CrossRef132
Shuichiro Watanabe, Shu Kumagai, Hiroshi Shibata. (2010) An interventional trial to improve nutritional status in the community-dwelling elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 47:5, 422-425
CrossRef133
U. Gröber, J. Hübner, P. Holzhauer, U.R. Kleeberg. (2010) Antioxidanzien und andere Mikronährstoffe in der komplementären Onkologie. Der Onkologe 16:1, 73-79
CrossRef134
Michal Vinkler, Tomáš Albrecht. (2010) Carotenoid maintenance handicap and the physiology of carotenoid-based signalisation of health. Naturwissenschaften 97:1, 19-28
CrossRef135
Jérôme Lapointe, Siegfried Hekimi. (2010) When a theory of aging ages badly. Cellular and Molecular Life Sciences 67:1, 1-8
CrossRef136
Johann C Brandes, Ruhul Amin, Fadlo Khuri, Dong Moon Shin. (2010) Prevention of Lung Cancer: Future Perspective with Natural Compounds. Tuberculosis and Respiratory Diseases 69:1, 1
CrossRef137
Anthony B. Miller, Jakob Linseisen. (2010) Achievements and future of nutritional cancer epidemiology. International Journal of CancerNA-NA
CrossRef138
M. BOLAND. 2010. ‘Designer’ milks: functional foods from milk. , 74-93.
CrossRef139
N BINKLEY. 2010. Alcohol Use and Bone Health in Men. , 435-442.
CrossRef140
Feral Ozturk, Mehmet Gul, Burhan Ates, I. Cetin Ozturk, Asli Cetin, Nigar Vardi, Ali Otlu, Ismet Yilmaz. (2009) Protective effect of apricot ( Prunus armeniaca L.) on hepatic steatosis and damage induced by carbon tetrachloride in Wistar rats. British Journal of Nutrition 102:12, 1767
CrossRef141
Matheus Augusto de Bittencourt Pasquali, Daniel Pens Gelain, Marcos Roberto de Oliveira, Guilherme Antônio Behr, Leonardo Lisbôa da Motta, Ricardo Fagundes da Rocha, Fábio Klamt, José Cláudio Fonseca Moreira. (2009) Vitamin A Supplementation for Different Periods Alters Oxidative Parameters in Lungs of Rats. Journal of Medicinal Food 12:6, 1375-1380
CrossRef142
Charles Rudin, John Minna. (2009) Cancer Stem Cells. Journal of Thoracic Oncology 4:Supplement 3, S1079-S1081
CrossRef143
Y. Chaiter, S. B. Gruber, A. Ben-Amotz, R. Almog, H. S. Rennert, R. Fischler, G. Rozen, G. Rennert. (2009) Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes & Control 20:8, 1327-1338
CrossRef144
Dean Ornish. (2009) Mostly Plants. The American Journal of Cardiology 104:7, 957-958
CrossRef145
Zachary T. Schafer, Alexandra R. Grassian, Loling Song, Zhenyang Jiang, Zachary Gerhart-Hines, Hanna Y. Irie, Sizhen Gao, Pere Puigserver, Joan S. Brugge. (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461:7260, 109-113
CrossRef146
Samir G. Sukkar. (2009) What about “5-a-day” dietary education programme 20 years later? The five colours of cancer and obesity prevention. Mediterranean Journal of Nutrition and Metabolism 2:2, 85-87
CrossRef147
Neil Binkley. (2009) Is Vitamin D the Fountain of Youth?. Endocrine Practice 15:6, 590-596
CrossRef148
Olaf Sommerburg, Nicole Karius, Werner Siems, Claus-Dieter Langhans, Michael Leichsenring, Nicolle Breusing, Tilman Grune. (2009) Proteasomal degradation of β-carotene metabolite-Modified proteins. BioFactors 35:5, 449-459
CrossRef149
G. P. Webb. (2009) Interpreting nutritional science: what have we learnt from the past?. Nutrition Bulletin 34:3, 309-315
CrossRef150
Megan Dann Fesinmeyer, Janet L. Stanford, Teresa A. Brentnall, Margaret T. Mandelson, Federico M. Farin, Sengkeo Srinouanprachanh, Zahra Afsharinejad, Gary E. Goodman, Matt J. Barnett, Melissa A. Austin. (2009) Association Between the Peroxisome Proliferator-Activated Receptor γ Pro12Ala Variant and Haplotype and Pancreatic Cancer in a High-Risk Cohort of Smokers. Pancreas 38:6, 631-637
CrossRef151
K. Svennevig. (2009) RE: "LONG-TERM USE OF -CAROTENE, RETINOL, LYCOPENE, AND LUTEIN SUPPLEMENTS AND LUNG CANCER RISK: RESULTS FROM THE VITAMINS AND LIFESTYLE (VITAL) STUDY". American Journal of Epidemiology 170:3, 401-402
CrossRef152
Stephen M. Sagar, Brian D. Lawenda. (2009) The role of integrative oncology in a tertiary prevention survivorship program. Preventive Medicine 49:2-3, 93-98
CrossRef153
Elisa V. Bandera, Dina M. Gifkins, Dirk F. Moore, Marjorie L. McCullough, Lawrence H. Kushi. (2009) Antioxidant vitamins and the risk of endometrial cancer: a dose–response meta-analysis. Cancer Causes & Control 20:5, 699-711
CrossRef154
Mats Olsson, Mark Wilson, Caroline Isaksson, Tobias Uller. (2009) Polymorphic ROS scavenging revealed by CCCP in a lizard. Naturwissenschaften 96:7, 845-849
CrossRef155
Robert G Fassett, Jeff S Coombes. (2009) Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiology 5:4, 333-342
CrossRef156
Ann M. Bode, Zigang Dong. (2009) Cancer prevention research — then and now. Nature Reviews Cancer 9:7, 508-516
CrossRef157
P. Hodek, J. Křížková, K. Burdová, M. Šulc, R. Kizek, J. Hudeček, M. Stiborová. (2009) Chemopreventive compounds—View from the other side. Chemico-Biological Interactions 180:1, 1-9
CrossRef158
Suaib Luqman, Shubhangi Kaushik, Suchita Srivastava, Ritesh Kumar, D.U. Bawankule, Anirban Pal, Mahendra P. Darokar, Suman P.S. Khanuja. (2009) Protective effect of medicinal plant extracts on biomarkers of oxidative stress in erythrocytes. Pharmaceutical Biology 47:6, 483-490
CrossRef159
Graziano Riccioni, Nicolantonio DʼOrazio, Nicola Palumbo, Valentina Bucciarelli, Emanuela di Ilio, Lydia A. Bazzano, Tonino Bucciarelli. (2009) Relationship between plasma antioxidant concentrations and carotid intima-media thickness: the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study. European Journal of Cardiovascular Prevention & Rehabilitation 16:3, 351-357
CrossRef160
S. T. Dance-Barnes, N. D. Kock, J. E. Moore, E. Y. Lin, L. J. Mosley, R. B. D'Agostino, T. P. McCoy, A. J. Townsend, M. S. Miller. (2009) Lung tumor promotion by curcumin. Carcinogenesis 30:6, 1016-1023
CrossRef161
William B. Grant. (2009) The Health Benefits of Solar Irradiance and Vitamin D and the Consequences of Their Deprivation. Clinical Reviews in Bone and Mineral Metabolism 7:2, 134-146
CrossRef162
Shu-Lan Yeh, Hui-Min Wang, Pei-Ying Chen, Tzu-Chin Wu. (2009) Interactions of β-carotene and flavonoids on the secretion of pro-inflammatory mediators in an in vitro system. Chemico-Biological Interactions 179:2-3, 386-393
CrossRef163
Matthew R. Richardson, Xianyin Lai, Joseph L. Dixon, Michael Sturek, Frank A. Witzmann. (2009) Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs. PROTEOMICS 9:9, 2468-2483
CrossRef164
Hussein A.N. Al-Wadei, Hildegard M. Schuller. (2009) β-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma
. European Journal of Cancer 45:7, 1257-1264
CrossRef165
Fethi Kamışlı, Fikret Karatas. (2009) Effects of sulphurisation on vitamins (A, C and E) and malondialdehyde in apricots. International Journal of Food Science & Technology 44:5, 987-993
CrossRef166
Emilio Herrera, Rafael Jiménez, Okezie I Aruoma, Serge Hercberg, Isidro Sánchez-García, César Fraga. (2009) Aspects of antioxidant foods and supplements in health and disease. Nutrition Reviews 67, S140-S144
CrossRef167
Yumie Takata, Irena B. King, Marian L. Neuhouser, Steve Schaffer, Matt Barnett, Mark Thornquist, Ulrike Peters, Gary E. Goodman. (2009) Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers. Cancer Causes & Control 20:4, 497-504
CrossRef168
(2009) Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims. Biotechnology Law Report 28:2, 241-258
CrossRef169
Kevin C. Chung, Jennifer A. Swanson, DeLaine Schmitz, Daniel Sullivan, Rod J. Rohrich. (2009) Introducing Evidence-Based Medicine to Plastic and Reconstructive Surgery. Plastic and Reconstructive Surgery 123:4, 1385-1389
CrossRef170
S. Honarbakhsh, M. Schachter. (2009) Vitamins and cardiovascular disease. British Journal of Nutrition 101:08, 1113
CrossRef171
Y.-L. Qiao, S. M. Dawsey, F. Kamangar, J.-H. Fan, C. C. Abnet, X.-D. Sun, L. L. Johnson, M. H. Gail, Z.-W. Dong, B. Yu, S. D. Mark, P. R. Taylor. (2009) Total and Cancer Mortality After Supplementation With Vitamins and Minerals: Follow-up of the Linxian General Population Nutrition Intervention Trial. JNCI Journal of the National Cancer Institute 101:7, 507-518
CrossRef172
Chun Liu, Xiang-Dong Wang, Lorelei Mucci, J. Michael Gaziano, Shumin M. Zhang. (2009) Modulation of lung molecular biomarkers by β-carotene in the Physicians' Health Study. Cancer 115:5, 1049-1058
CrossRef173
Umberto Cornelli. (2009) Antioxidant use in nutraceuticals. Clinics in Dermatology 27:2, 175-194
CrossRef174
Gwendolen Buhr, Connie W. Bales. (2009) Nutritional Supplements for Older Adults: Review and Recommendations—Part I. Journal of Nutrition For the Elderly 28:1, 5-29
CrossRef175
Stuart Richer, Geoffrey Harris, Steven Pratt. 2009. Age-Related Macular Degeneration. .
CrossRef176
Sheila George. 2009. Lung Cancer. .
CrossRef177
P Marques-Vidal, A Pécoud, D Hayoz, F Paccaud, V Mooser, G Waeber, P Vollenweider. (2009) Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study. European Journal of Clinical Nutrition 63:2, 273-281
CrossRef178
Heather K. Vincent, Cheryl M. Bourguignon, Arthur L. Weltman, Kevin R. Vincent, Eugene Barrett, Karen E. Innes, Ann G. Taylor. (2009) Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 58:2, 254-262
CrossRef179
Niki Katsiki, Christos Manes. (2009) Is there a role for supplemented antioxidants in the prevention of atherosclerosis?. Clinical Nutrition 28:1, 3-9
CrossRef180
Timothy Mainardi, Simi Kapoor, Leonard Bielory. (2009) Complementary and alternative medicine: Herbs, phytochemicals and vitamins and their immunologic effects. Journal of Allergy and Clinical Immunology 123:2, 283-294.e10
CrossRef181
K. Park, L. Harnack, D. R. Jacobs. (2009) Trends in Dietary Supplement Use in a Cohort of Postmenopausal Women From Iowa. American Journal of Epidemiology 169:7, 887-892
CrossRef182
E. J. Johnson. 2009. Nutrition and eye-related disorders. , 312-329.
CrossRef183
Jong-Myon Bae. (2009) Explaining Cancer Incidence in the Jejudo Population. Journal of Preventive Medicine and Public Health 42:1, 67
CrossRef184
M. J. Amiot-Carlin. 2009. Digestion and absorption of lipophilic food micronutrients. , 171-193.
CrossRef185
Abe E. Sahmoun, Gary G. Schwartz. (2009) Smoking and Supplement Use Among Men in a Rural Population. Journal of Dietary Supplements 6:3, 280-289
CrossRef186
D. Albanes. (2008) Vitamin Supplements and Cancer Prevention: Where Do Randomized Controlled Trials Stand?. JNCI Journal of the National Cancer Institute 101:1, 2-4
CrossRef187
J. Lin, N. R. Cook, C. Albert, E. Zaharris, J. M. Gaziano, M. Van Denburgh, J. E. Buring, J. E. Manson. (2008) Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial. JNCI Journal of the National Cancer Institute 101:1, 14-23
CrossRef188
Claudio Pelucchi, Luigino Dal Maso, Maurizio Montella, Maria Parpinel, Eva Negri, Renato Talamini, Aldo Giudice, Silvia Franceschi, Carlo La Vecchia. (2008) Dietary intake of carotenoids and retinol and endometrial cancer risk in an Italian case–control study. Cancer Causes & Control 19:10, 1209-1215
CrossRef189
David J.A. Jenkins, Tri H. Nguyen, Cyril W.C. Kendall, Dorothea A. Faulkner, Balachandran Bashyam, In Joo Kim, Chris Ireland, Darshna Patel, Edward Vidgen, Andrea R. Josse, Howard D. Sesso, Britt Burton-Freeman, Robert G. Josse, Lawrence A. Leiter, William Singer. (2008) The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 57:12, 1636-1644
CrossRef190
Mohamad Sidani, Carol Ziegler. (2008) Preventing Heart Disease: Who Needs to be Concerned and What to Do. Primary Care: Clinics in Office Practice 35:4, 589-607
CrossRef191
Kah Poh Tan, Kazuhiro Kosuge, Mingdong Yang, Shinya Ito. (2008) NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radical Biology and Medicine 45:12, 1663-1673
CrossRef192
Irene Hamrick, Sandra H. Counts. (2008) Vitamin and Mineral Supplements. Primary Care: Clinics in Office Practice 35:4, 729-747
CrossRef193
Barbara J. Boucher. (2008) Dietary supplement use and mortality in a cohort of Swedish men – comments by Boucher. British Journal of Nutrition 100:06, 1345
CrossRef194
Hanna R Coleman, Chi-Chao Chan, Frederick L Ferris, Emily Y Chew. (2008) Age-related macular degeneration. The Lancet 372:9652, 1835-1845
CrossRef195
J THARAPPEL, H LEHMLER, C SRINIVASAN, L ROBERTSON, B SPEAR, H GLAUERT. (2008) Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3′,4,4′-tetrachlorobiphenyl (PCB-77). Food and Chemical Toxicology 46:11, 3467-3474
CrossRef196
Eliane Kellen, Geertruida Bekkering. 2008. Can Fruit and Vegetable Consumption Oppose the Negative Health Effects of Tobacco?. , 311-320.
CrossRef197
David Thomas. 2008. Vitamins and Health in Older Persons. , 15-28.
CrossRef198
J. Sobesky. (2008) Schlaganfallprävention jenseits der Apotheke. Der Nervenarzt 79:10, 1156-1163
CrossRef199
L ZELEK, P LATINOMARTEL, N PECOLLO, E BARRANDON, S CZERNICHOW, P GALAN, S HERCBERG. (2008) Nutrition et prévention tertiaire des cancers. y a-t-il des recommandations ?. Cahiers de Nutrition et de Diététique 43:5, 235-241
CrossRef200
John Bertram. 2008. Modulation of Gene Expression by Dietary Carotenoids and Retinoids. .
CrossRef201
M. E. Wright, Y. Park, A. F. Subar, N. D. Freedman, D. Albanes, A. Hollenbeck, M. F. Leitzmann, A. Schatzkin. (2008) Intakes of Fruit, Vegetables, and Specific Botanical Groups in Relation to Lung Cancer Risk in the NIH-AARP Diet and Health Study. American Journal of Epidemiology 168:9, 1024-1034
CrossRef202
YeunHwa Gu, Yoshiaki Fujimiya, Yuka Itokawa, Masami Oshima, Jung-Sook Choi, Toshihiro Miura, Torao Ishida. (2008) Tumoricidal Effects of β-Glucans: Mechanisms Include Both Antioxidant Activity Plus Enhanced Systemic and Topical Immunity. Nutrition and Cancer 60:5, 685-691
CrossRef203
Luc Dauchet, Sandrine Péneau, Sandrine Bertrais, Anne Claire Vergnaud, Carla Estaquio, Emmanuelle Kesse-Guyot, Sébastien Czernichow, Alain Favier, Henri Faure, Pilar Galan, Serge Hercberg. (2008) Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. British Journal of Nutrition 100:03,
CrossRef204
Peter van Wijngaarden, Salmaan H Qureshi. (2008) Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. Clinical and Experimental Optometry 91:5, 427-437
CrossRef205
María Elena Martínez, James R. Marshall, Edward Giovannucci. (2008) Diet and cancer prevention: the roles of observation and experimentation. Nature Reviews Cancer 8:9, 694-703
CrossRef206
Paige Miller, Wendy Demark-Wahnefried, Denise Clutter Snyder, Richard Sloane, Miriam C. Morey, Harvey Cohen, Sibylle Kranz, Diane C. Mitchell, Terryl J. Hartman. (2008) Dietary supplement use among elderly, long-term cancer survivors. Journal of Cancer Survivorship 2:3, 138-148
CrossRef207
Stacey J. Bell, Gregory T. Grochoski. (2008) How Safe is Vitamin E Supplementation?. Critical Reviews in Food Science and Nutrition 48:8, 760-774
CrossRef208
P. Palozza, R. Sestito, N. Picci, P. Lanza, G. Monego, F. O. Ranelletti. (2008) The sensitivity to -carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis 29:11, 2153-2161
CrossRef209
Dunyaporn Trachootham, Weiqin Lu, Marcia A. Ogasawara, Nilsa Rivera-Del Valle, Peng Huang. (2008) Redox Regulation of Cell Survival. Antioxidants & Redox Signaling 10:8, 1343-1374
CrossRef210
D OUYANG, R ZHANG, L YI, Z XI. (2008) A synergistic effect of Cu2+ and norbixin on DNA damage. Food and Chemical Toxicology 46:8, 2802-2807
CrossRef211
Marie-France Demierre. 2008. RAS Signaling in Melanoma Development and Prevention. , 55-66.
CrossRef212
Goran Bjelakovic, Dimitrinka Nikolova, Rosa G Simonetti, Christian Gluud, Goran Bjelakovic. 2008. Antioxidant supplements for preventing gastrointestinal cancers. .
CrossRef213
Angela Risch, Christoph Plass. (2008) Lung cancer epigenetics and genetics. International Journal of Cancer 123:1, 1-7
CrossRef214
Tawee Tanvetyanon, Gerold Bepler. (2008) Beta‐carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers. Cancer 113:1, 150-157
CrossRef215
E BITAUBEPEREZ, I CAROPINA, L PEREZRODRIGUEZ. (2008) Kinetic model for growth of Phaeodactylum tricornutum in intensive culture photobioreactor. Biochemical Engineering Journal 40:3, 520-525
CrossRef216
AS Menon, AS Narula, AG Mathur. (2008) Multivitamins: Use or misuse?. Medical Journal Armed Forces India 64:3, 263-267
CrossRef217
Xuezhe Yin, Jishu Quan, Takemichi Kanazawa. (2008) Banana Prevents Plasma Oxidative Stress in Healthy Individuals. Plant Foods for Human Nutrition 63:2, 71-76
CrossRef218
M ANTONIOGARCIA, E MASSOGONZALEZ. (2008) Toxic effects of perinatal lead exposure on the brain of rats: Involvement of oxidative stress and the beneficial role of antioxidants. Food and Chemical Toxicology 46:6, 2089-2095
CrossRef219
J Evans. (2008) Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye 22:6, 751-760
CrossRef220
T. T. Schug, D. C. Berry, I. A. Toshkov, L. Cheng, A. Y. Nikitin, N. Noy. (2008) Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPAR / to RAR. Proceedings of the National Academy of Sciences 105:21, 7546-7551
CrossRef221
Joan Manel Gasent Blesa, Emilio Esteban González, Vicente Alberola Candel. (2008) Screening and chemoprevention in lung cancer. Clinical and Translational Oncology 10:5, 274-280
CrossRef222
Lucie Nováková, Dagmar Solichová, Soňa Pavlovičová, Petr Solich. (2008) Hydrophilic interaction liquid chromatography method for the determination of ascorbic acid. Journal of Separation Science 31:9, 1634-1644
CrossRef223
Theo M. Kok, Simone G. Breda, Margaret M. Manson. (2008) Mechanisms of combined action of different chemopreventive dietary compounds. European Journal of Nutrition 47:S2, 51-59
CrossRef224
Anup Kale, Sonia Gawande, Swati Kotwal. (2008) Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytotherapy Research 22:5, 567-577
CrossRef225
Olga Dosil-Díaz, Alberto Ruano-Ravina, Juan J. Gestal-Otero, Juan M. Barros-Dios. (2008) Consumption of fruit and vegetables and risk of lung cancer: A case-control study in Galicia, Spain. Nutrition 24:5, 407-413
CrossRef226
Megan Kendall, Marijka Batterham, Paul D. Prenzler, Danielle Ryan, Kevin Robards. (2008) Nutritional methodologies and their use in inter-disciplinary antioxidant research. Food Chemistry 108:2, 425-438
CrossRef227
Cindy K. Blair, Michelle Roesler, Yang Xie, Alan S. Gamis, Andrew F. Olshan, Nyla A. Heerema, Leslie L. Robison, Julie A. Ross. (2008) Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study. Paediatric and Perinatal Epidemiology 22:3, 288-295
CrossRef228
K. Richard Bruckdorfer. (2008) Antioxidants and CVD. Proceedings of the Nutrition Society 67:02, 214-222
CrossRef229
Eva Szabo. (2008) Primer: first do no harm—when is it appropriate to plan a cancer prevention clinical trial?. Nature Clinical Practice Oncology
CrossRef230
2008. References. , 291-324.
CrossRef231
François Meyer, Isabelle Bairati, André Fortin, Michel Gélinas, Abdenour Nabid, François Brochet, Bernard Têtu. (2008) Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: A randomized trial among head and neck cancer patients. International Journal of Cancer 122:7, 1679-1683
CrossRef232
Fen Wei Wang, Barry F. Uretsky, Jean L. Freeman, Dong Zhang, Sharon H. Giordano, James S. Goodwin. (2008) Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: Real or artefactual?. Catheterization and Cardiovascular Interventions 71:5, 636-643
CrossRef233
Richard Sadovsky, Nancy Collins, Ann P. Tighe, Stephen A. Brunton, Richard Safeer. (2008) Patient use of dietary supplements: a clinician's perspective. Current Medical Research and Opinion 24:4, 1209-1216
CrossRef234
J. Talvas, D. Gitenay, E. Rock. (2008) Fruits et cancer: de la cancérogenèse à l’épidémiologie. Phytothérapie 6:2, 96-101
CrossRef235
Anna Brzozowska, Joanna Kaluza, Kim T. B. Knoops, Lisette C. P. G. M. Groot. (2008) Supplement use and mortality: the SENECA study. European Journal of Nutrition 47:3, 131-137
CrossRef236
A RUANORAVINA. (2008) Factores etiológicos del cáncer de pulmón: fumador activo, fumador pasivo, carcinógenos medioambientales y factores genéticos. Medicina Clínica 130:9, 359-359
CrossRef237
N. Graue, A. Körber, E. Cesko, S. Piel, T. Jansen, J. Dissemond. (2008) Malnutrition bei Patienten mit Ulcus cruris. Der Hautarzt 59:3, 212-219
CrossRef238
Maria Messerer, Niclas Håkansson, Alicja Wolk, Agneta Åkesson. (2008) Dietary supplement use and mortality in a cohort of Swedish men. British Journal of Nutrition 99:03,
CrossRef239
G L Ambrosini, N H de Klerk, L Fritschi, D Mackerras, B Musk. (2008) Fruit, vegetable, vitamin A intakes, and prostate cancer risk. Prostate Cancer and Prostatic Diseases 11:1, 61-66
CrossRef240
George Davey Smith. (2008) Assessing Intrauterine Influences on Offspring Health Outcomes: Can Epidemiological Studies Yield Robust Findings?. Basic & Clinical Pharmacology & Toxicology 102:2, 245-256
CrossRef241
Jack Challem. (2008) Medical Journal Watch: Context and Applications. Alternative and Complementary Therapies 14:1, 48-52
CrossRef242
Linda Van Horn, Mikelle McCoin, Penny M. Kris-Etherton, Frances Burke, Jo Ann S. Carson, Catherine M. Champagne, Wahida Karmally, Geeta Sikand. (2008) The Evidence for Dietary Prevention and Treatment of Cardiovascular Disease. Journal of the American Dietetic Association 108:2, 287-331
CrossRef243
Jennifer S.L. Tan, Jie Jin Wang, Victoria Flood, Elena Rochtchina, Wayne Smith, Paul Mitchell. (2008) Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration. Ophthalmology 115:2, 334-341
CrossRef244
Han Wang, Jue Lin Deng, Jirong Yue, Jun Li, Yan Bin Hou, Jue Lin Deng. 2008. Prostaglandin E1 for preventing the progression of diabetic kidney disease. .
CrossRef245
Jennifer R Evans, Katherine S Henshaw, Jennifer R Evans. 2008. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. .
CrossRef246
L.A. Bazzano. 2008. Epidemiologic evidence for the effect of fruit and vegetables on cardiovascular diseases, diabetes and obesity. , 119-144.
CrossRef247
Emel Çalışkan-Can, Hikmet Fırat, Sadık Ardıç, Bolkan Şimşek, Meral Torun, Sevgi Yardim-Akaydin. (2008) Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clinical Chemistry and Laboratory Medicine 46:1, 107-112
CrossRef248
Marina Bar-Shai, Eli Carmeli, Predrag Ljubuncic, Abraham Z. Reznick. (2008) Exercise and immobilization in aging animals: The involvement of oxidative stress and NF-κB activation. Free Radical Biology and Medicine 44:2, 202-214
CrossRef249
(2008) Appendix 3: Physiology of β-Carotene. Comprehensive Reviews in Food Science and Food Safety 7:1, 110-110
CrossRef250
Y YUAN, Y GAO, J ZHAO, L MAO. (2008) Characterization and stability evaluation of β-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions. Food Research International 41:1, 61-68
CrossRef251
R. M. Faulks, S. Southon. 2008. Assessing the bioavailability of nutraceuticals. , 195-218.
CrossRef252
P. Terry, J. B. Terry, A. Wolk. (2008) Fruit and vegetable consumption in the prevention of cancer: an update. Journal of Internal Medicine 250:4, 280
CrossRef253
Scott M. Lippman, J. Jack Lee. 2008. Cancer Chemoprevention. , 711-720.
CrossRef254
Annia Galano, Armando Cruz-Torres. (2008) OH radical reactions with phenylalanine in free and peptide forms. Organic & Biomolecular Chemistry 6:4, 732
CrossRef255
R. M. Faulks, S. Southon. 2008. Assessing the bioavailability of nutraceuticals. , 3-25.
CrossRef256
D. Papandreou, F. Athanassiadou. (2008) Are maternal diet, birth weight, breastfeeding and antioxidants playing a role in pediatric leukemia? A review. Nutrition & Food Science 38:1, 32-40
CrossRef257
Kathryn L. Terry, Stacey A. Missmer, Susan E. Hankinson, Walter C. Willett, Immaculata De Vivo. (2008) Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata. American Journal of Obstetrics and Gynecology 198:1, 37.e1-37.e8
CrossRef258
Goran Bjelakovic, Lise Lotte Gluud, Dimitrinka Nikolova, Kate Whitfield, Jørn Wetterslev, Christian Gluud, Goran Bjelakovic. 2008. .
CrossRef259
M. Rehak, E. Fric, P. Wiedemann. (2008) Lutein und Antioxidantien zur Prävention der AMD. Der Ophthalmologe 105:1, 37-45
CrossRef260
A. Bardia, I. M. Tleyjeh, J. R. Cerhan, A. K. Sood, P. J. Limburg, P. J. Erwin, V. M. Montori. (2008) Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis. Mayo Clinic Proceedings 83:1, 23-34
CrossRef261
Boris Freidlin. 2007. Futility Analysis. .
CrossRef262
Mark D. Thornquist. 2007. The Carotene and Retinol Efficacy Trial (Caret). .
CrossRef263
Jennifer Evans. 2007. Eye Health. .
CrossRef264
Hanneke G.M. Wittgen, Léon C.L.T. van Kempen. (2007) Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Research 17:6, 400-409
CrossRef265
William C. Black. (2007) Computed tomography screening for lung cancer: Review of screening principles and update on current status. Cancer 110:11, 2370-2384
CrossRef266
Feral Temelli, Marleny Saldaña, Paul Moquin, Mei Sun. 2007. Supercritical Fluid Extraction of Specialty Oils. , 51-101.
CrossRef267
2007. References. , 224-238.
CrossRef268
W. N. Hittelman, D. D. Liu, J. M. Kurie, R. Lotan, J. S. Lee, F. Khuri, H. Ibarguen, R. C. Morice, G. Walsh, J. A. Roth, J. Minna, J. Y. Ro, A. Broxson, W. K. Hong, J. J. Lee. (2007) Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids. JNCI Journal of the National Cancer Institute 99:21, 1603-1612
CrossRef269
Ursula Werneke. (2007) Risk management of nutritional supplements in chronic illness: the implications for the care of cancer and depression. Proceedings of the Nutrition Society 66:04,
CrossRef270
Y CUI, Z LU, L BAI, Z SHI, W ZHAO, B ZHAO. (2007) β-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor γ expression and reactive oxygen species production in MCF-7 cancer cells. European Journal of Cancer 43:17, 2590-2601
CrossRef271
Giancarlo Aldini, Isabella Dalle-Donne, Roberto Maffei Facino, Aldo Milzani, Marina Carini. (2007) Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Medicinal Research Reviews 27:6, 817-868
CrossRef272
Anita F. Fernander, Vickie L. Shavers, George J. Hammons. (2007) A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups. Addiction 102, 43-57
CrossRef273
David R. Jacobs, Linda C. Tapsell. (2007) Food, Not Nutrients, Is the Fundamental Unit in Nutrition. Nutrition Reviews 65:10, 439-450
CrossRef274
François Meyer, Isabelle Bairati, Édith Jobin, Michel Gélinas, André Fortin, Abdenour Nabid, Bernard Têtu. (2007) Acute Adverse Effects of Radiation Therapy and Local Recurrence in Relation to Dietary and Plasma Beta Carotene and Alpha Tocopherol in Head and Neck Cancer Patients. Nutrition and Cancer 59:1, 29-35
CrossRef275
Howard N. Hodis, Wendy J. Mack. (2007) Postmenopausal hormone therapy in clinical perspective. Menopause 14:5, 944-957
CrossRef276
Ichiro Yoshino, Yoshihiko Maehara. (2007) Impact of Smoking Status on the Biological Behavior of Lung Cancer. Surgery Today 37:9, 725-734
CrossRef277
Cindy Davis. 2007. Mechanisms for Cancer-Protective Effects of Bioactive Dietary Components in Fruits and Vegetables. , 1187-1218.
CrossRef278
Judith Moreines, Richard Cotter, Leon Ellenbogen. 2007. Potential Benefits for the Use of Vitamin and Mineral Supplements. , 193-219.
CrossRef279
C.-X. Qu, F. Kamangar, J.-H. Fan, B. Yu, X.-D. Sun, P. R. Taylor, B. E. Chen, C. C. Abnet, Y.-L. Qiao, S. D. Mark, S. M. Dawsey. (2007) Chemoprevention of Primary Liver Cancer: A Randomized, Double-Blind Trial in Linxian, China. JNCI Journal of the National Cancer Institute 99:16, 1240-1247
CrossRef280
Rhonda S. Sebastian, Linda E. Cleveland, Joseph D. Goldman, Alanna J. Moshfegh. (2007) Older Adults Who Use Vitamin/Mineral Supplements Differ from Nonusers in Nutrient Intake Adequacy and Dietary Attitudes. Journal of the American Dietetic Association 107:8, 1322-1332
CrossRef281
Maqusood Ahamed, Mohd. Kaleem Javed Siddiqui. (2007) Environmental lead toxicity and nutritional factors. Clinical Nutrition 26:4, 400-408
CrossRef282
S Haldar, I R Rowland, Y A Barnett, I Bradbury, P J Robson, J Powell, J Fletcher. (2007) Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. European Journal of Clinical Nutrition 61:8, 1011-1022
CrossRef283
Keren Hirsch, Andrea Atzmon, Michael Danilenko, Joseph Levy, Yoav Sharoni. (2007) Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells. Breast Cancer Research and Treatment 104:2, 221-230
CrossRef284
C LIDEBJER, P LEANDERSON, J ERNERUDH, L JONASSON. (2007) Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases 17:6, 448-456
CrossRef285
David B. Rein, Jinan B. Saaddine, John S. Wittenborn, Kathleen E. Wirth, Thomas J. Hoerger, K.M. Venkat Narayan, Traci Clemons, Stephen W. Sorensen. (2007) Cost-effectiveness of Vitamin Therapy for Age-Related Macular Degeneration. Ophthalmology 114:7, 1319-1326
CrossRef286
Sara Raimondi, Seymour Garte, Radim J. Sram, Blanka Binkova, Ivan Kalina, K. Lyubomirova, Emanuela Taioli, Rajinder Singh, Peter B. Farmer. (2007) Effects of diet on biomarkers of exposure and effects, and on oxidative damage. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 620:1-2, 93-102
CrossRef287
A. Bardia, J. O. Ebbert, R. A. Vierkant, P. J. Limburg, K. Anderson, A. H. Wang, J. E. Olson, C. M. Vachon, J. R. Cerhan. (2007) Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality. JNCI Journal of the National Cancer Institute 99:11, 881-889
CrossRef288
R.S. Policegoudra, K. Abiraj, D. Channe Gowda, S.M. Aradhya. (2007) Isolation and characterization of antioxidant and antibacterial compound from mango ginger (Curcuma amada Roxb.) rhizome. Journal of Chromatography B 852:1-2, 40-48
CrossRef289
Gilbert S. Omenn. (2007) Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. European Journal of Cancer Prevention 16:3, 184-191
CrossRef290
Micheline M. Mathews-Roth. 2007. Beta-Carotene in Erythropoietic Protoporphyria. , 333-343.
CrossRef291
Diane Nykamp, Edie D. Kavanaugh, Amy P. Wenker. (2007) <b>Vitamins: The Wise Choice for Women with Cardiovascular Disease</b>. The Consultant Pharmacist 22:6, 490-502
CrossRef292
Kenichi Kitani. (2007) Pharmacological interventions in aging and age-associated disorders. Geriatrics & Gerontology International 7:2, 97-103
CrossRef293
Olivier Sorg, S Kuenzli, J. H. Saurat. 2007. Side Effects and Pitfalls in Retinoid Therapy. , 225-248.
CrossRef294
Ramzi Hajjar, Zeina Nahhas. 2007. Vitamin Disorders. , 137-178.
CrossRef295
Mika J. Thomson, Valentina Puntmann, Juan-Carlos Kaski. (2007) Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?. Cardiovascular Drugs and Therapy 21:3, 195-210
CrossRef296
Andreu Palou, Paula Oliver, Ana Ma Rodrìguez, Antoni Caimari. 2007. Functional Foods in the European Union. , 213-250.
CrossRef297
Ramón Rodrigo, Cristián Guichard, Roberto Charles. (2007) Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundamental & Clinical Pharmacology 21:2, 111-127
CrossRef298
Lars P. Christensen, Stine Kreutzmann. (2007) Determination of polyacetylenes in carrot roots (Daucus carotaL.) by high-performance liquid chromatography coupled with diode array detection. Journal of Separation Science 30:4, 483-490
CrossRef299
Nancy Nairi Maserejian, Edward Giovannucci, Bernard Rosner, Kaumudi Joshipura. (2007) Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. International Journal of Cancer 120:5, 970-977
CrossRef300
Iain L. C. Chapple, John B. Matthews. (2007) The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontology 2000 43:1, 160-232
CrossRef301
Christine A. Northrop-Clewes, David I. Thurnham. (2007) Monitoring micronutrients in cigarette smokers. Clinica Chimica Acta 377:1-2, 14-38
CrossRef302
Lawrence S Cozma. (2007) Nutrition and metabolism: cellular and extracellular antioxidant capacity and cardiovascular disease. Current Opinion in Lipidology 18:1, 110-112
CrossRef303
Hyesun P. McNulty, Jungsoo Byun, Samuel F. Lockwood, Robert F. Jacob, R. Preston Mason. (2007) Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768:1, 167-174
CrossRef304
J SERRANO, I GONI, F SAURACALIXTO. (2007) Food antioxidant capacity determined by chemical methods may underestimate the physiological antioxidant capacity. Food Research International 40:1, 15-21
CrossRef305
Dugald Seely, Diana Stempak, Sylvain Baruchel. (2007) A Strategy for Controlling Potential Interactions Between Natural Health Products and Chemotherapy. Journal of Pediatric Hematology/Oncology 29:1, 32-47
CrossRef306
F KARATAS, F KAMISLI. (2007) Variations of vitamins (A, C and E) and MDA in apricots dried in IR and microwave. Journal of Food Engineering 78:2, 662-668
CrossRef307
Geoffrey P. Webb. (2007) Nutritional supplements and conventional medicine; what should the physician know?. Proceedings of The Nutrition Society 66:4,
CrossRef308
Graziano Riccioni, Tonino Bucciarelli, Barbara Mancini, Carmine Di Ilio, Valerie Capra, Nicolantonio D’Orazio. (2007) The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opinion on Investigational Drugs 16:1, 25-32
CrossRef309
Mihye KIM, Akira MURAKAMI, Hajime OHIGASHI. (2007) Modifying Effects of Dietary Factors on (−)-Epigallocatechin-3-gallate-induced Pro-matrix Metalloproteinase-7 Production in HT-29 Human Colorectal Cancer Cells. Bioscience, Biotechnology, and Biochemistry 71:10, 2442-2450
CrossRef310
Jonathan Yeoh, Joanne Sims, Robyn H Guymer. (2006) A review of drug options in age-related macular degeneration therapy and potential new agents. Expert Opinion on Pharmacotherapy 7:17, 2355-2368
CrossRef311
Yang Kun, Umar Ssonko Lule, Ding Xiao-Lin. (2006) Lycopene: Its Properties and Relationship to Human Health. Food Reviews International 22:4, 309-333
CrossRef312
Sherri Sheinfeld Gorin, Catharine Wang, Peter Raich, Deborah J. Bowen, Jennifer Hay. (2006) Decision making in cancer primary prevention and chemoprevention. Annals of Behavioral Medicine 32:3, 179-187
CrossRef313
Anna Denny. (2006) Dietary Supplements and Functional Foods. Nutrition Bulletin 31:4, 354-355
CrossRef314
David R Thomas. (2006) Vitamin supplements for the elderly: are they worth it?. Aging Health 2:6, 883-886
CrossRef315
Jie Jin Wang. (2006) Genetic and modifiable risk factors for age-related macular degeneration. Expert Review of Ophthalmology 1:2, 181-194
CrossRef316
S YEH, S WU. (2006) Effects of quercetin on β-apo-8′-carotenal-induced DNA damage and cytochrome P1A2 expression in A549 cells. Chemico-Biological Interactions 163:3, 199-206
CrossRef317
Isabelle Bairati, François Meyer, Edith Jobin, Michel Gélinas, André Fortin, Abdenour Nabid, François Brochet, Bernard Têtu. (2006) Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. International Journal of Cancer 119:9, 2221-2224
CrossRef318
S HERCBERG. (2006) L’étude SU.VI.MAX, un essai contrôlé randomisé, en double aveugle, testant l’effet de la supplémentation en vitamins et minéraux antioxydants sur la santé. Annales Pharmaceutiques Françaises 64:6, 397-401
CrossRef319
Mauro Serafini, Debora Villano, Giovanni Spera, Nicoletta Pellegrini. (2006) Redox Molecules and Cancer Prevention: The Importance of Understanding the Role of the Antioxidant Network. Nutrition and Cancer 56:2, 232-240
CrossRef320
Matthew R. Ramsey, Norman E. Sharpless. (2006) ROS as a tumour suppressor?. Nature Cell Biology 8:11, 1213-1215
CrossRef321
J Austin, N Singhal, R Voigt, F Smaill, M J Gill, S Walmsley, I Salit, J Gilmour, W F Schlech, S Choudhri, A Rachlis, J Cohen, S Trottier, E Toma, P Phillips, P M Ford, R Woods, J Singer, D P Zarowny, D W Cameron. (2006) A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. European Journal of Clinical Nutrition 60:11, 1266-1276
CrossRef322
Eva Szabo. (2006) Selecting targets for cancer prevention: where do we go from here?. Nature Reviews Cancer 6:11, 867-874
CrossRef323
Jie Sun, Rui Hai Liu. (2006) Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Letters 241:1, 124-134
CrossRef324
Gad Rennert. (2006) Are we taking the right approach in planning chemoprevention studies?. Nature Clinical Practice Oncology 3:9, 464-465
CrossRef325
Takeshi Suzuki, Kenji Wakai, Keitaro Matsuo, Kaoru Hirose, Hidemi Ito, Kiyonori Kuriki, Shigeki Sato, Ryuzo Ueda, Yasuhisa Hasegawa, Kazuo Tajima. (2006) Effect of dietary antioxidants and risk of oral, pharyngeal and laryngeal squamous cell carcinoma according to smoking and drinking habits. Cancer Science 97:8, 760-767
CrossRef326
Serge Hercberg, Sebastien Czernichow, Pilar Galan. (2006) Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study. British Journal of Nutrition 96:S1, S28-S30
CrossRef327
Helman S. Alfonso, Lin Fritschi, Nicholas H. de Klerk, Gina L. Ambrosini, John Beilby, Nola Olsen, Arthur William Musk. (2006) Plasma vitamin concentrations and incidence of mesothelioma and lung cancer in individuals exposed to crocidolite at Wittenoom, Western Australia. European Journal of Cancer Prevention 15:4, 290-294
CrossRef328
J SPENCE. (2006) Challenges related to the composition of functional foods. Journal of Food Composition and Analysis 19, S4-S6
CrossRef329
L LEA, P HEPBURN. (2006) Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme. Food and Chemical Toxicology 44:8, 1213-1222
CrossRef330
W.-c. You, L. M. Brown, L. Zhang, J.-y. Li, M.-l. Jin, Y.-s. Chang, J.-l. Ma, K.-f. Pan, W.-d. Liu, Y. Hu, S. Crystal-Mansour, D. Pee, W. J. Blot, J. F. Fraumeni, G.-w. Xu, M. H. Gail. (2006) Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions. JNCI Journal of the National Cancer Institute 98:14, 974-983
CrossRef331
Tawimas SHAIPANICH, Annette MCWILLIAMS, Stephen LAM. (2006) Early detection and chemoprevention of lung cancer. Respirology 11:4, 366-372
CrossRef332
G. BJELAKOVIC, A. NAGORNI, D. NIKOLOVA, R. G. SIMONETTI, M. BJELAKOVIC, C. GLUUD. (2006) Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Alimentary Pharmacology and Therapeutics 24:2, 281-291
CrossRef333
L CHRISTENSEN, K BRANDT. (2006) Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity and analysis. Journal of Pharmaceutical and Biomedical Analysis 41:3, 683-693
CrossRef334
L. Rosen. (2006) In Defense of the Randomized Controlled Trial for Health Promotion Research. American Journal of Public Health 96:7, 1181-1186
CrossRef335
K. A. Cronin, M. H. Gail, Z. Zou, P. B. Bach, J. Virtamo, D. Albanes. (2006) Validation of a Model of Lung Cancer Risk Prediction Among Smokers. JNCI Journal of the National Cancer Institute 98:9, 637-640
CrossRef336
Mario Luiz Conte Frota, Evandro Gomes Silva, Guilherme Antônio Behr, Marcos Roberto Oliveira, Felipe Dal-Pizzol, Fábio Klamt, José Cláudio Fonseca Moreira. (2006) All-trans retinoic acid induces free radical generation and modulate antioxidant enzyme activities in rat sertoli cells. Molecular and Cellular Biochemistry 285:1-2, 173-179
CrossRef337
Jennifer R Evans, Jennifer R Evans. 2006. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. .
CrossRef338
Kei Shimoda, Yoko Kondo, Koichi Abe, Hatsuyuki Hamada, Hiroki Hamada. (2006) Formation of water-soluble vitamin derivatives from lipophilic vitamins by cultured plant cells. Tetrahedron Letters 47:16, 2695-2698
CrossRef339
G. G. Schwartz, W. J. Blot. (2006) Vitamin D Status and Cancer Incidence and Mortality: Something New Under the Sun. JNCI Journal of the National Cancer Institute 98:7, 428-430
CrossRef340
S. J. Freemantle, K. H. Dragnev, E. Dmitrovsky. (2006) The Retinoic Acid Paradox in Cancer Chemoprevention. JNCI Journal of the National Cancer Institute 98:7, 426-427
CrossRef341
S. E. Rasmussen, N. L. Andersen, L. O. Dragsted, J. C. Larsen. (2006) A safe strategy for addition of vitamins and minerals to foods. European Journal of Nutrition 45:3, 123-135
CrossRef342
S YEH, W WANG, C HUANG, M HU. (2006) Flavonoids suppresses the enhancing effect of β-carotene on DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A549 cells. Chemico-Biological Interactions 160:2, 175-182
CrossRef343
Hussein A.N. Al-Wadei, Takashi Takahashi, Hildegard M. Schuller. (2006) Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by β-carotene via activation of cAMP, PKA, CREB and ERK1/2. International Journal of Cancer 118:6, 1370-1380
CrossRef344
Marie-France Demierre. (2006) What about chemoprevention for melanoma?. Current Opinion in Oncology 18:2, 180-184
CrossRef345
Maria V. Grau, Judy R. Rees, John A. Baron. (2006) Chemoprevention in Gastrointestinal Cancers: Current Status. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:3, 281-287
CrossRef346
Oliver Gautschi, Barbara Hugli, Annemarie Ziegler, Colette Bigosch, Naomi L. Bowers, Daniel Ratschiller, Monika Jermann, Rolf A. Stahel, Jim Heighway, Daniel C. Betticher. (2006) Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer 51:3, 303-311
CrossRef347
Frank Hu. 2006. Plant-Based Diets and Prevention of Cardiovascular Disease. , 127-136.
CrossRef348
Eunyoung Cho, David J. Hunter, Donna Spiegelman, Demetrius Albanes, W. Lawrence Beeson, Piet A. van den Brandt, Graham A. Colditz, Diane Feskanich, Aaron R. Folsom, Gary E. Fraser, Jo L. Freudenheim, Edward Giovannucci, R. Alexandra Goldbohm, Saxon Graham, Anthony B. Miller, Thomas E. Rohan, Thomas A. Sellers, Jarmo Virtamo, Walter C. Willett, Stephanie A. Smith-Warner. (2006) Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: A pooled analysis of 8 prospective studies. International Journal of Cancer 118:4, 970-978
CrossRef349
I-M. Lee, J. M. Gaziano, J. E. Buring. (2006) Vitamin E in the Prevention of Prostate Cancer: Where Are We Today?. JNCI Journal of the National Cancer Institute 98:4, 225-227
CrossRef350
Peep V. Algvere, John Marshall, Stefan Seregard. (2006) Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmologica Scandinavica 84:1, 4-15
CrossRef351
Sara ÅM Bergquist, Ulla E Gertsson, Marie E Olsson. (2006) Influence of growth stage and postharvest storage on ascorbic acid and carotenoid content and visual quality of baby spinach (Spinacia oleracea L.). Journal of the Science of Food and Agriculture 86:3, 346-355
CrossRef352
Howard D Sesso. (2006) Carotenoids and cardiovascular disease: what research gaps remain?. Current Opinion in Lipidology 17:1, 11-16
CrossRef353
Leonardo A.M. Zornoff, Beatriz B. Matsubara, Luiz S. Matsubara, Paula S. Azevedo, Marcos F. Minicucci, Alvaro O. Campana, Sergio A.R. Paiva. (2006) β-Carotene supplementation results in adverse ventricular remodeling after acute myocardial infarction. Nutrition 22:2, 146-151
CrossRef354
Jean-Claude Tardif. (2006) Antioxidants: The good, the bad and the ugly. Canadian Journal of Cardiology 22, 61B-65B
CrossRef355
L BERK. (2006) Primer on Integrative Oncology. Hematology/Oncology Clinics of North America 20:1, 213-231
CrossRef356
David R Thomas. (2006) Vitamins in aging, health, and longevity. Clinical Interventions in Aging 1:1, 81-91
CrossRef357
Y KUROIWA, A NISHIKAWA, T IMAZAWA, Y KITAMURA, K KANKI, Y ISHII, T UMEMURA, M HIROSE. (2006) A subchronic toxicity study of dunaliella carotene in F344 rats. Food and Chemical Toxicology 44:1, 138-145
CrossRef358
Ugo Pastorino. (2006) Early Detection of Lung Cancer. Respiration 73:1, 5-13
CrossRef359
&NA;. (2006) Vitamin Supplements. Obstetrics & Gynecology 107:1, 174-176
CrossRef360
David C. Gritz, Muthiah Srinivasan, Scott D. Smith, Usha Kim, Thomas M. Lietman, John H. Wilkins, Brinda Priyadharshini, Srinivasan Aravind, N. Venkatesh Prajna, Gilbert Smolin, Ravilla Duraisami Thulasiraj, Sivasubramaniam Selvaraj, John P. Whitcher. (2006) Antioxidants in Prevention of Cataracts in South India: Methodology and Baseline Data*. Ophthalmic Epidemiology 13:2, 97-107
CrossRef361
Melpo Christofidou-Solomidou, Vladimir R Muzykantov. (2006) Antioxidant Strategies in Respiratory Medicine. Treatments in Respiratory Medicine 5:1, 47-78
CrossRef362
Armando Cruz-Torres, Annia Galano, J. Raúl Alvarez-Idaboy. (2006) Kinetics and mechanism of the β-alanine + OH gas phase reaction: A quantum mechanical approach. Physical Chemistry Chemical Physics 8:2, 285
CrossRef363
Yusuke Hiraku, Mariko Murata, Shosuke Kawanishi. (2006) Role of Oxidative DNA Damage in Dietary Carcinogenesis. Genes and Environment 28:4, 127-140
CrossRef364
Virginie Maillard, Claude Hoinard, Khelifa Arab, Marie-Lise Jourdan, Philippe Bougnoux, Véronique Chajès. (2006) Dietary β-carotene inhibits mammary carcinogenesis in rats depending on dietary α-linolenic acid content. British Journal of Nutrition 96:01, 18
CrossRef365
2006. Vitamin A: Carotenoids. , 3642-3653.
CrossRef366
Barnett S. Kramer, Joan Wilentz, Duane Alexander, John Burklow, Lawrence M. Friedman, Richard Hodes, Ruth Kirschstein, Amy Patterson, Griffin Rodgers, Stephen E. Straus. (2006) Getting It Right: Being Smarter about Clinical Trials. PLoS Medicine 3:6, e144
CrossRef367
Ross Prentice. 2005. Observational Studies and Intervention Trials in Exercise, Diet, and Cancer Prevention Research. , 3-11.
CrossRef368
Norman I. Krinsky, Elizabeth J. Johnson. (2005) Carotenoid actions and their relation to health and disease. Molecular Aspects of Medicine 26:6, 459-516
CrossRef369
P. Palozza, A. Sheriff, S. Serini, A. Boninsegna, N. Maggiano, F. O. Ranelletti, G. Calviello, A. Cittadini. (2005) Lycopene induces apoptosis in immortalized fibroblasts exposed to tobacco smoke condensate through arresting cell cycle and down-regulating cyclin D1, pAKT and pBad. Apoptosis 10:6, 1445-1456
CrossRef370
(2005) Second primary cancer prevention: the conundrum of antioxidants. Focus on Alternative and Complementary Therapies 10:4, 293-294
CrossRef371
Mark A. Moyad. (2005) Prescription versus herbal medications for prostate cancer prevention: Why history cannot be allowed to repeat itself in your clinical practice. Current Prostate Reports 3:4, 160-168
CrossRef372
Hiroshi Ohshima, Hiroshi Tazawa, Bakary S. Sylla, Tomohiro Sawa. (2005) Prevention of human cancer by modulation of chronic inflammatory processes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 591:1-2, 110-122
CrossRef373
Yafei Zhang, Rena Li. 2005. Nutrition, Brain Aging, and Alzheimer’s Disease. , 409-441.
CrossRef374
W. J. Petty, N. Li, A. Biddle, R. Bounds, C. Nitkin, Y. Ma, K. H. Dragnev, S. J. Freemantle, E. Dmitrovsky. (2005) A Novel Retinoic Acid Receptor Isoform and Retinoid Resistance in Lung Carcinogenesis. JNCI Journal of the National Cancer Institute 97:22, 1645-1651
CrossRef375
Shosuke Kawanishi, Shinji Oikawa, Mariko Murata. (2005) Evaluation for Safety of Antioxidant Chemopreventive Agents. Antioxidants & Redox Signaling 7:11-12, 1728-1739
CrossRef376
Jayne V. Woodside, Damian McCall, Claire McGartland, Ian S. Young. (2005) Micronutrients: dietary intake v. supplement use. Proceedings of the Nutrition Society 64:04, 543-553
CrossRef377
Gordon T McInnes. (2005) Antioxidants and hypertension: another false dawn?. Journal of Hypertension 23:11, 1963-1966
CrossRef378
P Galan, F E Viteri, S Bertrais, S Czernichow, H Faure, J Arnaud, D Ruffieux, S Chenal, N Arnault, A Favier, A-M Roussel, S Hercberg. (2005) Serum concentrations of β-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. European Journal of Clinical Nutrition 59:10, 1181-1190
CrossRef379
Stephanie M. Dorosko. (2005) Vitamin A, Mastitis, and Mother-to-Child Transmission of HIV-1 through Breast-feeding: Current Information and Gaps in Knowledge. Nutrition Reviews 63:10, 332-346
CrossRef380
Katsuhisa Sakano, Mika Mizutani, Mariko Murata, Shinji Oikawa, Yusuke Hiraku, Shosuke Kawanishi. (2005) Procyanidin B2 has anti- and pro-oxidant effects on metal-mediated DNA damage. Free Radical Biology and Medicine 39:8, 1041-1049
CrossRef381
Doris M. Benbrook, Scott A. Kamelle, Suresh B. Guruswamy, Stan A. Lightfoot, Teresa L. Rutledge, Natalie S. Gould, Bethany N. Hannafon, S. Terence Dunn, K. Darrell Berlin. (2005) Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Investigational New Drugs 23:5, 417-428
CrossRef382
Ian Constable, Wei-Yong Shen, Elizabeth Rakoczy. (2005) Emerging biological therapies for age-related macula degeneration. Expert Opinion on Biological Therapy 5:10, 1373-1385
CrossRef383
B Cartmel, J Dziura, M R Cullen, S Vegso, G S Omenn, G E Goodman, C A Redlich. (2005) Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). European Journal of Clinical Nutrition 59:10, 1173-1180
CrossRef384
S. T. Mayne, S. M. Lippman. (2005) Cigarettes: A Smoking Gun in Cancer Chemoprevention. JNCI Journal of the National Cancer Institute 97:18, 1319-1321
CrossRef385
M. Touvier, E. Kesse, F. Clavel-Chapelon, M.-C. Boutron-Ruault. (2005) Dual Association of -Carotene With Risk of Tobacco-Related Cancers in a Cohort of French Women. JNCI Journal of the National Cancer Institute 97:18, 1338-1344
CrossRef386
Anne Harvey. (2005) Blackmores denies claim of prevention or treatment of AMD. Clinical and Experimental Optometry 88:5, 352-353
CrossRef387
Guy W. Bylsma, Robyn H. Guymer. (2005) Treatment of age-related macular degeneration. Clinical and Experimental Optometry 88:5, 322-334
CrossRef388
David Kitts. 2005. Antioxidant Phytochemicals and Potential Synergistic Activities at Reducing Risk of Cardiovascular Disease. , 27-62.
CrossRef389
François Meyer, Pilar Galan, Pierre Douville, Isabelle Bairati, Pastelle Kegle, Sandrine Bertrais, Carla Estaquio, Serge Hercberg. (2005) Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. International Journal of Cancer 116:2, 182-186
CrossRef390
William J. Blot, Wong-Ho Chow, Joseph K. McLaughlin. 2005. Environmental Epidemiology. .
CrossRef391
P. J. Skerrett, Charles H. Hennekens. 2005. Physicians' Health Study. .
CrossRef392
Aminah Jatoi, Brent Williams, Frank Nichols, Randolph Marks, Marie-Christine Aubry, Jason Wampfler, Erin E. Finke, Ping Yang. (2005) Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients?. Lung Cancer 49:1, 77-84
CrossRef393
F. Ziemssen, M. Warga, K. U. Bartz-Schmidt, H. Wilhelm. (2005) „Haben Sie ein Mittel gegen Makuladegeneration?“. Der Ophthalmologe 102:7, 715-725
CrossRef394
W SIEMS, I WISWEDEL, C SALERNO, C CRIFO, W AUGUSTIN, L SCHILD, C LANGHANS, O SOMMERBURG. (2005) β-Carotene breakdown products may impair mitochondrial functions — potential side effects of high-dose β-carotene supplementation. The Journal of Nutritional Biochemistry 16:7, 385-397
CrossRef395
Victor Cohen, Fadlo R Khuri. (2005) Chemoprevention of lung cancer: concepts and strategies. Expert Review of Anticancer Therapy 5:3, 549-565
CrossRef396
Stephen Barnes, Jeevan Prasain. (2005) Current progress in the use of traditional medicines and nutraceuticals. Current Opinion in Plant Biology 8:3, 324-328
CrossRef397
Helman S. Alfonso, Lin Fritschi, Nicholas H. de Klerk, Gina Ambrosini, John Beilby, Nola Olsen, A William Musk. (2005) Plasma Concentrations of Retinol, Carotene, and Vitamin E and Mortality in Subjects With Asbestosis in a Cohort Exposed to Crocidolite in Wittenoom, Western Australia. Journal of Occupational and Environmental Medicine 47:6, 573-579
CrossRef398
Suresh H. Moolgavkar. (2005) A review and critique of the EPA’s rationale for a fine particle standard. Regulatory Toxicology and Pharmacology 42:1, 123-144
CrossRef399
Werner Siems, Ingrid Wiswedel, Avdulla Alija, Nikolaus Bresgen, Peter Eckl, Claus-Dieter Langhans, Olaf Sommerburg. 2005. _-Carotene Cleavage Products Impair Cellular and Mitochondrial Functions and May Lead to Genotoxicity. .
CrossRef400
J Michael Gaziano, Howard Sesso. 2005. Carotenoids and Cardiovascular Disease. .
CrossRef401
Kyung-Jin Yeum, Giancarlo Aldini, Elizabeth Johnson, Robert Russell, Norman Krinsky. 2005. Effect of Feeding and Then Depleting a High Fruit and Vegetable Diet on Oxidizability in Human Serum. .
CrossRef402
Yoav Sharoni, Riad Agbaria, Hadar Amir, Anat Ben-Dor, Noga Dubi, Yudit Giat, Keren Hirsh, Gaby Izumchenko, Marina Khanin, Elena Kirilov, Amit Nahum, Michael Steiner, Yossi Walfisch, Shlomo Walfisch, Michael Danilenko, Joseph Levy. 2005. Regulation of Transcription by Antioxidant Carotenoids. .
CrossRef403
B Nier, Peter Weinberg, B Ewins, S Cremers. 2005. Effects of Antioxidants on Gene Expression in Endothelial Cells. , 141-180.
CrossRef404
Si
n Astley. (2005) Antioxidants and 21st century nutrition. Food Science <html_ent glyph="@amp;" ascii="&"/> Technology Bulletin: Functional Foods 2:2, 19-29
CrossRef405
Fiona Mathews, Andrew Neil. (2005) Antioxidants and preterm prelabour rupture of the membranes. BJOG: An International Journal of Obstetrics & Gynaecology 112:5, 588-594
CrossRef406
Francesc Fatj??, Joaquim Fern??ndez-Sol??, Meritxell Llu??s, Montserrat Elena, Eva Bad??a, Emilio Sacanella, Ram??n Estruch, Josep-Mar??a Nicol??s. (2005) Myocardial Antioxidant Status in Chronic Alcoholism. Alcoholism: Clinical & Experimental Research 29:5, 864-870
CrossRef407
I. Bairati, F. Meyer, M. Gelinas, A. Fortin, A. Nabid, F. Brochet, J.-P. Mercier, B. Tetu, F. Harel, B. Masse, E. Vigneault, S. Vass, P. del Vecchio, J. Roy. (2005) A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients. JNCI Journal of the National Cancer Institute 97:7, 481-488
CrossRef408
E. S. Kim, W. K. Hong. (2005) An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention. JNCI Journal of the National Cancer Institute 97:7, 468-470
CrossRef409
Ming-Dauh Wang, Seymour Geisser. (2005) Optimal dichotomization of screening test variables. Journal of Statistical Planning and Inference 131:1, 191-206
CrossRef410
Serge Hercberg, Sandrine Bertrais, Sébastien Czernichow, Nathalie Noisette, Pilar Galan, Adèle Jaouen, Jean Tichet, Serge Briancon, Alain Favier, Louise Mennen, Anne-Marie Roussel. (2005) Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX study. Lipids 40:4, 335-342
CrossRef411
Karin B. Michels. (2005) The role of nutrition in cancer development and prevention. International Journal of Cancer 114:2, 163-165
CrossRef412
Robyn Heather Guymer, Anthony Wai-ip Chiu, Lyndell Lim, Paul Nigel Baird. (2005) HMG CoA Reductase Inhibitors (Statins): Do They Have a Role in Age-related Macular Degeneration?. Survey of Ophthalmology 50:2, 194-206
CrossRef413
(2005) High-dose antioxidants to prevent cancer: hype or hoax?. Focus on Alternative and Complementary Therapies 10:1, 29-31
CrossRef414
T DESMETTRE, J LECERF. (2005) Alicaments ou supplémentations à doses nutritionnelles : quel avenir pour la micronutrition en ophtalmologie ?!. Journal Français d'Ophtalmologie 28:3, 239-242
CrossRef415
Jayadev Raju, Malisetty V. Swamy, Indranie Cooma, Jagan M.R. Patlolla, Brian Pittman, Bandaru S. Reddy, Vernon E. Steele, Chinthalapally V. Rao. (2005) Low doses of β-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. International Journal of Cancer 113:5, 798-802
CrossRef416
JOHN SHI, QIN QU, YUKIO KAKÙDA, DAVID YEUNG, YUEMING JIANG. (2005) Stability and Synergistic Effect of Antioxidative Properties of Lycopene and Other Active Components. Critical Reviews in Food Science and Nutrition 44:7-8, 559-573
CrossRef417
B. Porcelli, L. Terzuoli, B. Frosi, C. Felici, L. Barabesi, S. Naddeo, S. Meini, D. Pieragalli, I. Baldi, G. Donato, E. Marinello, M Giubbolini, C. Setacci. (2005) Antioxidant Status in Peripheral Vascular Atherosclerosis. International Journal of Angiology 14:1, 7-10
CrossRef418
Ivonne M. C. M. Rietjens, Martijn J. Martena, Marelle G. Boersma, Wim Spiegelenberg, Gerrit M. Alink. (2005) Molecular mechanisms of toxicity of important food-borne phytotoxins. Molecular Nutrition & Food Research 49:2, 131-158
CrossRef419
Ali El-Agamey, Marc Burke, Ruth Edge, Edward J. Land, David J. McGarvey, T. George Truscott. (2005) Photolysis of carotenoids in chloroform: enhanced yields of carotenoid radical cations in the presence of a tryptophan ester. Radiation Physics and Chemistry 72:2-3, 341-345
CrossRef420
Alice H Lichtenstein. (2005) Nutrients and cardiovascular disease: no easy answers – editorial review. Current Opinion in Lipidology 16:1, 1-3
CrossRef421
Jean-Claude Tardif. (2005) Antioxidants and atherosclerosis: Emerging drug therapies. Current Atherosclerosis Reports 7:1, 71-77
CrossRef422
F. Mencarelli, M.C. Salcini, A. Bellincontro. 2005. Consumer risk in storage and shipping of raw fruits and vegetables. , 556-598.
CrossRef423
Kenji Wakai, Masahiko Ando, Kotaro Ozasa, Yoshinori Ito, Koji Suzuki, Yoshikazu Nishino, Shin-ichi Kuriyama, Nao Seki, Takaaki Kondo, Yoshiyuki Watanabe, Yoshiyuki Ohno, Akiko Tamakoshi. (2005) Updated Information on Risk Factors for Lung Cancer: Findings from the JACC Study. Journal of Epidemiology 15:Supplement_II, S134-S139
CrossRef424
R.H.J. Breuer, P.E. Postmus, E.F. Smit. (2005) Molecular Pathology of Non-Small-Cell Lung Cancer. Respiration 72:3, 313-330
CrossRef425
G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens, G. S. Omenn, B. Valanis, J. H. Williams. (2004) The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping -Carotene and Retinol Supplements. JNCI Journal of the National Cancer Institute 96:23, 1743-1750
CrossRef426
A. J. Duffield-Lillico, C. B. Begg. (2004) Reflections on the Landmark Studies of -Carotene Supplementation. JNCI Journal of the National Cancer Institute 96:23, 1729-1731
CrossRef427
K. Swindells, L. E. Rhodes. (2004) Influence of oral antioxidants on ultraviolet radiation-induced skin damage in humans. Photodermatology, Photoimmunology and Photomedicine 20:6, 297-304
CrossRef428
David I. Thurnham. (2004) An overview of interactions between micronutrients and of micronutrients with drugs, genes and immune mechanisms. Nutrition Research Reviews 17:02, 211
CrossRef429
Ross L. Prentice. (2004) Chronic disease prevention: public health potential and research needs. Statistics in Medicine 23:22, 3409-3420
CrossRef430
A.M. Bode, Z. Dong. (2004) Targeting signal transduction pathways by chemopreventive agents. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 555:1-2, 33-51
CrossRef431
Eleonora Miquel Becker, Lise R. Nissen, Leif H. Skibsted. (2004) Antioxidant evaluation protocols: Food quality or health effects. European Food Research and Technology 219:6, 561-571
CrossRef432
Nalini Sharma, Bradley Trope, Timothy O. Lipman. (2004) Vitamin Supplementation. Journal of Clinical Gastroenterology 38:10, 844-854
CrossRef433
Susan Steck-Scott, Michele R. Forman, Anne Sowell, Craig B. Borkowf, Paul S. Albert, Martha Slattery, Brenda Brewer, Bette Caan, Electra Paskett, Frank Iber, Walt Kikendall, James Marshall, Moshe Shike, Joel Weissfeld, Kirk Snyder, Arthur Schatzkin, Elaine Lanza, . (2004) Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. International Journal of Cancer 112:2, 295-305
CrossRef434
S. Packianathan, Rajendra G. Mehta, Rajeshwari R. Mehta, William H. Hall, Philip S. Boerner, Laurel A. Beckett, Srinivasan Vijayakumar. (2004) Designing a Randomized Phase I/II Prostate Cancer Chemoprevention Trial Using 1??-Hydroxy-24-Ethyl-Cholecalciferol, an Analogue of Vitamin D3. The Cancer Journal 10:6, 357-367
CrossRef435
I. T. Johnson. (2004) Micronutrients and cancer. Proceedings of the Nutrition Society 63:04, 587-595
CrossRef436
Thomas Menke, Petra Niklowitz, Gideon de Sousa, Thomas Reinehr, Werner Andler. (2004) Comparison of coenzyme Q10 plasma levels in obese and normal weight children. Clinica Chimica Acta 349:1-2, 121-127
CrossRef437
T DESMETTRE, J LECERF, E SOUIED. (2004) Nutrition et dégénérescence maculaire liée à l’âge. Journal Français d'Ophtalmologie 27:9, 38-56
CrossRef438
Jane Higdon, Balz Frei. 2004. Vitamin C, Vitamin E, and b-Carotene in Cancer Chemoprevention. .
CrossRef439
John Dore. 2004. Astaxanthin and Cancer Chemoprevention. .
CrossRef440
Jeffrey Blumberg. 2004. Commentary 1. .
CrossRef441
G Bjelakovic, D Nikolova, RG Simonetti, C Gluud, Goran Bjelakovic. 2004. Antioxidant supplements for preventing gastrointestinal cancers. .
CrossRef442
David Forman, Douglas Altman. (2004) Vitamins to prevent cancer: supplementary problems. The Lancet 364:9441, 1193-1194
CrossRef443
Philippe P. Hujoel. (2004) Endpoints in periodontal trials: the need for an evidence-based research approach. Periodontology 2000 36:1, 196-204
CrossRef444
Jack L. Arbiser, Chun-Yang Fan, Xiaobo Su, Beth O. Van Emburgh, Francesca Cerimele, Mark Steven Miller, Jeff Harvell, M. Marinkovich. (2004) Involvement of p53 and p16 Tumor Suppressor Genes in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. Journal of Investigative Dermatology 123:4, 788-790
CrossRef445
Wendy M.R. van Herpen-broekmans, Ineke A.A. Kl
CrossRef446
José A Luchsinger, Richard Mayeux. (2004) Dietary factors and Alzheimer's disease. The Lancet Neurology 3:10, 579-587
CrossRef447
Goran Bjelakovic, Dimitrinka Nikolova, Rosa G Simonetti, Christian Gluud. (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. The Lancet 364:9441, 1219-1228
CrossRef448
Jose M. Ordovas, Dolores Corella. (2004) NUTRITIONAL GENOMICS. Annual Review of Genomics and Human Genetics 5:1, 71-118
CrossRef449
Shuko Nojiri, Hiroyuki Daida, Yutaka Inaba. (2004) Antioxidants and cardiovascular disease: Still a topic of interest. Environmental Health and Preventive Medicine 9:5, 200-213
CrossRef450
MARTIJN B. KATAN, NICOLE M. ROOS. (2004) Promises and Problems of Functional Foods. Critical Reviews in Food Science and Nutrition 44:5, 369-377
CrossRef451
Nabil Saba, Sanjay Jain, Fadlo Khuri. (2004) Chemoprevention in lung cancer. Current Problems in Cancer 28:5, 287-306
CrossRef452
R. L. Prentice, W. C. Willett, P. Greenwald, D. Alberts, L. Bernstein, N. F. Boyd, T. Byers, S. K. Clinton, G. Fraser, L. Freedman, D. Hunter, V. Kipnis, L. N. Kolonel, B. S. Kristal, A. Kristal, J. W. Lampe, A. McTiernan, J. Milner, R. E. Patterson, J. D. Potter, E. Riboli, A. Schatzkin, A. Yates, E. Yetley. (2004) Nutrition and Physical Activity and Chronic Disease Prevention: Research Strategies and Recommendations. JNCI Journal of the National Cancer Institute 96:17, 1276-1287
CrossRef453
J Michael Gaziano, Howard Sesso. 2004. Heart and Vascular Diseases. , 473-490.
CrossRef454
David Hughes. 2004. Carotenoids and Immune Responses. , 503-517.
CrossRef455
Paola Palozza. 2004. Evidence for Pro-Oxidant Effects of Carotenoids In Vitro and In Vivo. , 127-149.
CrossRef456
Cheryl Rock. 2004. Relationship of Carotenoids to Cancer. , 373-407.
CrossRef457
Xiang-Dong Wang. 2004. Carotenoid Oxidative/Degradative Products and Their Biological Activities. , 313-335.
CrossRef458
Robert Russell, Guangwen Tang. 2004. Bioequivalence of Provitamin A Carotenoids. , 279-294.
CrossRef459
Margaret Wright, Demetrius Albanes. 2004. Potential Adverse Effects of beta-Carotene Supplementation in Cigarette Smokers and Heavier Drinkers. , 531-545.
CrossRef460
Susan Mayne, Helmut Sies, Norman Krinsky. 2004. Carotenoids. , 547-551.
CrossRef461
Gordon Lowe, Andrew Young, Denise Phillip. 2004. Carotenoid Antioxidant Activity. , 105-126.
CrossRef462
Wilhelm Stahl, Michael Danilenko, Yoav Sharoni, Joseph Levy. 2004. Anticancer Activity of Carotenoids. , 165-196.
CrossRef463
Micheline Mathews-Roth. 2004. Therapeutic Uses of Carotenoids in Skin Photosensitivity Diseases. , 519-529.
CrossRef464
Ann Cantrell, T George Truscott. 2004. Carotenoids and Radicals; Interactions with Other Nutrients. , 31-52.
CrossRef465
F Visioli, S Grande, P Bogani, C Galli. (2004) The role of antioxidants in the Mediterranean diets: focus on cancer. European Journal of Cancer Prevention 13:4, 337-343
CrossRef466
A. Lavy, A. Karban, A. Suissa, K. Yassin, I. Hermesh, A. Ben-Amotz. (2004) Natural β-Carotene for the Prevention of Post-ERCP Pancreatitis. Pancreas 29:2, e45-e50
CrossRef467
M A Martinez-Gonzalez, R Estruch. (2004) Mediterranean diet, antioxidants and cancer: the need for randomized trials. European Journal of Cancer Prevention 13:4, 327-335
CrossRef468
J Rodenburg, MN Vissers, A Wiegman, MD Trip, HD Bakker, John JP Kastelein. (2004) Familial hypercholesterolemia in children. Current Opinion in Lipidology 15:4, 405-411
CrossRef469
Michele Giuliani, Daniela Antuzzi, Carlo Lajolo, Lorenza Mistura, Roberta Ricci. (2004) Influence of β-carotene on lysosomal hydrolases and their natural substrates in major salivary glands of hamsters treated with 7,12-dimethylbenzanthracene (DMBA). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 138:4, 445-452
CrossRef470
M.R. Forman, S.D. Hursting, A. Umar, J.C. Barrett. (2004) NUTRITION AND CANCER PREVENTION: A Multidisciplinary Perspective on Human Trials*. Annual Review of Nutrition 24:1, 223-254
CrossRef471
K Brandt, L.P Christensen, J Hansen-Møller, S.L Hansen, J Haraldsdottir, L Jespersen, S Purup, A Kharazmi, V Barkholt, H Frøkiær, M Kobæk-Larsen. (2004) Health promoting compounds in vegetables and fruits. Trends in Food Science & Technology 15:7-8, 384-393
CrossRef472
Victor Cohen, Fadlo R Khuri. (2004) Chemoprevention of lung cancer. Current Opinion in Pulmonary Medicine 10:4, 279-283
CrossRef473
Catherine Sauvaget, Fumiyoshi Kasagi, Charles A Waldren. (2004) Dietary factors and cancer mortality among atomic-bomb survivors. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 551:1-2, 145-152
CrossRef474
Hildegard M Schuller, B Porter, A Riechert, K Walker, R Schmoyer. (2004) Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 45:1, 11-18
CrossRef475
Halla Skuladottir, Anne Tjoenneland, Kim Overvad, Connie Stripp, Jane Christensen, Ole Raaschou-Nielsen, Jørgen H Olsen. (2004) Does insufficient adjustment for smoking explain the preventive effects of fruit and vegetables on lung cancer?. Lung Cancer 45:1, 1-10
CrossRef476
JOYE K. WILLCOX, SARAH L. ASH, GEORGE L. CATIGNANI. (2004) Antioxidants and Prevention of Chronic Disease. Critical Reviews in Food Science and Nutrition 44:4, 275-295
CrossRef477
Henry C Lukaski. (2004) Vitamin and mineral status: effects on physical performance. Nutrition 20:7-8, 632-644
CrossRef478
Laura M Hix, Samuel F Lockwood, John S Bertram. (2004) Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives. Cancer Letters 211:1, 25-37
CrossRef479
Roger Stupp, Christian Monnerat, Andrew T Turrisi, Michael C Perry, Serge Leyvraz. (2004) Small cell lung cancer: state of the art and future perspectives. Lung Cancer 45:1, 105-117
CrossRef480
Richard C Hartley, Malcolm W Kennedy. (2004) Are carotenoids a red herring in sexual display?. Trends in Ecology & Evolution 19:7, 353-354
CrossRef481
S.Michael Sharp, Rebecca D Pentz. (2004) Issues, both ethical and practical, in the development and conduct of chemoprevention trials. Current Problems in Cancer 28:4, 186-200
CrossRef482
Peter Møller, Steffen Loft. (2004) Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 551:1-2, 79-89
CrossRef483
A. D. Dangour, V. L. Sibson, A. E. Fletcher. (2004) Hormones and Supplements: Do They Work?: Micronutrient Supplementation in Later Life: Limited Evidence for Benefit. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:7, B659-B673
CrossRef484
MITALI BASU CHATTOPADHYAY, MAHENDRA KUMAR CB, P SURESH KANNA, RAJARSHI SANKAR RAY, SOUVIK ROY, MALAY CHATTERJEE. (2004) Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis. Journal of Gastroenterology and Hepatology 19:6, 683-693
CrossRef485
F. Shahidi. (2004) Functional Foods: Their Role in Health Promotion and Disease Prevention. Journal of Food Science 69:5, R146-R149
CrossRef486
Karen Riedl, Kostyantyn Krysan, Mehis Põld, Harnisha Dalwadi, Nathalie Heuze-Vourc’h, Mariam Dohadwala, Ming Liu, Xiaoyan Cui, Robert Figlin, Jenny T Mao, Robert Strieter, Sherven Sharma, Steven M Dubinett. (2004) Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resistance Updates 7:3, 169-184
CrossRef487
SA Stanner, J Hughes, CNM Kelly, J Buttriss. (2004) A review of the epidemiological evidence for the ‘antioxidant hypothesis’. Public Health Nutrition 7:03,
CrossRef488
Ernest T. Hawk, Asad Umar, Jaye L. Viner. (2004) Colorectal cancer chemoprevention—an overview of the science1 1This article was prepared in our capacity as employees of the U.S. Federal Government.. Gastroenterology 126:5, 1423-1447
CrossRef489
Alexandra Alves-Rodrigues, Andrew Shao. (2004) The science behind lutein. Toxicology Letters 150:1, 57-83
CrossRef490
P. Strazzullo, L. Scalfi, F. Branca, G. Cairella, F. Garbagnati, A. Siani, G. Barba, P. Rubba, G. Mancia. (2004) Nutrition and prevention of ischemic stroke: present knowledge, limitations and future perspectives. Nutrition, Metabolism and Cardiovascular Diseases 14:2, 97-114
CrossRef491
Robert S Rosenson. (2004) Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 173:1, 1-12
CrossRef492
H TAPIERO. (2004) Influence of alcohol consumption and smoking habits on human health. Biomedecine & Pharmacotherapy 58:2, 75-76
CrossRef493
H Tapiero, D.M Townsend, K.D Tew. (2004) The role of carotenoids in the prevention of human pathologies. Biomedicine & Pharmacotherapy 58:2, 100-110
CrossRef494
Timothy J Key, Arthur Schatzkin, Walter C Willett, Naomi E Allen, Elizabeth A Spencer, Ruth C Travis. (2004) Diet, nutrition and the prevention of cancer. Public Health Nutrition 7:1a,
CrossRef495
C. A. Northrop-Clewes, D. T. Thurnham. 2004. Vitamins. , 681-707.
CrossRef496
(2004) High-dose Antioxidant Supplementation and Cataract Risk. Nutrition Reviews 62:1, 28-32
CrossRef497
Shigeru Hisamichi. (2004) Science and Ethics in Epidemiology. Journal of Epidemiology 14:4, 105-111
CrossRef498
Mi Kyung Kim, Satoshi Sasaki, Shizuka Sasazuki, Shunji Okubo, Masato Hayashi, Shoichiro Tsugane. (2004) Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects. British Journal of Nutrition 91:01, 81
CrossRef499
F. Shahidi. 2004. Food phenolics and cancer chemoprevention. , 669-680.
CrossRef500
Ntei Abudu, James J Miller, Mohammed Attaelmannan, Stanley S Levinson. (2004) Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clinica Chimica Acta 339:1-2, 11-25
CrossRef501
Myung-Hee Kang, Yoo Kyoung Park, Hye-Young Kim, Tae Seok Kim. (2004) Green vegetable drink consumption protects peripheral lymphocytes DNA damage in Korean smokers. BioFactors 22:1-4, 245-247
CrossRef502
Shari S. Bassuk, Christine M. Albert, Nancy R. Cook, Elaine Zaharris, Jean G. MacFadyen, Eleanor Danielson, Martin Van Denburgh, Julie E. Buring, Joann E. Manson. (2004) The Women's Antioxidant Cardiovascular Study: Design and Baseline Characteristics of Participants. Journal of Women's Health 13:1, 99-117
CrossRef503
N. M. de Roos. 2004. The potential and limits of functional foods in preventing cardiovascular disease. , 1-9.
CrossRef504
Marian L. Neuhouser. (2004) Flavonoids and Cancer Prevention: What Is the Evidence in Humans?. Pharmaceutical Biology 42:s1, 36-45
CrossRef505
Bernd van der Loo, Ralf Labugger, Claude P. Aebischer, Markus Bachschmid, Volker Spitzer, Juliane Kilo, Lukas Altwegg, Volker Ullrich, Thomas F. L??scher. (2004) Age-Related Changes of Vitamin A Status. Journal of Cardiovascular Pharmacology 43:1, 26-30
CrossRef506
Stephanie A. Smith-Warner, Donna Spiegelman, Shiaw-Shyuan Yaun, Demetrius Albanes, W. Lawrence Beeson, Piet A. van den Brandt, Diane Feskanich, Aaron R. Folsom, Gary E. Fraser, Jo L. Freudenheim, Edward Giovannucci, R. Alexandra Goldbohm, Saxon Graham, Lawrence H. Kushi, Anthony B. Miller, Pirjo Pietinen, Thomas E. Rohan, Frank E. Speizer, Walter C. Willett, David J. Hunter. (2003) Fruits, vegetables and lung cancer: A pooled analysis of cohort studies. International Journal of Cancer 107:6, 1001-1011
CrossRef507
Carla Lopes, Susana Casal, Beatriz Oliveira, Henrique Barros. 2003. Retinol, Beta-Carotene, and Alpha-Tocopherol in Heart Disease. .
CrossRef508
Frederick Khachik, Nitin Telang, Fumio Enjo, Martin Lipkin. 2003. Development of a Mixture of Dietary Carotenoids as Cancer Chemopreventive Agents. .
CrossRef509
Yoav Sharoni, Riad Agbaria, Hadar Amir, Anat Ben-Dor, Irene Bobilev, Noga Doubi, Yudit Giat, Keren Hirsh, Gaby Izumchenko, Marina Khanin, Elena Kirilov, Rita Krimer, Amit Nahum, Michael Steiner, Yossi Walfisch, Shlomo Walfisch, Gabi Zango, Michael Danilenko, Joseph Levy. (2003) Modulation of transcriptional activity by antioxidant carotenoids. Molecular Aspects of Medicine 24:6, 371-384
CrossRef510
S Yeh. (2003) Oxidized β-carotene inhibits gap junction intercellular communication in the human lung adenocarcinoma cell line A549. Food and Chemical Toxicology 41:12, 1677-1684
CrossRef511
T STOLL, U SCHWEIGGERT, A SCHIEBER, R CARLE. (2003) Process for the recovery of a carotene-rich functional food ingredient from carrot pomace by enzymatic liquefaction. Innovative Food Science & Emerging Technologies 4:4, 415-423
CrossRef512
Gordon M. Lowe, Konstantinos Vlismas, Andrew J. Young. (2003) Carotenoids as prooxidants?. Molecular Aspects of Medicine 24:6, 363-369
CrossRef513
Nico van Zandwijk, Fred R Hirsch. (2003) Chemoprevention of lung cancer: current status and future prospects. Lung Cancer 42:2, 71-79
CrossRef514
Paola Palozza, Simona Serini, Fiorella Di Nicuolo, Elisabetta Piccioni, Gabriella Calviello. (2003) Prooxidant effects of β-carotene in cultured cells. Molecular Aspects of Medicine 24:6, 353-362
CrossRef515
Guy De Backer, Ettore Ambrosioni, Knut Broch-Johnsen, Carlos Brotons, Renata Cifkova, Jean Dallongeville, Shah Ebrahim, Ole Faergeman, Ian Graham, Guiseppe Mancia, Volkert Manger Cats, Kristina Orth-Gom??r, Joep Perk, Kalevi Py??r??l??, Jos?? L. Rodicio, Susana Sans, Vedat Sansoy, Udo Sechtem, Sigmund Silber, Troels Thomsen, David Wood. (2003) European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European Journal of Cardiovascular Prevention and Rehabilitation 10:Supplement 1, S1-S78
CrossRef516
Marek Jakóbisiak, Witold Lasek, Jakub Gołb. (2003) Natural mechanisms protecting against cancer. Immunology Letters 90:2-3, 103-122
CrossRef517
G. Nagel, A. Nieters, N. Becker, J. Linseisen. (2003) The influence of the dietary intake of fatty acids and antioxidants on hay fever in adults. Allergy 58:12, 1277-1284
CrossRef518
Carla K. Miller, Teri Russell, Grace Kissling. (2003) Decision-making patterns for dietary supplement purchases among women aged 25 to 45 years. Journal of the American Dietetic Association 103:11, 1523-1526
CrossRef519
Jean-Charles Soria, Edward S Kim, Jéôme Fayette, Sylvie Lantuejoul, Eric Deutsch, Waun Ki Hong. (2003) Chemoprevention of lung cancer. The Lancet Oncology 4:11, 659-669
CrossRef520
Gil Hardy, Ines Hardy, Patrick A Ball. (2003) Nutraceuticals - a pharmaceutical viewpoint: part II. Current Opinion in Clinical Nutrition and Metabolic Care 6:6, 661-671
CrossRef521
William B. Armstrong, X. Steven Wan, Ann R. Kennedy, Thomas H. Taylor, Frank L. Meyskens. (2003) Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. The Laryngoscope 113:10, 1687-1702
CrossRef522
David L. Steward, Frida Wiener, Lyon L. Gleich, Grace Falciglia. (2003) Dietary Antioxidant Intake in Patients at Risk for Second Primary Cancer. The Laryngoscope 113:9, 1487-1493
CrossRef523
Naoki INUI, Shigekazu SASAKI, Takafumi SUDA, Kingo CHIDA, Hirotoshi NAKAMURA. (2003) The loss of retinoic acid receptor ?, ? and alcohol dehydrogenase3 expression in non-small cell lung cancer. Respirology 8:3, 302-309
CrossRef524
W.Jeffrey Petty, Konstantin H. Dragnev, Ethan Dmitrovsky. (2003) Cyclin D1 as a target for chemoprevention. Lung Cancer 41, 155-161
CrossRef525
Susanne L Hansen, Stig Purup, Lars P Christensen. (2003) Bioactivity of falcarinol and the influenceof processing and storage on its content in carrots (Daucus carota L). Journal of the Science of Food and Agriculture 83:10, 1010-1017
CrossRef526
John C. Mathers. (2003) Nutrition and cancer prevention: diet-gene interactions. Proceedings of the Nutrition Society 62:03, 605-610
CrossRef527
Garry G. Duthie, Peter T. Gardner, Janet A. M. Kyle. (2003) Plant polyphenols: are they the new magic bullet?. Proceedings of the Nutrition Society 62:03, 599-603
CrossRef528
Fábio Klamt, Felipe Dal-Pizzol, Rafael Roehrs, Ramatis Birnfeld de Oliveira, Rodrigo Dalmolin, João A.P Henriques, Heloisa Helena Rodrigues de Andrades, Ana Lı́gia Lia de Paula Ramos, Jenifer Saffi, José Cláudio Fonseca Moreira. (2003) Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by Vitamin a supplementation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 539:1-2, 117-125
CrossRef529
B. McKevith, C. Kelly, S. Stanner, J. Hughes, J. Buttriss. (2003) The Food Standards Agency's antioxidants in food programme - a summary*. Journal of Human Nutrition and Dietetics 16:4, 257-263
CrossRef530
Martijn B. Katan, Scott M. Grundy, Peter Jones, Malcolm Law, Tatu Miettinen, Rodolfo Paoletti. (2003) Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels. Mayo Clinic Proceedings 78:8, 965-978
CrossRef531
M. B. Katan, S. M. Grundy, P. Jones, M. Law, T. Miettinen, R. Paoletti, . (2003) Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels. Mayo Clinic Proceedings 78:8, 965-978
CrossRef532
Kiyoko Kubomura, Dennis Gordon. 2003. Beverages as Delivery Systems for Nutraceuticals. .
CrossRef533
Moreno Paolini, Marion Nestle. (2003) Pitfalls of enzyme-based molecular anticancer dietary manipulations: food for thought. Mutation Research/Reviews in Mutation Research 543:3, 181-189
CrossRef534
Moreno Paolini, Sherif Z Abdel-Rahman, Andrea Sapone, Gian Franco Pedulli, Paolo Perocco, Giorgio Cantelli-Forti, Marvin S Legator. (2003) β-Carotene: a cancer chemopreventive agent or a co-carcinogen?. Mutation Research/Reviews in Mutation Research 543:3, 195-200
CrossRef535
Lori J Wirth, Robert I Haddad, Marshall R Posner. (2003) Progress and perspectives in chemoprevention of head and neck cancer. Expert Review of Anticancer Therapy 3:3, 339-355
CrossRef536
Norman I. Krinsky, Kyung-Jin Yeum. (2003) Carotenoid–radical interactions. Biochemical and Biophysical Research Communications 305:3, 754-760
CrossRef537
Errol Zeiger. (2003) Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens. Mutation Research/Reviews in Mutation Research 543:3, 191-194
CrossRef538
Wendy L. McBee, Anne S. Lindblad, Frederick L. Ferris. (2003) Who should receive oral supplement treatment for age-related macular degeneration?. Current Opinion in Ophthalmology 14:3, 159-162
CrossRef539
J. A. Baron, B. F. Cole, L. Mott, R. Haile, M. Grau, T. R. Church, G. J. Beck, E. R. Greenberg. (2003) Neoplastic and Antineoplastic Effects of -Carotene on Colorectal Adenoma Recurrence: Results of a Randomized Trial. JNCI Journal of the National Cancer Institute 95:10, 717-722
CrossRef540
B. Levin. (2003) Potential Pitfalls in the Use of Surrogate Endpoints in Colorectal Adenoma Chemoprevention. JNCI Journal of the National Cancer Institute 95:10, 697-699
CrossRef541
J AMBATI, B AMBATI, S YOO, S IANCHULEV, A ADAMIS. (2003) Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies1. Survey of Ophthalmology 48:3, 257-293
CrossRef542
Norman J Temple, Kerri Kaiser Gladwin. (2003) Fruit, vegetables, and the prevention of cancer. Nutrition 19:5, 467-470
CrossRef543
Victor J Stevens, Russell E Glasgow, Deborah J Toobert, Njeri Karanja, K.Sabina Smith. (2003) One-year results from a brief, computer-assisted intervention to decrease consumption of fat and increase consumption of fruits and vegetables. Preventive Medicine 36:5, 594-600
CrossRef544
Magali Caraballoso, Montse Sacristan, Consol Serra, Xavier Bonfill Cosp, Magali Caraballoso. 2003. Drugs for preventing lung cancer in healthy people. .
CrossRef545
(2003) Effect of Lycopene on the Insulin-like Growth Factor-I Receptor Signaling Pathway in Human Colon Cancer HT-29 Cells. Journal of the Korean Society of Food Science and Nutrition 32:3, 437-443
CrossRef546
Anthony Trewavas, Derek Stewart. (2003) Paradoxical effects of chemicals in the diet on health. Current Opinion in Plant Biology 6:2, 185-190
CrossRef547
Cheryl L. Rock. (2003) Carotenoid update. Journal of the American Dietetic Association 103:4, 423-425
CrossRef548
Carl H. Snyderman. (2003) Nutrition and head and neck cancer. Current Oncology Reports 5:2, 158-163
CrossRef549
Emma A. Meagherx. (2003) Treatment of Atherosclerosis in the New Millennium: Is There a Role for Vitamin E?. Preventive Cardiology 6:2, 85-90
CrossRef550
Elisa Borras, Rosa Zaragoza, Maria Morante, Concha Garcia, Amparo Gimeno, Gerardo Lopez-Rodas, Teresa Barber, Vicente J. Miralles, Juan R. Vina, Luis Torres. (2003) In vivo studies of altered expression patterns of p53 and proliferative control genes in chronic vitamin A deficiency and hypervitaminosis. European Journal of Biochemistry 270:7, 1493-1501
CrossRef551
G DUTHIE. (2003) Antioxidants. Medicine 31:4, 25-26
CrossRef552
P. B. Bach, M. W. Kattan, M. D. Thornquist, M. G. Kris, R. C. Tate, M. J. Barnett, L. J. Hsieh, C. B. Begg. (2003) Variations in Lung Cancer Risk Among Smokers. JNCI Journal of the National Cancer Institute 95:6, 470-478
CrossRef553
Diane E. Stover. (2003) Prevention of lung cancer. Comprehensive Therapy 29:1, 28-34
CrossRef554
James M. Shikany, Ruth E. Patterson, Tanya Agurs-Collins, Garnet Anderson. (2003) Antioxidant supplement use in Women’s Health Initiative participants. Preventive Medicine 36:3, 379-387
CrossRef555
Nitsan Maharshak, Johnatan Shapiro, Henri Trau. (2003) Carotenoderma - a review of the current literature. International Journal of Dermatology 42:3, 178-181
CrossRef556
Ruey-Hong Wong, Ching-Ying Yeh, Yu-Mei Hsueh, Jung-Der Wang, Yu-Chen Lei, Tsun-Jen Cheng. (2003) Association of hepatitis virus infection, alcohol consumption and plasma vitamin A levels with urinary 8-hydroxydeoxyguanosine in chemical workers. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 535:2, 181-186
CrossRef557
J. M. Kurie, R. Lotan, J. J. Lee, J. S. Lee, R. C. Morice, D. D. Liu, X.-C. Xu, F. R. Khuri, J. Y. Ro, W. N. Hittelman, G. L. Walsh, J. A. Roth, J. D. Minna, W. K. Hong. (2003) Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor- Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled Trial. JNCI Journal of the National Cancer Institute 95:3, 206-214
CrossRef558
Byung Mu Lee, Kwang-Kyun Park. (2003) Beneficial and adverse effects of chemopreventive agents. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523-524, 265-278
CrossRef559
Nico van Zandwijk, Ugo Pastorino. (2003) Chemoprevention of lung cancer: soon daily practice?. Expert Review of Anticancer Therapy 3:1, 91-98
CrossRef560
Taik-Koo Yun. (2003) Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523-524, 63-74
CrossRef561
Kenneth R. Epstein. (2003) The role of carotenoids on the risk of lung cancer. Seminars in Oncology 30:1, 86-93
CrossRef562
G. Davey Smith. (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. International Journal of Epidemiology 32:1, 1-22
CrossRef563
S. Southon, R. Faulks. 2003. Carotenoids in food: bioavailability and functional benefits. , 107-127.
CrossRef564
Jerzy E Tyczynski, Freddie Bray, D Maxwell Parkin. (2003) Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology 4:1, 45-55
CrossRef565
Yoshinori Ito, Kenji Wakai, Koji Suzuki, Akiko Tamakoshi, Nao Seki, Masahiko Ando, Yoshikazu Nishino, Takaaki Kondo, Yoshiyuki Watanabe, Kotaro Ozasa, Yoshiyuki Ohno, . (2003) Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. Cancer Science 94:1, 57-63
CrossRef566
Edzard Schwedhelm, Renke Maas, Raphael Troost, Rainer H B??ger. (2003) Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress. Clinical Pharmacokinetics 42:5, 437-459
CrossRef567
George A. Stouffer, Richard G. Sheahan, Steven J. Riley, George A. Stouffer. (2003) The Antioxidant Vitamins and Coronary Heart Disease: Part II. Randomized Clinical Trials. The American Journal of the Medical Sciences 325:1, 15-19
CrossRef568
P. Greenwald. (2003) -Carotene and Lung Cancer: A Lesson for Future Chemoprevention Investigations?. JNCI Journal of the National Cancer Institute 95:1, 1E-1E
CrossRef569
Judy L. Buttriss, Joyce Hughes, Colette N. M. Kelly, Sara Stanner. (2002) Antioxidants in food: a summary of the review conducted for the Food Standards Agency. Nutrition Bulletin 27:4, 227-236
CrossRef570
Annette McWilliams, Stephen Lam. (2002) New approaches to lung cancer prevention. Current Oncology Reports 4:6, 487-494
CrossRef571
Noel W Solomons. (2002) Ethical consequences for professionals from the globalization of food, nutrition and health. Asia Pacific Journal of Clinical Nutrition 11:s3, S653-S665
CrossRef572
Qing Su, Kevin G Rowley, Nicholas D.H Balazs. (2002) Carotenoids: separation methods applicable to biological samples. Journal of Chromatography B 781:1-2, 393-418
CrossRef573
Theodore W. Marcy, Michael Stefanek, Kimberly M. Thompson. (2002) Genetic Testing for Lung Cancer Risk. If Physicians Can Do It, Should They?. Journal of General Internal Medicine 17:12, 946-951
CrossRef574
R SAMSON. (2002) Miscellaneous medications for the management of atherosclerosis: Mayhem or miracle?. Seminars in Vascular Surgery 15:4, 275-287
CrossRef575
M Rodrı́guez-Comesaña, M.S Garcı́a-Falcón, J Simal-Gándara. (2002) Control of nutritional labels in beverages with added vitamins: screening of β-carotene and ascorbic acid contents. Food Chemistry 79:2, 141-144
CrossRef576
Stanley T. Omaye. (2002) Metabolic modulation of carbon monoxide toxicity. Toxicology 180:2, 139-150
CrossRef577
David L. DeMets. (2002) Clinical trials in the new millennium. Statistics in Medicine 21:19, 2779-2787
CrossRef578
David Kritchevsky, Shirley A Tepper, Susanne K Czarnecki, Kalyana Sundram. (2002) Red palm oil in experimental atherosclerosis. Asia Pacific Journal of Clinical Nutrition 11:s7, S433-S437
CrossRef579
Graeme A Clugston, Trudy E Smith. (2002) Global nutrition problems and novel foods. Asia Pacific Journal of Clinical Nutrition 11:s6, S100-S111
CrossRef580
Ernest T. Hawk, Paul J. Limburg, Jaye L. Viner. (2002) Epidemiology and prevention of colorectal cancer. Surgical Clinics of North America 82:5, 905-941
CrossRef581
Leonard Kritharides, Roland Stocker. (2002) The use of antioxidant supplements in coronary heart disease. Atherosclerosis 164:2, 211-219
CrossRef582
Rajindar S Sohal, Robin J Mockett, William C Orr. (2002) Mechanisms of aging: an appraisal of the oxidative stress hypothesis1,2 1This article is part of a series of reviews on “Oxidative Stress and Aging.” The full list of papers may be found on the homepage of the journal. 2Guest Editor: Rajindar S. Sohal. Free Radical Biology and Medicine 33:5, 575-586
CrossRef583
Stephen S Hecht. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. The Lancet Oncology 3:8, 461-469
CrossRef584
L LEMARCHAND. (2002) Cancer preventive effects of flavonoids—a review. Biomedecine & Pharmacotherapy 56:6, 296-301
CrossRef585
Edward S. Kim, Fadlo R. Khuri. (2002) Chemoprevention of lung cancer. Current Oncology Reports 4:4, 341-346
CrossRef586
Petr Zatloukal, Lubos Petruzelka, Filip Janku. (2002) Highlights from the 7th Central European Lung Cancer Conference. Lung Cancer 37:1, 103-108
CrossRef587
(2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. The Lancet 360:9326, 23-33
CrossRef588
Mark Messina, Clare Hasler, Susan Kundrat, Eric Gugger. 2002. Industrial Processing and Preparation of Isoflavones. .
CrossRef589
Andressa A.A Santos, Márcia V.G Silva, Luana T.A Guerreiro, Marcelo V Alves, Vera L.F Cunha Bastos, Jayme Cunha Bastos, Karla Kovary. (2002) Influence of norbixin on plasma cholesterol-associated lipoproteins, plasma arylesterase/paraoxonase activity and hepatic lipid peroxidation of Swiss mice on a high fat diet. Food Chemistry 77:4, 393-399
CrossRef590
K C Johnson, S Pan, Y Mao. (2002) Risk factors for male breast cancer in Canada, 1994–1998. European Journal of Cancer Prevention 11:3, 253-263
CrossRef591
Sı́lvia Catarina Salgado Oloris, Maria Lúcia Zaidan Dagli, José Luiz Guerra. (2002) Effect of β-carotene on the development of the solid Ehrlich tumor in mice. Life Sciences 71:6, 717-724
CrossRef592
M. S. Cooke, M. D. Evans, N. Mistry, J. Lunec. (2002) Role of dietary antioxidants in the prevention of in vivo oxidative DNA damage. Nutrition Research Reviews 15:01, 19
CrossRef593
JH John, S Ziebland, P Yudkin, LS Roe, HAW Neil. (2002) Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. The Lancet 359:9322, 1969-1974
CrossRef594
Guo-quan Chen, Bingzhen Lin, Marcia I. Dawson, Xiao-kun Zhang. (2002) Nicotine modulates the effects of retinoids on growth inhibition and RAR? expression in lung cancer cells. International Journal of Cancer 99:2, 171-178
CrossRef595
M. I. COVAS, J. MARRUGAT, M. FITÓ, R. ELOSUA, C. LA TORRE-BORONAT. (2002) Scientific Aspects That Justify the Benefits of the Mediterranean Diet. Annals of the New York Academy of Sciences 957:1, 162-173
CrossRef596
Mrinalini Kulkarni, Peter D. Reaven. (2002) Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes. Current Diabetes Reports 2:3, 269-273
CrossRef597
R Laughlin. (2002) Preparation and physical characterization of pure β-carotene. Chemistry and Physics of Lipids 115:1-2, 63-76
CrossRef598
JR Evans, Jennifer Evans. 2002. Antioxidant vitamin and mineral supplements for age-related macular degeneration. .
CrossRef599
Elizabeth J. Johnson. (2002) The Role of Carotenoids in Human Health. Nutrition in Clinical Care 5:2, 56-65
CrossRef600
Georgianne Valli, Elsa-Grace V Giardina. (2002) Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects. Journal of the American College of Cardiology 39:7, 1083-1095
CrossRef601
I-M Lee, N R Cook, J E Manson, J E Buring. (2002) Randomised β-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level?. British Journal of Cancer 86:5, 698-701
CrossRef602
Albert Ferro. (2002) Statins and vascular protection: a ‘radical’ view. Journal of Hypertension 20:3, 359-361
CrossRef603
Nico van Zandwijk, Fred R. Hirsch. (2002) Chemoprevention strategies for non-small cell lung cancer. Current Opinion in Oncology 14:2, 185-190
CrossRef604
Kathryn Smith Bilello, Susan Murin, Richard A Matthay. (2002) Epidemiology, etiology, and prevention of lung cancer. Clinics in Chest Medicine 23:1, 1-25
CrossRef605
Serap Hast
CrossRef606
Paola Palozza, Simona Serini, Angela Torsello, Alma Boninsegna, Valeria Covacci, Nicola Maggiano, Franco O. Ranelletti, Federica I. Wolf, Gabriella Calviello. (2002) Regulation of cell cycle progression and apoptosis by ?-carotene in undifferentiated and differentiated HL-60 leukemia cells: Possible involvement of a redox mechanism. International Journal of Cancer 97:5, 593-600
CrossRef607
Edward S. Kim, Waun Ki Hong, Fadlo Raja Khuri. (2002) C
HEMOPREVENTION OF AERODIGESTIVE TRACT CANCERS . Annual Review of Medicine 53:1, 223-243
CrossRef608
P van den Brandt, L Voorrips, I Hertz-Picciotto, D Shuker, H Boeing, G Speijers, C Guittard, J Kleiner, M Knowles, A Wolk, A Goldbohm. (2002) The contribution of epidemiology. Food and Chemical Toxicology 40:2-3, 387-424
CrossRef609
Mark A Moyad. (2002) The placebo effect and randomized trials: analysis of alternative medicine. Urologic Clinics of North America 29:1, 135-155
CrossRef610
Denise D. Hermann. (2002) Naturoceutical Agents in the Management of Cardiovascular Disease. American Journal of Cardiovascular Drugs 2:3, 173-196
CrossRef611
Hans K. Biesalski. (2002) Nutraceuticals: the link between nutrition and medicine1. Cutaneous and Ocular Toxicology 21:1-2, 9-30
CrossRef612
Jean-Claude Tardif, Jean Gr??goire, Philippe L. L??Allier. (2002) Prevention of Restenosis with Antioxidants. American Journal of Cardiovascular Drugs 2:5, 323-334
CrossRef613
Morten Lacour, Jens Folke Kiilgaard, Mogens Holst Nissen. (2002) Age-Related Macular Degeneration. Drugs & Aging 19:2, 101-133
CrossRef614
Ethan Dmitrovsky, Michael B. Sporn. 2002. Chemoprevention, Pharmacology of. , 449-455.
CrossRef615
Brahmajee K. Nallamothu, A. Mark Fendrick, Gilbert S. Omenn. (2002) Homocyst(e)ine and Coronary Heart Disease. PharmacoEconomics 20:7, 429-442
CrossRef616
Azadeh Stark. (2002) An historical review of the Harvard and the National Cancer Institute food frequency questionnaires: Their similarities, differences, and their limitations in assessment of food intake. Ecology of Food and Nutrition 41:1, 35-74
CrossRef617
Eva Lonn. (2001) Do antioxidant vitamins protect against atherosclerosis? The proof is still lacking. Journal of the American College of Cardiology 38:7, 1795-1798
CrossRef618
KONSTANTIN H. DRAGNEV, SARAH J. FREEMANTLE, MICHAEL J. SPINELLA, ETHAN DMITROVSKY. (2001) Cyclin Proteolysis as a Retinoid Cancer Prevention Mechanism. Annals of the New York Academy of Sciences 952:1, 13-22
CrossRef619
MARK MESSINA, JOHANNA W LAMPE, DIANE F BIRT, LAWRENCE J APPEL, ELIZABETH PIVONKA, BARBARA BERRY, DAVID R JACOBS. (2001) Reductionism and the Narrowing Nutrition Perspective. Journal of the American Dietetic Association 101:12, 1416-1419
CrossRef620
Aileen Robertson. (2001) Social inequalities and the burden of food-related ill-health. Public Health Nutrition 4:6a,
CrossRef621
Nico van Zandwijk. (2001) Chemoprevention of lung cancer. Lung Cancer 34, 91-94
CrossRef622
F BOHM, R EDGE, M BURKE, T TRUSCOTT. (2001) Dietary uptake of lycopene protects human cells from singlet oxygen and nitrogen dioxide – ROS components from cigarette smoke. Journal of Photochemistry and Photobiology B: Biology 64:2-3, 176-178
CrossRef623
Diane L. Tribble. (2001) Antioxidants and atherosclerotic cardiovascular disease: unresolved issues. Coronary Artery Disease 12:7, 541-546
CrossRef624
Christopher D. Gardner. (2001) The role of plant-based diets in the treatment and prevention of coronary artery disease. Coronary Artery Disease 12:7, 553-559
CrossRef625
A Schieber, F.C Stintzing, R Carle. (2001) By-products of plant food processing as a source of functional compounds — recent developments. Trends in Food Science & Technology 12:11, 401-413
CrossRef626
Maike Wolters, Andreas Hahn. (2001) Der schmale Grat zwischen Prävention und Placebo: Nahrungsergänzungsmittel. Biologie in unserer Zeit 31:6, 367-375
CrossRef627
S Pruthi, T G Allison, D D Hensrud. (2001) Vitamin E supplementation in the prevention of coronary heart disease.. Mayo Clinic Proceedings 76:11, 1131-1136
CrossRef628
Charles Lieber. 2001. Alcohol. .
CrossRef629
Allen Perelson, Leon Ellenbogen. 2001. Rationale for Use of Vitamin and Mineral Supplements. .
CrossRef630
Ritva Butrum, Elizabeth Weisburger. 2001. Chemoprevention of Cancer in Humans by Dietary Means. .
CrossRef631
Kasey Heintz, Thomas Boileau, Denise Deming, Christine Atkinson, John Erdman. 2001. Carotenoids. .
CrossRef632
Charanjit Kaur, Harish C. Kapoor. (2001) Antioxidants in fruits and vegetables - the millennium’s health. International Journal of Food Science & Technology 36:7, 703-725
CrossRef633
Charanjit Kaur, Harish C. Kapoor. (2001) Antioxidants in fruits and vegetables - the millennium's health. International Journal of Food Science and Technology 36:7, 703-725
CrossRef634
P. Terry, J. B. Terry, A. Wolk. (2001) Fruit and vegetable consumption in the prevention of cancer: an update. Journal of Internal Medicine 250:4, 280-290
CrossRef635
David A. Hughes. (2001) Dietary carotenoids and human immune function. Nutrition 17:10, 823-827
CrossRef636
Adrianne Bendich. (2001) Micronutrients in women’s health and immune function. Nutrition 17:10, 858-867
CrossRef637
LINDA VAN HORN, NANCY ERNST. (2001) A Summary of the Science Supporting the New National Cholesterol Education Program Dietary Recommendations. Journal of the American Dietetic Association 101:10, 1148-1154
CrossRef638
R. Chernoff. (2001) Nutrition and Health Promotion in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:Supplement 2, 47-53
CrossRef639
Norman I. Krinsky. (2001) Carotenoids as antioxidants. Nutrition 17:10, 815-817
CrossRef640
Garry J. Handelman. (2001) The evolving role of carotenoids in human biochemistry. Nutrition 17:10, 818-822
CrossRef641
Shinkan Tokudome, Kiyonori Kuriki, Malcolm A. Moore. (2001) Seaweed and Cancer Prevention. Cancer Science 92:9, 1008-1010
CrossRef642
F.A. Fitzpatrick. (2001) Inflammation, carcinogenesis and cancer. International Immunopharmacology 1:9-10, 1651-1667
CrossRef643
Sampath Parthasarathy, Nadya Khan-Merchant, Meera Penumetcha, Bobby V. Khan, Nalini Santanam. (2001) Did the antioxidant trials fail to validate the oxidation hypothesis?. Current Atherosclerosis Reports 3:5, 392-398
CrossRef644
U. Pastorino. (2001) Molecular Targeting: the New Challenge in Lung Cancer Prevention. JNCI Journal of the National Cancer Institute 93:16, 1190-1191
CrossRef645
J. J. Lee. (2001) Long-Term Impact of Smoking on Lung Epithelial Proliferation in Current and Former Smokers. Journal of the National Cancer Institute 93:14, 1081-1088
CrossRef646
E. Szabo. (2001) Lung Epithelial Proliferation: a Biomarker for Chemoprevention Trials?. Journal of the National Cancer Institute 93:14, 1042-1043
CrossRef647
M. Paolini. (2001) Chemoprevention or Antichemo- prevention? A Salutary Warning From the beta-Carotene Experience. Journal of the National Cancer Institute 93:14, 1110-1111
CrossRef648
Clare Hasler, Alicia Moag-Stahlberg, Denise Webb, Marsha Hudnall. (2001) How to Evaluate the Safety, Efficacy, and Quality of Functional Foods and Their Ingredients. Journal of the American Dietetic Association 101:7, 733-736
CrossRef649
M Törnwall. (2001) α-Tocopherol (vitamin E) and β-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. Atherosclerosis 157:1, 167-173
CrossRef650
Hemendra N. Basu, Anthony J. Del Vecchio, Frank Flider, Frank T. Orthoeter. (2001) Nutritional and potential disease prevention properties of carotenoids. Journal of the American Oil Chemists' Society 78:7, 665-675
CrossRef651
WILLIAM J. ELLIS, RUTH ETZIONI, ROBERT L. VESSELLA, CHENGCHENG HU, GARY E. GOODMAN. (2001) SERIAL PROSTATE SPECIFIC ANTIGEN, FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AND COMPLEXED PROSTATE SPECIFIC ANTIGEN FOR THE DIAGNOSIS OF PROSTATE CANCER. THE JOURNAL OF UROLOGY93-99
CrossRef652
WILLIAM J. ELLIS, RUTH ETZIONI, ROBERT L. VESSELLA, CHENGCHENG HU, GARY E. GOODMAN. (2001) SERIAL PROSTATE SPECIFIC ANTIGEN, FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AND COMPLEXED PROSTATE SPECIFIC ANTIGEN FOR THE DIAGNOSIS OF PROSTATE CANCER. The Journal of Urology 166:1, 93-99
CrossRef653
Rafael J. Gaytan, L. Michael Prisant. (2001) Oral Nutritional Supplements and Heart Disease: A Review. American Journal of Therapeutics 8:4, 255-274
CrossRef654
R. Menéndez, R. Más, J. Illnait, J. Pérez, A.M. Amor, J.C. Fernández, R.M. González. (2001) Effects of D-002 on Lipid Peroxidation in Older Subjects. Journal of Medicinal Food 4:2, 71-77
CrossRef655
Robert Russell. 2001. Lycopene and Lutein. .
CrossRef656
Hans Biesalski. 2001. Nutraceuticals. .
CrossRef657
David W. Crabb, J. Pinairs, R. Hasanadka, M. Fang, M. A. Leo, Charles S. Lieber, Hidekazu Tsukamoto, K. Motomura, T. Miyahara, M. Ohata, William Bosron, S. Sanghani, N. Kedishvili, Haruko Shiraishi, Hirokazu Yokoyama, Michiko Miyagi, Hiromasa Ishii, Ina Bergheim, Ina Menzl, Alexandr Parlesak, Christiane Bode. (2001) Alcohol and Retinoids. Alcoholism: Clinical and Experimental Research 25:s1, 207S-217S
CrossRef658
Diane F. Birt, Suzanne Hendrich, Weiqun Wang. (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics 90:2-3, 157-177
CrossRef659
P Greenwald. (2001) Diet and cancer prevention. European Journal of Cancer 37:8, 948-965
CrossRef660
Paola Palozza, Gabriella Calviello, Simona Serini, Nicola Maggiano, Paola Lanza, Franco O Ranelletti, Gianna Maria Bartoli. (2001) β-carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radical Biology and Medicine 30:9, 1000-1007
CrossRef661
Vanessa J Poustie, Patricia Rutherford, Vanessa J Poustie. 2001. Dietary treatment for familial hypercholesterolaemia. .
CrossRef662
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, S. L. Graziano, D. R. Gandara, G. Okawara, C. L. Woodhouse, B. Williams, C. Perez, H. W. Kim, R. Lotan, J. A. Roth, W. K. Hong. (2001) Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute 93:8, 605-618
CrossRef663
P. Terry, E. Giovannucci, K. B. Michels, L. Bergkvist, H. Hansen, L. Holmberg, A. Wolk. (2001) Fruit, Vegetables, Dietary Fiber, and Risk of Colorectal Cancer. JNCI Journal of the National Cancer Institute 93:7, 525-533
CrossRef664
Karla Kovary, Tatiana S. Louvain, Maria C. Costa e Silva, Franco Albano, Barbara B. M. Pires, Gustavo A. T. Laranja, Celso L. S. Lage, Israel Felzenszwalb. (2001) Biochemical behaviour of norbixin during in vitro DNA damage induced by reactive oxygen species. British Journal of Nutrition 85:04, 431
CrossRef665
Andrew R. Collins. (2001) Carotenoids and genomic stability. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 475:1-2, 21-28
CrossRef666
Michael Fenech, Lynnette R. Ferguson. (2001) Vitamins/minerals and genomic stability in humans. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 475:1-2, 1-6
CrossRef667
M BURKE, R EDGE, E LAND, T TRUSCOTT. (2001) Characterisation of carotenoid radical cations in liposomal environments: interaction with vitamin C. Journal of Photochemistry and Photobiology B: Biology 60:1, 1-6
CrossRef668
P Zhang. (2001) DNA strand breakage and oxygen tension: effects of β-carotene, α-tocopherol and ascorbic acid. Food and Chemical Toxicology 39:3, 239-246
CrossRef669
Susan Taylor Mayne, Douglas E. Morse. (2001) Nutrition and Oral Precancerous Lesions. Nutrition in Clinical Care 4:2, 94-102
CrossRef670
MARION NESTLE. (2001) Genetically Engineered “Golden” Rice Unlikely to Overcome Vitamin A Deficiency. Journal of the American Dietetic Association 101:3, 289-290
CrossRef671
Joseph B. Guttenplan, Michael Chen, Wieslawa Kosinska, Seth Thompson, Zhonglin Zhao, Leonard A. Cohen. (2001) Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Letters 164:1, 1-6
CrossRef672
Jennifer R. Evans. (2001) Risk Factors for Age-related Macular Degeneration. Progress in Retinal and Eye Research 20:2, 227-253
CrossRef673
Alice H. Lichtenstein. (2001) Approaches to reducing cardiovascular disease risk: food or pills?. Current Opinion in Lipidology 12:1, 1-3
CrossRef674
P Zhang. (2001) Antioxidant and prooxidant roles for β-carotene, α-tocopherol and ascorbic acid in human lung cells. Toxicology in Vitro 15:1, 13-24
CrossRef675
David W. Crabb, J. Pinairs, R. Hasanadka, M. Fang, M. A. Leo, Charles S. Lieber, Hidekazu Tsukamoto, K. Motomura, T. Miyahara, M. Ohata, William Bosron, S. Sanghani, N. Kedishvili, Haruko Shiraishi, Hirokazu Yokoyama, Michiko Miyagi, Hiromasa Ishii, Ina Bergheim, Ina Menzl, Alexandr Parlesak, Christiane Bode. (2001) Alcohol and Retinoids. Alcoholism: Clinical and Experimental Research 25:Supplement, 207S
CrossRef676
Aukje K. Mantel-Teeuwisse, Judith M.E. Kloosterman, Anke Hilse Maitland-van der Zee, Olaf H. Klungel, Arijan J. Porsius, Anthonius de Boer. (2001) Drug-Induced Lipid Changes. Drug Safety 24:6, 443-456
CrossRef677
Lori L. Schoonover. (2001) Oxidative Stress and the Role of Antioxidants in Cardiovascular Risk Reduction. Progress in Cardiovascular Nursing 16:1, 30-32
CrossRef678
Taik-Koo Yun. (2001) Panax ginseng—a non-organ-specific cancer preventive?. The Lancet Oncology 2:1, 49-55
CrossRef679
Roberto Marchioli, Carlo Schweiger, Giacomo Levantesi, Luigi Tavazzi, Franco Valagussa. (2001) Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data. Lipids 36:S1, S53-S63
CrossRef680
(2001) Position of the American Dietetic Association. Journal of the American Dietetic Association 101:1, 115-125
CrossRef681
Paul S. Bernstein, Nikita B. Katz. (2001) The role of ocular free radicals in age-related macular degeneration. Cutaneous and Ocular Toxicology 20:2-3, 141-181
CrossRef682
Devraj U. Nayak, Carol Karmen, William H. Frishman, Babak A. Vakili. (2001) Antioxidant Vitamins and Enzymatic and Synthetic Oxygen-Derived Free Radical Scavengers in the Prevention and Treatment of Cardiovascular Disease. Heart Disease28-45
CrossRef683
Francesco Visioli, Claudio Galli. (2001) The role of antioxidants in the mediterranean diet. Lipids 36:S1, S49-S52
CrossRef684
A Ruano-Ravina, A Figueiras, Jm Barros-Dios. (2000) Diet and lung cancer: a new approach. European Journal of Cancer Prevention 9:6, 395-400
CrossRef685
Gary M. Strauss, Lorenzo Dominioni. (2000) Perception, paradox, paradigm. Cancer 89:S11, 2422-2431
CrossRef686
Angus W. G. Walls, Jimmy G. Steele, Aubrey Sheiham, Wagner Marcenes, Paula J. Moynihan. (2000) Oral Health and Nutrition in Older People. Journal of Public Health Dentistry 60:4, 304-307
CrossRef687
Daniel Steinberg. (2000) Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?. Current Opinion in Lipidology 11:6, 603-607
CrossRef688
Gary M. Strauss. (2000) Randomized population trials and screening for lung cancer. Cancer 89:S11, 2399-2421
CrossRef689
Gary M. Strauss. (2000) Randomized population trials and screening for lung cancer. Cancer 89:S11, 2399-2421
CrossRef690
Gary M. Strauss, Lorenzo Dominioni. (2000) Perception, paradox, paradigm. Cancer 89:S11, 2422-2431
CrossRef691
Gary M. Strauss. (2000) Randomized population trials and screening for lung cancer. Cancer 89:S11, 2399-2421
CrossRef692
Gary M. Strauss, Lorenzo Dominioni. (2000) Perception, paradox, paradigm. Cancer 89:S11, 2422-2431
CrossRef693
Gary M. Strauss. (2000) Randomized population trials and screening for lung cancer. Cancer 89:S11, 2399-2421
CrossRef694
Gary M. Strauss, Lorenzo Dominioni. (2000) Perception, paradox, paradigm. Cancer 89:S11, 2422-2431
CrossRef695
Gary M. Strauss. (2000) Randomized population trials and screening for lung cancer. Cancer 89:S11, 2399-2421
CrossRef696
Gary M. Strauss, Lorenzo Dominioni. (2000) Perception, paradox, paradigm. Cancer 89:S11, 2422-2431
CrossRef697
T S Tsang, M E Barnes, B J Gersh, S N Hayes. (2000) Risks of coronary heart disease in women: current understanding and evolving concepts.. Mayo Clinic Proceedings 75:12, 1289-1303
CrossRef698
Stanley Omaye, Michael Dubick. 2000. Modification of Atherogenesis and Heart Disease by Grape Wine and Tea Polyphenols. .
CrossRef699
Ann M Bode, Zigang Dong. (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. The Lancet Oncology 1:3, 181-188
CrossRef700
Daniel Bunout. (2000) Therapeutic potential of vitamin E in heart disease. Expert Opinion on Investigational Drugs 9:11, 2629-2636
CrossRef701
Colin Berry. (2000) The realities of pesticide use. Pest Management Science 56:11, 947-949
CrossRef702
Anna D'Odorico, Diego Martines, Stefan Kiechl, Georg Egger, Friedrich Oberhollenzer, Piero Bonvicini, Giacomo Carlo Sturniolo, Remo Naccarato, Johann Willeit. (2000) High plasma levels of α- and β-carotene are associated with a lower risk of atherosclerosis. Atherosclerosis 153:1, 231-239
CrossRef703
Elizabeth J. Johnson. (2000) The Role of Lutein in Disease Prevention. Nutrition in Clinical Care 3:5, 289-296
CrossRef704
S. G. Worthley, G. Helft, A. G. Zaman, V. Fuster, J. J. Badimon. (2000) Atherosclerosis and the vulnerable plaque - pathogenesis: Part I. Australian and New Zealand Journal of Medicine 30:5, 600-607
CrossRef705
Cora J Dillard, J Bruce German. (2000) Phytochemicals: nutraceuticals and human health. Journal of the Science of Food and Agriculture 80:12, 1744-1756
CrossRef706
Patrizia Riso, Marisa Porrini. 2000. Tomatoes and Health Promotion. .
CrossRef707
Kim O’Neill, Stephen Standage, Bronwyn Hughes, Byron Murray. 2000. Fruits and Vegetables and the Prevention of Oxidative DNA Damage. .
CrossRef708
Alberico Luigi Catapano, Franco Maria Maggi, Elena Tragni. (2000) Low density lipoprotein oxidation, antioxidants, and atherosclerosis. Current Opinion in Cardiology 15:5, 355-363
CrossRef709
Teresa Bermejo Vicedo, Francisco Jose Hidalgo Correas. 2000. Antioxidants as Therapies of Diseases of Old Age. , 343-357.
CrossRef710
Alan Dumoff. (2000) Medical Boards' Prohibitions Against Physician Supplement Sales. Alternative and Complementary Therapies 6:4, 226-232
CrossRef711
Ernest T. Hawk, Scott M. Lippman. (2000) PRIMARY CANCER PREVENTION TRIALS. Hematology/Oncology Clinics of North America 14:4, 809-830
CrossRef712
Gilles R. Dagenais, Roberto Marchioli, Gianni Tognoni, Salim Yusuf. (2000) Beta-carotene, vitamin C, and vitamin E and cardiovascular diseases. Current Cardiology Reports 2:4, 293-299
CrossRef713
Charles S. Lieber. (2000) A
LCOHOL : Its Metabolism and Interaction With Nutrients. Annual Review of Nutrition 20:1, 395-430
CrossRef714
Yoav Sharoni, Michael Danilenko, Joseph Levy. (2000) Molecular mechanisms for the anticancer activity of the carotenoid lycopene. Drug Development Research 50:3-4, 448-456
CrossRef715
Sridevi Devaraj, Ishwarlal Jialal. (2000) Antioxidants and vitamins to reduce cardiovascular disease. Current Atherosclerosis Reports 2:4, 342-351
CrossRef716
Tim E Byers. (2000) Nutrition and cancer: ten lessons from the 20th century. Nutrition 16:7-8, 561-563
CrossRef717
Pocock, Stuart J., Elbourne, Diana R., . (2000) Randomized Trials or Observational Tribulations?. New England Journal of Medicine 342:25, 1907-1909
Full Text718
Jun Peng, Graham L Jones, Kenneth Watson. (2000) Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. Free Radical Biology and Medicine 28:11, 1598-1606
CrossRef719
K.R. Martin, D. Wu, M. Meydani. (2000) The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis 150:2, 265-274
CrossRef720
Garry G. Duthie, Susan J. Duthie, Janet A. M. Kyle. (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutrition Research Reviews 13:01, 79
CrossRef721
F Meyskens Jr. (2000) Cancer population genetics and tumour prevention an unfulfilled paradigm. European Journal of Cancer 36:10, 1189-1192
CrossRef722
H van den Berg, R Faulks, H Fernando Granado, J Hirschberg, B Olmedilla, G Sandmann, S Southon, W Stahl. (2000) The potential for the improvement of carotenoid levels in foods and the likely systemic effects. Journal of the Science of Food and Agriculture 80:7, 880-912
CrossRef723
M.Sanz Alaejos, F.J Dı́az Romero, C Dı́az Romero. (2000) Selenium and cancer: some nutritional aspects. Nutrition 16:5, 376-383
CrossRef724
Cheryl L. Rock, Johanna W. Lampe, Ruth E. Patterson. (2000) Nutrition, Genetics, and Risks of Cancer. Annual Review of Public Health 21:1, 47-64
CrossRef725
R SMITH, T GLYNN. (2000) EPIDEMIOLOGY OF LUNG CANCER. Radiologic Clinics of North America 38:3, 453-470
CrossRef726
Simin Nikbin Meydani, Timothy McElreavy, Mohsen Meydani. 2000. Antioxidants and Immune Response. , 183-205.
CrossRef727
Cristina Colomé, José Martı́nez-González, Francisco Vidal, Conxita de Castellarnau, Lina Badimon. (2000) Small oxidative changes in atherogenic LDL concentrations irreversibly regulate adhesiveness of human endothelial cells: effect of the lazaroid U74500A. Atherosclerosis 149:2, 295-302
CrossRef728
Peng Zhang, Stanley T. Omaye. (2000) β-Carotene and protein oxidation: effects of ascorbic acid and α-tocopherol. Toxicology 146:1, 37-47
CrossRef729
A Decensi. (2000) Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer. European Journal of Cancer 36:6, 694-709
CrossRef730
Imad Shureiqi, Pavan Reddy, Dean E Brenner. (2000) Chemoprevention: general perspective. Critical Reviews in Oncology/Hematology 33:3, 157-167
CrossRef731
Gary E Goodman. (2000) Prevention of lung cancer. Critical Reviews in Oncology/Hematology 33:3, 187-197
CrossRef732
Harri Vainio. (2000) Chemoprevention of cancer: lessons to be learned from beta-carotene trials. Toxicology Letters 112-113, 513-517
CrossRef733
Koyamangalath Krishnan, Mack T Ruffin, Dean E Brenner. (2000) Chemoprevention for colorectal cancer. Critical Reviews in Oncology/Hematology 33:3, 199-219
CrossRef734
Lihang Yao, Yuexia Liang, Walter S. Trahanovsky, Robert E. Serfass, Wendy S. White. (2000) Use of a 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids 35:3, 339-348
CrossRef735
Brian D Cox, Margaret J Whichelow, A Toby Prevost. (2000) Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer. Public Health Nutrition 3:01,
CrossRef736
Kathryn A Carolin, Helen A Pass. (2000) Prevention of breast cancer. Critical Reviews in Oncology/Hematology 33:3, 221-238
CrossRef737
Donna Zimmaro Bliss, Jennifer McLaughlin, Hans-Joachim Jung, Ann Lowry, Kay Savik, Linda Jensen. (2000) Comparison of the Nutritional Composition of Diets of Persons With Fecal Incontinence and That of Age- and Gender-matched Controls. Journal of Wound, Ostomy and Continence Nursing 27:2, 90-91
CrossRef738
Abby S Bloch. (2000) Pushing the envelope of nutrition support: complementary therapies. Nutrition 16:3, 236-239
CrossRef739
Fadlo R. Khuri, Scott M. Lippman. (2000) Lung cancer chemoprevention. Seminars in Surgical Oncology 18:2, 100-105
CrossRef740
Maret G. Traber, Albert van der Vliet, Abraham Z. Reznick, Carroll E. Cross. (2000) TOBACCO-RELATED DISEASES. Clinics in Chest Medicine 21:1, 173-187
CrossRef741
Gail Shaw Wright, Michael E. Gruidl. (2000) Early detection and prevention of lung cancer. Current Opinion in Oncology 12:2, 143-148
CrossRef742
Donald D. Hensrud. (2000) Clinical Preventive Medicine in Primary Care: Background and Practice: 2. Delivering Primary Preventive Services. Mayo Clinic Proceedings 75:3, 255-264
CrossRef743
D D Hensrud. (2000) Clinical preventive medicine in primary care: background and practice: 2. Delivering primary preventive services.. Mayo Clinic Proceedings 75:3, 255-264
CrossRef744
Wendy Demark-Wahnefried, Bercedis Peterson, Colleen McBride, Isaac Lipkus, Elizabeth Clipp. (2000) Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88:3, 674-684
CrossRef745
Earl S Ford, Wayne H Giles. (2000) Serum Vitamins, Carotenoids, and Angina Pectoris. Annals of Epidemiology 10:2, 106-116
CrossRef746
Elizabeth J. Johnson. (2000) The Role of Lycopene in Health and Disease. Nutrition in Clinical Care 3:1, 35-43
CrossRef747
William A. Pryor, Wilhelm Stahl, Cheryl L. Rock. (2000) Beta Carotene: From Biochemistry to Clinical Trials. Nutrition Reviews 58:2, 39-53
CrossRef748
Sergio A.R. Paiva, Alvaro O. Campana, Irma Godoy. (2000) Nutrition Support for the Patient with Chronic Obstructive Pulmonary Disease. Nutrition in Clinical Care 3:1, 44-50
CrossRef749
William G Christen, J.Michael Gaziano, Charles H Hennekens. (2000) Design of Physicians' Health Study II—A Randomized Trial of Beta-Carotene, Vitamins E and C, and Multivitamins, in Prevention of Cancer, Cardiovascular Disease, and Eye Disease, and Review of Results of Completed Trials. Annals of Epidemiology 10:2, 125-134
CrossRef750
Neil J. Stone, Robert Kushner. (2000) EFFECTS OF DIETARY MODIFICATION AND TREATMENT OF OBESITY. Medical Clinics of North America 84:1, 95-122
CrossRef751
John C. Mathers. 2000. Food and Cancer Prevention: Human Intervention Studies. , 395-403.
CrossRef752
E. A. M. de Deckere, P. M. Verschuren. 2000. Functional fats and spreads. , 233-257.
CrossRef753
Kathryn M. Rexrode, I-Min Lee, Nancy R. Cook, Charles H. Hennekens, Julie E. Buring. (2000) Baseline Characteristics of Participants in the Women's Health Study. Journal of Women's Health & Gender-Based Medicine 9:1, 19-27
CrossRef754
Yusuke KANKE, Masahiko IWAMA. (2000) Journal of the Food Hygienic Society of Japan (Shokuhin Eiseigaku Zasshi) 41:2, 95-108
CrossRef755
Eric B. Rimm, Meir J. Stampfer. (2000) ANTIOXIDANTS FOR VASCULAR DISEASE. Medical Clinics of North America 84:1, 239-249
CrossRef756
James E. Trosko, Chia Cheng Chang. (2000) Modulation of cell-cell communication in the cause and chemoprevention/chemotherapy of cancer. BioFactors 12:1-4, 259-263
CrossRef757
Dae Joong Kim, Nobuo Takasuka, Hoyoku Nishino, Hiroyuki Tsuda. (2000) Chemoprevention of lung cancer by lycopene. BioFactors 13:1-4, 95-102
CrossRef758
Frank L. Meyskens. (2000) Criteria for implementation of large and multiagent clinical chemoprevention trials. Journal of Cellular Biochemistry 77:S34, 115-120
CrossRef759
K Klipstein-Grobusch, L.J Launer, J.M Geleijnse, H Boeing, A Hofman, J.C.M Witteman. (2000) Serum carotenoids and atherosclerosis. Atherosclerosis 148:1, 49-56
CrossRef760
Dean E. Brenner. (2000) Multiagent chemopreventive agent combinations. Journal of Cellular Biochemistry 77:S34, 121-124
CrossRef761
I.-M. Lee, N. R. Cook, J. E. Manson, J. E. Buring, C. H. Hennekens. (1999) -Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. JNCI Journal of the National Cancer Institute 91:24, 2102-2106
CrossRef762
J. R. Marshall. (1999) -Carotene: a Miss for Epidemiology. JNCI Journal of the National Cancer Institute 91:24, 2068-2069
CrossRef763
Pierre H.M. van Golde, Lisette M. Sloots, Wim P. Vermeulen, Jos P.M. Wielders, Herman Ch. Hart, Bonno N. Bouma, Albert van de Wiel. (1999) The role of alcohol in the anti low density lipoprotein oxidation activity of red wine. Atherosclerosis 147:2, 365-370
CrossRef764
David L DeMets, Stuart J Pocock, Desmond G Julian. (1999) The agonising negative trend in monitoring of clinical trials. The Lancet 354:9194, 1983-1988
CrossRef765
Susan E. Lenhart, Jean M. Nappi. (1999) Vitamins for the Management of Cardiovascular Disease: A Simple Solution to a Complex Problem?. Pharmacotherapy 19:12, 1400-1414
CrossRef766
Paula F Inserra, Shuguang Jiang, David Solkoff, Jeongmin Lee, Zhen Zhang, Minjan Xu, Robert Hesslink, John Wise, Ronald R Watson. (1999) Immune Function in Elderly Smokers and Nonsmokers Improves During Supplementation with Fruit and Vegetable Extracts. Integrative Medicine 2:1, 3-10
CrossRef767
S. M. Lippman, P. H. Brown. (1999) Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost. JNCI Journal of the National Cancer Institute 91:21, 1809-1819
CrossRef768
Steven K. Clinton. (1999) The dietary antioxidant network and prostate carcinoma. Cancer 86:9, 1629-1631
CrossRef769
Stephan Fichtlscherer, Andreas M. Zeiher. (1999) Endotheliale Funktionsstörung bei Patienten mit akutem Koronarsyndrom. Herz 24:7, 534-543
CrossRef770
Jonathan M. Kurie. (1999) The biologic basis for the use of retinoids in cancer prevention and treatment. Current Opinion in Oncology 11:6, 497
CrossRef771
Nancy R. Cook, Meir J. Stampfer, Jing Ma, JoAnn E. Manson, Frank M. Sacks, Julie E. Buring, Charles H. Hennekens. (1999) ?-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 86:9, 1783-1792
CrossRef772
Martin J Kendall, Sarah L Nuttall. (1999) Anti-oxidant therapy for the treatment of coronary artery disease. Expert Opinion on Investigational Drugs 8:11, 1763-1784
CrossRef773
Garry G. Duthie. (1999) Determination of activity of antioxidants in human subjects. Proceedings of the Nutrition Society 58:04, 1015-1024
CrossRef774
JR Evans, K Henshaw, Jennifer Evans. 1999. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. .
CrossRef775
TAIK-KOO YUN. (1999) Update from Asia: Asian Studies on Cancer Chemoprevention. Annals of the New York Academy of Sciences 889:1 CANCER PREVEN, 157-192
CrossRef776
Noel W. Solomons. (1999) Giving a Bad Name to a Perfectly Good Nutrient. Nutrition Reviews 57:10, 327-328
CrossRef777
A. Tavani, C. La Vecchia. (1999) β-Carotene and risk of coronary heart disease. A review of observational and intervention studies. Biomedicine & Pharmacotherapy 53:9, 409-416
CrossRef778
GUIDO BIASCO, GIAN MARIA PAGANELLI. (1999) European Trials on Dietary Supplementation for Cancer Prevention. Annals of the New York Academy of Sciences 889:1 CANCER PREVEN, 152-156
CrossRef779
Alberico Luigi Catapano, Elena Tragni. (1999) Antioxidants and coronary artery disease. Current Atherosclerosis Reports 1:3, 221-229
CrossRef780
John C. Mathers, John Burn. (1999) Nutrition in cancer prevention. Current Opinion in Oncology 11:5, 402
CrossRef781
Deborah J. Bowen, Brenda Cartmel, Matt Barnett, Gary Goodman, Gilbert S. Omenn. (1999) Predictors of participant retention in two chemoprevention feasibility trials. Annals of Behavioral Medicine 21:3, 210-215
CrossRef782
V. Z. Lankin, A. K. Tikhaze, G. G. Konovalova, A. I. Kozachenko. (1999) Concentration-dependent inversion of antioxidant and prooxidant effects of β-carotene in tissuesin vivo. Bulletin of Experimental Biology and Medicine 128:3, 930-932
CrossRef783
Herbert S Rosenkranz. (1999) From mutagen hunter to genome defender, a change in paradigm. Mutation Research/Reviews in Mutation Research 437:2, 113-119
CrossRef784
Xiang-Dong Wang, Robert M. Russell. (1999) Procarcinogenic and Anticarcinogenic Effects of β-Carotene. Nutrition Reviews 57:9, 263-272
CrossRef785
S HERCBERG. (1999) ?THE SU.VI.MAX STUDY?: A Primary Prevention Trial using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers. Food and Chemical Toxicology 37:9-10, 925-930
CrossRef786
H. Gylling, P. Puska, E. Vartiainen, T.A. Miettinen. (1999) Retinol, vitamin D, carotenes and α-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine. Atherosclerosis 145:2, 279-285
CrossRef787
David A. Hughes. (1999) Effects of carotenoids on human immune function. Proceedings of the Nutrition Society 58:03, 713-718
CrossRef788
Mario Pirisi, Edda Federico, Nadia Bortolotti, Carlo Fabris, Edmondo Falleti, Giorgio Soardo, Fabio Gonano, Ettore Bartoli. (1999) Effect of eating on plasma radical-trapping antioxidant activity (TRAP) in patients with cirrhosis. Clinical Biochemistry 32:6, 447-453
CrossRef789
Carrie A. Redlich, Joyce S. Chung, Mark R. Cullen, William S. Blaner, Ariette M. Van Bennekum, Lars Berglund. (1999) Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 145:2, 425-432
CrossRef790
Dale A. Cooper, Alison L. Eldridge, John C. Peters. (1999) Dietary Carotenoids and Certain Cancers, Heart Disease, and Age-related Macular Degeneration: A Review of Recent Research. Nutrition Reviews 57:7, 201-214
CrossRef791
Monika Eichholzer, Brigitte Bisig. (1999) Ungen
CrossRef792
Charles S Lieber, Chaim S Abittan. (1999) Pharmacology and metabolism of alcohol, including its metabolic effects and interactions with other drugs. Clinics in Dermatology 17:4, 365-379
CrossRef793
MARIAN L NEUHOUSER, RUTH E PATTERSON, LISA LEVY. (1999) Motivations for Using Vitamin and Mineral Supplements. Journal of the American Dietetic Association 99:7, 851-854
CrossRef794
Ursula Arens. (1999) Vitamin and mineral supplementation. POSITION PAPER approved by the Council of the British Dietetic Association on 13 January 1999. Journal of Human Nutrition and Dietetics 12:3, 171-178
CrossRef795
(1999) Position of The American Dietetic Association and Dietitians of Canada. Journal of the American Dietetic Association 99:6, 738-751
CrossRef796
Robert M. Russell, Helen Rasmussen, Fada. (1999) The Impact of Nutritional Needs of Older Adults on Recommended Food Intakes. Nutrition in Clinical Care 2:3, 164-176
CrossRef797
Ittai Neuman, Hermona Nahum, Ami Ben-Amotz. (1999) Prevention of exercise-induced asthma by a natural isomer mixture of β-carotene. Annals of Allergy, Asthma & Immunology 82:6, 549-553
CrossRef798
Jayne V Woodside, Ian S Young, John W.G Yarnell, Heather E Roxborough, Dorothy McMaster, Evelyn E McCrum, K.Fred Gey, Alun Evans. (1999) Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial. Atherosclerosis 144:2, 419-427
CrossRef799
David I. Thurnham, Christine A. Northrop-Clewes. (1999) Optimal nutrition: vitamin A and the carotenoids. Proceedings of the Nutrition Society 58:02, 449-457
CrossRef800
Najla Guthrie, Kenneth K Carroll. (1999) Specific versus non-specific effects of dietary fat on carcinogenesis. Progress in Lipid Research 38:3, 261-271
CrossRef801
Dale A. Cooper, Alison L. Eldridge, John C. Peters. (1999) Dietary Carotenoids and Lung Cancer: A Review of Recent Research. Nutrition Reviews 57:5, 133-145
CrossRef802
Colleen Keller, Colleen Keller, Colleen Keller. (1999) Supplemental and Complementary Alternatives to Hormone Replacement Therapy. Journal of the American Academy of Nurse Practitioners 11:5, 187-198
CrossRef803
Helena Gylling, Tatu A. Miettinen. (1999) Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 48:5, 575-580
CrossRef804
Jarmo Virtamo. (1999) Vitamins and lung cancer. Proceedings of the Nutrition Society 58:02, 329-333
CrossRef805
Tammy R Dugas, Diane W Morel, Earl H Harrison. (1999) Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radical Biology and Medicine 26:9-10, 1238-1244
CrossRef806
Carrie A. Redlich, Joyce S. Chung, Mark R. Cullen, William S. Blaner, Ariette M. Van Bennekum, Lars Berglund. (1999) Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 143:2, 427-434
CrossRef807
Vince P Palace, Neelam Khaper, Qining Qin, Pawan K Singal. (1999) Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radical Biology and Medicine 26:5-6, 746-761
CrossRef808
Andrew R. Collins. (1999) Oxidative DNA damage, antioxidants, and cancer. BioEssays 21:3, 238-246
CrossRef809
David L. DeMets. (1999) Statistics and ethics in medical research. Science and Engineering Ethics 5:1, 97-117
CrossRef810
P Perocco, M Paolini, M Mazzullo, G.L Biagi, G Cantelli-Forti. (1999) β-Carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 440:1, 83-90
CrossRef811
E. Giovannucci. (1999) Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature. JNCI Journal of the National Cancer Institute 91:4, 317-331
CrossRef812
J. O. Boyle, J. Langenfeld, F. Lonardo, D. Sekula, P. Reczek, V. Rusch, M. I. Dawson, E. Dmitrovsky. (1999) Cyclin D1 Proteolysis: a Retinoid Chemoprevention Signal in Normal, Immortalized, and Transformed Human Bronchial Epithelial Cells. JNCI Journal of the National Cancer Institute 91:4, 373-379
CrossRef813
Fumio Furukawa, Akiyoshi Nishikawa, Ken-ichiro Kasahara, In-Seon Lee, Keiji Wakabayashi, Michihito Takahashi, Masao Hirose. (1999) Inhibition by beta-Carotene of Upper Respiratory Tumorigenesis in Hamsters Receiving Diethylnitrosamine Followed by Cigarette Smoke Exposure. Cancer Science 90:2, 154-161
CrossRef814
C. O. Granai. (1999) Expectations about alternative therapies and women with gynecological cancer. Current Opinion in Obstetrics and Gynaecology 11:1, 3-10
CrossRef815
William G. Christen, Julie E. Buring, JoAnn E. Manson, Charles H. Hennekens. (1999) Beta-carotene supplementation. Current Opinion in Lipidology 10:1, 29-34
CrossRef816
Epstein, Franklin H., , Ross, Russell, . (1999) Atherosclerosis — An Inflammatory Disease. New England Journal of Medicine 340:2, 115-126
Full Text817
R. Lotan. (1999) Lung Cancer Promotion by -Carotene and Tobacco Smoke: Relationship to Suppression of Retinoic Acid Receptor- and Increased Activator Protein-1?. JNCI Journal of the National Cancer Institute 91:1, 7-9
CrossRef818
D. Kromhout. 1999. Are Antioxidants Effective in Primary Prevention of Coronary Heart Disease?. , 20-26.
CrossRef819
J.T. Salonen. 1999. Aantioxidants, Lipid Peroxidation and Cardiovascular Diseases. , 3-8.
CrossRef820
I-Min Lee. (1999) Antioxidant Vitamins in the Prevention of Cancer. Proceedings of the Association of American Physicians 111:1, 10-15
CrossRef821
Maria G Salgo, Rafael Cueto, Gary W Winston, William A Pryor. (1999) Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radical Biology and Medicine 26:1-2, 162-173
CrossRef822
YISHAI LEVY. (1999) Antioxidant Vitamin Intake in Adolescent Israeli Girls. Journal of Nutritional and Environmental Medicine 9:1, 23-27
CrossRef823
Hadar Amir, Michael Karas, Judith Giat, Michael Danilenko, Rachel Levy, Tikva Yermiahu, Joseph Levy, Yoav Sharoni. (1999) Lycopene and 1,25‐dihydroxyvitamin d 3 cooperate in the inhibition of cell cycle progression and induction of differentiation in hl‐60 leukemic cells. Nutrition and Cancer 33:1, 105-112
CrossRef824
Monique Saintot, Nadine Bernard, Cecile Astre, Mariette Gerber, Inserm-crlc. (1999) Ozone Exposure and Blood Antioxidants: A Study in a Periurban Area in Southern France. Archives of Environmental Health: An International Journal 54:1, 34-39
CrossRef825
Andrew R. Collins. 1999. Oxidative Damage to DNA: A Likely Cause of Cancer?. , 417-422.
CrossRef826
D. Kromhout. (1999) Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective. Lipids 34:S1, S27-S31
CrossRef827
Joseph Levy, Michael Danilenko, Michael Karas, Hadar Amir, Amit Nahum, Yudit Giat, Yoav Sharoni. 1999. Mechanisms of Action of the Antioxidant Lycopene in Cancer. , 377-384.
CrossRef828
Lars Ovesen. (1999) Functional foods: some relevant considerations?. British Food Journal 101:10, 809-817
CrossRef829
Steven H. Zeisel, Rudolf I. Salganik. (1999) Antioxidants and nutrition support. Current Opinion in Clinical Nutrition and Metabolic Care 2:1, 1-3
CrossRef830
R Doll. (1999) The Pierre Denoix Memorial Lecture: Nature and nurture in the control of cancer. European Journal of Cancer 35:1, 16-23
CrossRef831
J. Michael Gaziano. (1999) Antioxidant Vitamins and Cardiovascular Disease. Proceedings of the Association of American Physicians 111:1, 2-9
CrossRef832
Betty Jane Burri, Andrew Clifford, Zisca Dixon. 1999. β-Carotene Normalizes Oxidative Damage in Carotenoid-Depleted Women. , 231-233.
CrossRef833
Henk Berg. (1999) Carotenoid Interactions. Nutrition Reviews 57:1, 1-10
CrossRef834
Christos Lionis, Åshild Faresjö, Melpomeni Skoula, Maria Kapsokefalou, Tomas Faresjö. (1998) Antioxidant effects of herbs in Crete. The Lancet 352:9145, 1987-1988
CrossRef835
Thomson, Hunt, Zorich. (1998) Review article: olestra and its gastrointestinal safety. Alimentary Pharmacology and Therapeutics 12:12, 1185-1200
CrossRef836
Andrew R Collins. (1998) Molecular epidemiology in cancer research. Molecular Aspects of Medicine 19:6, 359-432
CrossRef837
Agostino Faggiotto, Andrea Poli, Alberico Luigi Catapano. (1998) Antioxidants and coronary artery disease. Current Opinion in Lipidology 9:6, 541-549
CrossRef838
Elizabeth J Mayer-Davis, Ronny A Bell, Beth A Reboussin, Julia Rushing, Julie A Marshall, Richard F Hamman. (1998) Antioxidant nutrient intake and diabetic retinopathy. Ophthalmology 105:12, 2264-2270
CrossRef839
GILBERT S OMENN. (1998) An Assessment of the Scientific Basis for Attempting to Define the Dietary Reference Intake for Beta Carotene. Journal of the American Dietetic Association 98:12, 1406-1409
CrossRef840
JOSEPH KOLARS, CANDACE KURTH. (1998) Influence of diet, vitamins and chemotherapeutic agents on gastrointestinal cancer. Journal of Gastroenterology and Hepatology 13:11-s4, S173-S177
CrossRef841
Wilson H. Miller. (1998) The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83:8, 1471-1482
CrossRef842
David Wood, Guy De Backer, Ole Faergeman, Ian Graham, Giuseppe Mancia, Kalevi Pyörälä. (1998) Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2. Atherosclerosis 140:2, 199-270
CrossRef843
C ROCK. (1998) NUTRITIONAL FACTORS IN CANCER PREVENTION. Hematology/Oncology Clinics of North America 12:5, 975-991
CrossRef844
S. Bradley, R. Shinton. (1998) Why is there an association between eating fruit and vegetables and a lower risk of stroke?. Journal of Human Nutrition and Dietetics 11:5, 363-372
CrossRef845
M YOU, G BERGMAN. (1998) PRECLINICAL AND CLINICAL MODELS OF LUNG CANCER CHEMOPREVENTION. Hematology/Oncology Clinics of North America 12:5, 1037-1053
CrossRef846
F MEYSKENSJR. (1998) PRINCIPLES OF HUMAN CHEMOPREVENTION. Hematology/Oncology Clinics of North America 12:5, 935-941
CrossRef847
Koyamangalath Krishnan, Mack T. Ruffin, Dean E. Brenner. (1998) CLINICAL MODELS OF CHEMOPREVENTION FOR COLON CANCER. Hematology/Oncology Clinics of North America 12:5, 1079-1113
CrossRef848
Paola Palozza. (1998) Prooxidant Actions of Carotenoids in Biologic Systems. Nutrition Reviews 56:9, 257-265
CrossRef849
KIM M OLDHAM, PHYLLIS E BOWEN. (1998) Oxidative Stress in Critical Care. Journal of the American Dietetic Association 98:9, 1001-1008
CrossRef850
Andrew R Collins, Katarı́na Rašlová, Martina Somorovská, Helena Petrovská, Adriana Ondrušová, Branislav Vohnout, Radoslav Fábry, Mária Dušinská. (1998) DNA Damage in Diabetes: Correlation with a Clinical Marker. Free Radical Biology and Medicine 25:3, 373-377
CrossRef851
Ami Ben-Amotz, Rachel Fishier. (1998) Analysis of carotenoids with emphasis on 9-cis β-carotene in vegetables and fruits commonly consumed in Israel. Food Chemistry 62:4, 515-520
CrossRef852
A.Maziar Zafari, Nanette K. Wenger. (1998) Secondary prevention of coronary heart disease. Archives of Physical Medicine and Rehabilitation 79:8, 1006-1017
CrossRef853
A. T. Diplock, J.-L. Charuleux, G. Crozier-Willi, F. J. Kok, C. Rice-Evans, M. Roberfroid, W. Stahl, J. Viña-Ribes. (1998) Functional food science and defence against reactive oxidative species. British Journal of Nutrition 80:S1, S77
CrossRef854
&NA; Ylä-Herttuala. (1998) Is oxidized low‐density lipoprotein present in vivo?. Current Opinion in Lipidology 9:4, 337-344
CrossRef855
S Hercberg. (1998) A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General Population The SU.VI.MAX Study—Design, Methods, and Participant Characteristics. Controlled Clinical Trials 19:4, 336-351
CrossRef856
Aminah Jatoi, Benedict D.T. Daly, Gertrude Kramer, Joel B. Mason. (1998) A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients. Journal of Surgical Oncology 68:4, 231-236
CrossRef857
S. E. Gariballa, A. J. Sinclair. (1998) Nutrition, ageing and ill health. British Journal of Nutrition 80:01, 7
CrossRef858
Serge Hercberg, Pilar Galan, Paul Preziosi, Maria-Jose Alfarez, Clotilde Vazquez. (1998) The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers. Nutrition 14:6, 513-520
CrossRef859
Takashi Sugimura. (1998) Cancer prevention: past, present, future. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 402:1-2, 7-14
CrossRef860
Donald D. Hensrud, Douglas C. Heimburger. (1998) DIET, NUTRIENTS, AND GASTROINTESTINAL CANCER. Gastroenterology Clinics of North America 27:2, 325-346
CrossRef861
K Liede, J Hietanen, L Saxen, J Haukka, T Timonen, R Hayrinen-Immonen, OP Heinonen. (1998) Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers. Oral Diseases 4:2, 78-83
CrossRef862
Gilbert S. Omenn. (1998) CHEMOPREVENTION OF LUNG CANCER: The Rise and Demise of Beta-Carotene. Annual Review of Public Health 19:1, 73-99
CrossRef863
M.Cristina Leske, Leo T Chylack, Qimei He, Suh-Yuh Wu, Elinor Schoenfeld, Judith Friend, John Wolfe. (1998) Antioxidant vitamins and nuclear opacities. Ophthalmology 105:5, 831-836
CrossRef864
Francis R Heller, Olivier Descamps, Jean-Claude Hondekijn. (1998) LDL oxidation: therapeutic perspectives. Atherosclerosis 137, S25-S31
CrossRef865
M Mathews-Roth. (1998) Treatment of the Cutaneous Porphyrias. Clinics in Dermatology 16:2, 295-298
CrossRef866
Steven K. Clinton. (1998) Lycopene: Chemistry, Biology, and Implications for Human Health and Disease. Nutrition Reviews 56:2, 35-51
CrossRef867
B Valanis, DrPH. (1998) Mailing Strategies and Costs of Recruiting Heavy Smokers in CARET, a Large Chemoprevention Trial. Controlled Clinical Trials 19:1, 25-38
CrossRef868
Kedar N. Prasad, William Cole, Peter Hovland. (1998) Cancer prevention studies: Past, present, and future directions. Nutrition 14:2, 197-210
CrossRef869
Okezie I. Aruoma. (1998) Free radicals, oxidative stress, and antioxidants in human health and disease. Journal of the American Oil Chemists' Society 75:2, 199-212
CrossRef870
Elke Konings, E.Robert Greenberg. (1998) Antioxidant supplements and colorectal cancer. Nutrition 14:2, 245-247
CrossRef871
Paul A. Lachance. (1998) Cancer prevention studies—Past, present, and future directions. Nutrition 14:2, 237-238
CrossRef872
L Repetto, C Granetto, A Venturino, M Aapro. (1998) Screening and chemoprevention. Critical Reviews in Oncology/Hematology 27:2, 111-115
CrossRef873
Nicholas H. de Klerk, A. William Musk, Gina L. Ambrosini, Jan L. Eccles, Janice Hansen, Nola Olsen, V. Lynne Watts, Helen G. Lund, S. C. Pang, John Beilby, Michael S. T. Hobbs. (1998) Vitamin A and cancer prevention II: Comparison of the effects of retinol and β-carotene. International Journal of Cancer 75:3, 362-367
CrossRef874
A. William Musk, Nicholas H. de Klerk, Gina L. Ambrosini, Jan L. Eccles, Janice Hansen, Nola J. Olsen, V. Lynne Watts, Helen G. Lund, S. C. Pang, John Beilby, Michael S. T. Hobbs. (1998) Vitamin A and cancer prevention I: Observations in workers previously exposed to asbestos at Wittenoom, Western Australia. International Journal of Cancer 75:3, 355-361
CrossRef875
P. Marmillot, S. Satchithanandam, Q. H. Liu, M. R. Lakshman. (1998) Taurocholate stimulates the absorption and biotransformation of β-carotene in intact and lymph duct-cannulated ferrets. Nutrition and Cancer 31:1, 18-23
CrossRef876
Makoto Mino. (1998) A personal overview of vitamin E research. BioFactors 7:1-2, 175-179
CrossRef877
K. Fred Gey. (1998) Vitamins E plus C and interacting conutrients required for optimal health. BioFactors 7:1-2, 113-174
CrossRef878
Andreas Gescher, Ugo Pastorino, Simon M. Plummer, Margaret M. Manson. (1998) Suppression of tumour development by substances derived from the diet-mechanisms and clinical implications. British Journal of Clinical Pharmacology 45:1, 1-12
CrossRef879
Anna R. Giuliano, Susan Gapstur. (1998) Can Cervical Dysplasia and Cs Nutrients?. Nutrition Reviews 56:1, 9-16
CrossRef880
Reina Garcia-Closas, Antonio Agudo, Carlos Gonzalez, Elio Riboli. (1998) Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutrition and Cancer 32:3, 154-158
CrossRef881
Homer S. Black. (1998) Radical interception by carotenoids and effects on UV carcinogenesis. Nutrition and Cancer 31:3, 212-217
CrossRef882
A Simonne. (1997) Ascorbic Acid and Provitamin A Contents in Unusually Colored Bell Peppers (Capsicum annuumL.). Journal of Food Composition and Analysis 10:4, 299-311
CrossRef883
Manuel Sandoval, Robert A. Ronzio, Dave N. Muanza, David A. Clark, Mark J.S. Miller. (1997) Peroxynitrite-Induced Apoptosis in Epithelial (T84) and Macrophage (RAW 264.7) Cell Lines: Effect of Legume-Derived Polyphenols (Phytolens). Nitric Oxide 1:6, 476-483
CrossRef884
STEPHEN S. HECHT. (1997) Tobacco and Cancer: Approaches Using Carcinogen Biomarkers and Chemoprevention. Annals of the New York Academy of Sciences 833:1 Cancer, 91-111
CrossRef885
Vladimir Krutovskikh, Makoto Asamoto, Nobuo Takasuka, Michiaki Murakoshi, Hoyoku Nishino, Hiroyuki Tsuda. (1997) Differential Dose-dependent Effects of alpha-, beta-Carotenes and Lycopene on Gap-junctional Intercellular Communication in Rat Liver in vivo. Cancer Science 88:12, 1121-1124
CrossRef886
Damiano Baldassarre, Guido Franceschini, Giulia Peruzzotti, Bruno Brusoni, Cesare R. Sirtori. (1997) Clinical Evaluation of Probucol in Hypercholesterolemia: Individual Lipoprotein Responses and Inhibitory Effect on Carotid Atherosclerosis Progression. Journal of Cardiovascular Pharmacology 30:6, 784-789
CrossRef887
R EDGE, D MCGARVEY, T TRUSCOTT. (1997) The carotenoids as anti-oxidants — a review. Journal of Photochemistry and Photobiology B: Biology 41:3, 189-200
CrossRef888
A Mortensen. (1997) Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Letters 418:1-2, 91-97
CrossRef889
Dae Joong Kim, Nobuo Takasuka, Jin Man Kim, Kazunori Sekine, Tomonori Ota, Makoto Asamoto, Michiaki Murakoshi, Hoyoku Nishino, Zohar Nir, Hiroyuki Tsuda. (1997) Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Letters 120:1, 15-22
CrossRef890
Garry J. Handelman. (1997) High-Dose Vitamin Supplements for Cigarette Smokers: Caution Is Indicated. Nutrition Reviews 55:10, 369-370
CrossRef891
Helen J. Palmer, K. Eric Paulson. (1997) Reactive Oxygen Species and Antioxidants in Signal Transduction and Gene Expression. Nutrition Reviews 55:10, 353-361
CrossRef892
L.P.L. van de Vijver, A.F.M. Kardinaal, D.E. Grobbee, H.M.G. Princen, G. van Poppel. (1997) Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence. Prostaglandins, Leukotrienes and Essential Fatty Acids 57:4-5, 479-487
CrossRef893
Cheryl L. Rock. (1997) Carotenoids: Biology and treatment. Pharmacology & Therapeutics 75:3, 185-197
CrossRef894
Susan Murin, Janet Hilbert, Sharon J. Reilly. (1997) Cigaret smoking and the lung. Clinical Reviews in Allergy & Immunology 15:3, 307-361
CrossRef895
Lori Mosca, Melvyn Rubenfire, Caroline Mandel, Cheryl Rock, Tom Tarshis, Alan Tsai, Thomas Pearson. (1997) Antioxidant Nutrient Supplementation Reduces the Susceptibility of Low Density Lipoprotein to Oxidation in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 30:2, 392-399
CrossRef896
A Agudo. (1997) Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain. European Journal of Cancer 33:8, 1256-1261
CrossRef897
Charles H. Hennekens. (1997) β-Carotene supplementation and cancer prevention. Nutrition 13:7-8, 697-699
CrossRef898
. (1997) Antioxiderende vitamines, cardiovasculaire ziekten en kanker. Medisch-Farmaceutische Mededelingen 35:7, 130-131
CrossRef899
Seymour L. Romney, Gloria Y.F. Ho, Prabhudas R. Palan, Jayasri Basu, Anna S. Kadish, Sara Klein, Magdy Mikhail, Robert J. Hagan, Chee Jen Chang, Robert D. Burk. (1997) Effects of β-Carotene and Other Factors on Outcome of Cervical Dysplasia and Human Papillomavirus Infection. Gynecologic Oncology 65:3, 483-492
CrossRef900
Frances A. Shepherd. (1997) Alternatives to chemotherapy and radiotherapy as adjuvant treatment for lung cancer. Lung Cancer 17, S121-S136
CrossRef901
Nigel Stephens. (1997) Anti-oxidant therapy for ischaemic heart disease: where do we stand?. The Lancet 349:9067, 1710-1711
CrossRef902
F KHURI, J KURIE, W HONG. (1997) CHEMOPREVENTION OF RESPIRATORY TRACT CANCER. Hematology/Oncology Clinics of North America 11:3, 387-408
CrossRef903
Janne M Rapola, Jarmo Virtamo, Samuli Ripatti, Jussi K Huttunen, Demetrius Albanes, Philip R Taylor, Olli P Heinonen. (1997) Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. The Lancet 349:9067, 1715-1720
CrossRef904
Eijiro Okajima, Seiichiro Ozono, Takehiro Endo, Toshimitsu Majima, Masahiro Tsutsumi, Tomokazu Fukuda, Hiroyuki Akai, Ayumi Denda, Yoshihiko Hirao, Eigoro Okajima, Hoyoku Nishino, Zohar Nir, Yoichi Konishi. (1997) Chemopreventive Efficacy of Piroxicam Administered Alone or in Combination with Lycopene and beta-Carotene on the Development of Rat Urinary Bladder Carcinoma after A N-Butyl-N-(4-hydroxybutyl)nitrosamine Treatment. Cancer Science 88:6, 543-552
CrossRef905
Margarita M. Sotelo, Susan R. Johnson. (1997) THE EFFECTS OF HORMONE REPLACEMENT THERAPY ON CORONARY HEART DISEASE. Endocrinology & Metabolism Clinics of North America 26:2, 313-328
CrossRef906
H. Park, P. A. Seib, O. K. Chung, L. M. Seitz. (1997) Fortifying Bread with Each of Three Antioxidants 1. Cereal Chemistry 74:3, 202-206
CrossRef907
Michael Osborne, Peter Boyle, Martin Lipkin. (1997) Cancer prevention. The Lancet 349, S27-S30
CrossRef908
Takuji Tanaka. (1997) Chemo
revention of human cancer: biology and therapy. Critical Reviews in Oncology/Hematology 25:3, 139-174
CrossRef909
VICTOR HERBERT. (1997) The Value of Antioxidant Supplements vs their Natural Counterparts. Journal of the American Dietetic Association 97:4, 375
CrossRef910
David I. Thurnham. (1997) Antioxidants in healthy elderly Parisians. Nutrition 13:4, 377-378
CrossRef911
CHERYL L. ROCK, ROBERTA. JACOB, PHYLLIS E. BOWEN. (1997) Authors' Reply. Journal of the American Dietetic Association 97:4, 375-376
CrossRef912
Yoshitaka Tsubono, Shunji Okubo, Masato Hayashi, Tadao Kakizoe, Shoichiro Tsugane. (1997) A Randomized Controlled Trial for Chemoprevention of Gastric Cancer in High-risk Japanese Population; Study Design, Feasibility and Protocol Modification. Cancer Science 88:4, 344-349
CrossRef913
Michael J. Wargovich. (1997) Experimental evidence for cancer preventive elements in foods. Cancer Letters 114:1-2, 11-17
CrossRef914
O. Korver. (1997) ‘Healthy’ developments in the food industry. Cancer Letters 114:1-2, 19-23
CrossRef915
J. V. Woodside, I. S. Young, J. W. G. Yarnell, D. McMaster, A. E. Evans. (1997) The effects of oral vitamin supplementation on cardiovascular risk factors. Proceedings of the Nutrition Society 56:1B, 479-488
CrossRef916
John D. Potter. (1997) β-Carotene and the role of intervention studies. Cancer Letters 114:1-2, 329-331
CrossRef917
Matti Rautalahti, Demetrius Albanes, Jarmo Virtamo, Philip R. Taylor, Jussi K. Huttunen, Olli P. Heinonen. (1997) Beta-carotene did not work: aftermath of the ATBC study. Cancer Letters 114:1-2, 235-236
CrossRef918
Andrew Arnold. (1997) Moving promising research findings to the clinic: Methodological issues in the design and conduct of clinical trials of retinoids. International Journal of Cancer 70:4, 467-469
CrossRef919
Takuji Tanaka. (1997) Effect of diet on human carcinogenesis. Critical Reviews in Oncology/Hematology 25:2, 73-95
CrossRef920
Pierre Astorg, Sandra Gradelet, Joel Leclerc, Marie-Helene Siess. (1997) Effects of provitamin a or non-provitamin a carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutrition and Cancer 27:3, 245-249
CrossRef921
Linda C. Koo. (1997) Diet and lung cancer 20+ years later: More questions than answers?. International Journal of Cancer 71:S10, 22-29
CrossRef922
Paola Palozza, Gabriella Calviello, Simona Serini, Piera Moscato, Chiara Luberto, Gianna Maria Bartoli. (1997) Antitumor effect of an oral administration of canthaxanthin on BALB/c mice bearing thymoma cells. Nutrition and Cancer 28:2, 199-205
CrossRef923
Curtis Mettlin. (1997) Chemoprevention: Will it work?. International Journal of Cancer 71:S10, 18-21
CrossRef924
Janusz Pawlęga, Jadwiga Rachtan, Tadeusz Dyba. (1997) Evaluation of Certain Risk Factors for Lung Cancer in Cracow (Poland): A Case-Control Study. Acta Oncologica 36:5, 471-476
CrossRef925
Julie E. Buring, Charles H. Hennekens. (1997) Antioxidant Vitamins and Cardiovascular Disease. Nutrition Reviews 55:1, S53-S58
CrossRef926
Pierre Astorg, Sandra Gradelet, Raymond Berges, Marc Suschetet. (1997) Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutrition and Cancer 29:1, 60-68
CrossRef927
William Cole, Kedar Prasad. (1997) Contrasting effects of vitamins as modulators of apoptosis in cancer cells and normal cells: A review. Nutrition and Cancer 29:2, 97-103
CrossRef928
Youping He, Martin Root, Robert Parker, T. Colin Campbell. (1997) Effects of carotenoid-rich food extracts on the development of preneoplastic lesions in rat liver and on in vivo and in vitro antioxidant status. Nutrition and Cancer 27:3, 238-244
CrossRef929
Joel Schwartz, Gerald Shklar. (1997) Retinoid and carotenoid angiogenesis: A possible explanation for enhanced oral carcinogenesis. Nutrition and Cancer 27:2, 192-199
CrossRef930
Luc Thiberville, Peter Payne, Josette Metayer, Jüergen Vielkinds, Jean Leriche, Branko Palcic, Stephen Lam. (1997) Molecular follow-up of a preinvasive bronchial lesion treated by 13-CIS-retinoic acid. Human Pathology 28:1, 108-110
CrossRef931
(1996) Lack of effect of beta-carotene on incidence of cancer and CV disease. Focus on Alternative and Complementary Therapies 1:1, 24-25
CrossRef932
Koyamangalath Krishnan, Dean E. Brenner. (1996) CHEMOPREVENTION OF COLORECTAL CANCER. Gastroenterology Clinics of North America 25:4, 821-858
CrossRef933
Aurel P. Lupulescu. (1996) Hormones, vitamins, and growth factors in cancer treatment and prevention: A critical appraisal. Cancer 78:11, 2264-2280
CrossRef934
G S Omenn. (1996) Comment: genetics and public health.. American Journal of Public Health 86:12, 1701-1704
CrossRef935
Committee Members, Thomas J. Ryan, Jeffrey L. Anderson, Elliott M. Antman, Blaine A. Braniff, Neil H. Brooks, Robert M. Califf, L. David Hillis, Loren F. Hiratzka, Elliott Rapaport, Barbara J. Riegel, Richard O. Russell, Earl E. Smith, W. Douglas Weaver, James L. Ritchie, Melvin D. Cheitlin, Kim A. Eagle, Timothy J. Gardner, Arthur Garson, Raymond J. Gibbons, Richard P. Lewis, Robert A. O'Rourke, Thomas J. Ryan. (1996) ACC/AHA guidelines for the management of patients with acute myocardial infarction. Journal of the American College of Cardiology 28:5, 1328-1419
CrossRef936
(1996) Antioxidant Vitamins, Cancer, and Cardiovascular Disease. New England Journal of Medicine 335:14, 1065-1069
Full Text937
G PASCAL. (1996) Des aliments fonctionnels pour demain?. Biofutur 1996:160, 27-30
CrossRef938
Juan Sastre, Federico V. Pallardó, Jose Viña. (1996) Glutathione, oxidative stress and aging. AGE 19:4, 129-139
CrossRef939
James H. O'Keefe, Robert D. Conn, Carl J. Lavie, Timothy M. Bateman. (1996) The New Paradigm for Coronary Artery Disease: Altering Risk Factors, Atherosclerotic Plaques, and Clinical Prognosis. Mayo Clinic Proceedings 71:10, 957-965
CrossRef940
J.Michael Gaziano. (1996) Antioxidants in cardiovascular disease: Randomized trials. Nutrition 12:9, 583-588
CrossRef941
J. Michael Gaziano. (1996) Antioxidants in Cardiovascular Disease: Randomized Trials. Nutrition Reviews 54:6, 175-177
CrossRef942
Luigi M. Luca, Sharon A. Ross. (1996) Beta-Carotene Increases Lung Cancer Incidence in Cigarette Smokers. Nutrition Reviews 54:6, 178-180
CrossRef943
John W. Erdman. (1996) Beta-Carotene and the Carotenoids: Beyond the Intervention Trials. Nutrition Reviews 54:6, 185-188
CrossRef944
Greenberg, E. Robert, Sporn, Michael B., . (1996) Antioxidant Vitamins, Cancer, and Cardiovascular Disease. New England Journal of Medicine 334:18, 1189-1190
Full Text945
Hennekens, Charles H., Buring, Julie E., Manson, JoAnn E., Stampfer, Meir, Rosner, Bernard, Cook, Nancy R., Belanger, Charlene, LaMotte, Frances, Gaziano, J. Michael, Ridker, Paul M., Willett, Walter, Peto, Richard, . (1996) Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease. New England Journal of Medicine 334:18, 1145-1149
Full Text946
(1996) Clinical development plan: Vitamin A. Journal of Cellular Biochemistry 63:S26, 269-307
CrossRef947
(1996) Review. Clinical Chemistry and Laboratory Medicine 34:8, 599-608
CrossRef
- Letters
